首页 » 细胞株Cell Lines 98及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 98及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV98
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   Tu 212

AC   CVCL_4915

SY   Tu-212; Tu212

DR   BioSample; SAMN03151960

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T20 ! T404

OI   CVCL_1T19 ! T406 [Human HNSCC]

OI   CVCL_4910 ! Tu 138

OI   CVCL_1T17 ! Tu 158LN

OI   CVCL_4911 ! Tu 159

OI   CVCL_4914 ! Tu 182

OI   CVCL_1T18 ! Tu 212LN

CA   Cancer cell line

//

ID   Tu 212LN

AC   CVCL_1T18

SY   Tu-212LN

DR   BioSample; SAMN03151961

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 8,9

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T20 ! T404

OI   CVCL_1T19 ! T406 [Human HNSCC]

OI   CVCL_4910 ! Tu 138

OI   CVCL_1T17 ! Tu 158LN

OI   CVCL_4911 ! Tu 159

OI   CVCL_4914 ! Tu 182

OI   CVCL_4915 ! Tu 212

CA   Cancer cell line

//

ID   Tu 686

AC   CVCL_4916

SY   Tu-686; Tu686

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Tu To

AC   CVCL_3328

DR   CLO; CLO_0009445

DR   ATCC; CRL-1298

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   TU-1

AC   CVCL_M530

RX   PubMed=10936422;

RX   PubMed=11818668;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Tu-2449

AC   CVCL_D318

SY   TU2449

RX   PubMed=9160879;

RX   PubMed=10493969;

DI   NCIt; C21932; Mouse astrocytic tumours

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   TU-ECS-1

AC   CVCL_IP26

RX   PubMed=27889902;

CC   Doubling time: 18.2 +- 2.1 hours (PubMed=27889902).

DI   NCIt; C42700; Uterine carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-MM-1

AC   CVCL_1G72

RX   PubMed=26070481;

CC   Doubling time: 67.9 hours (PubMed=26070481).

CC   Omics: Deep exome analysis.

CC   Omics: Genome sequenced.

DI   NCIt; C7633; Peritoneal mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-OC-1

AC   CVCL_L700

SY   TUOC1

DR   Cosmic; 1889261

RX   PubMed=23430509;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 38.4 +- 3.5 hours (PubMed=23430509).

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-OC-2

AC   CVCL_HE46

RX   PubMed=26960408;

CC   Characteristics: Does not express ARID1A.

CC   Doubling time: 37.5 +- 3.3 hours (PubMed=26960408).

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-OM-1

AC   CVCL_W127

SY   TUOM-1

DR   Cosmic; 2429305

RX   PubMed=19154404;

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-OS-3

AC   CVCL_K033

SY   TUOS-3

RX   PubMed=21610153;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TU-OS-4

AC   CVCL_K032

SY   TUOS-4

RX   PubMed=21610153;

RX   PubMed=23274876;

CC   Doubling time: 53.3 +- 8.1 hours (PubMed=23274876).

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Tu167LN1

AC   CVCL_1Q85

RX   PubMed=12907203;

CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4912 ! Tu 167

SX   Male

CA   Cancer cell line

//

ID   TUAT-BME-11

AC   CVCL_Z083

SY   BME-11

RX   DOI=10.1303/aez.29.604;

CC   Group: Insect cell line.

CC   Breed/subspecies: Kuroko.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TUAT-BME-15

AC   CVCL_Z084

SY   BME-15

RX   DOI=10.1303/aez.29.604;

CC   Group: Insect cell line.

CC   Breed/subspecies: Kuroko.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TUAT-SpLi-221

AC   CVCL_Z519

SY   TUAT-SpLi221; SpLi-221; SpLi221

DR   CLO; CLO_0050004

DR   NISES; SK0016

DR   RCB; RCB0406

RX   DOI=10.1303/aez.30.75;

RX   PubMed=10358729;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275023

CC   Group: Insect cell line.

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Female

CA   Spontaneously immortalized cell line

//

ID   TUB-4D

AC   CVCL_GZ11

RX   PubMed=2842332;

WW   http://icoregon.technologypublisher.com/technology/18058

CC   Selected for resistance to: ChEBI; CHEBI:48267; Tubercidin (7-deazaadenosine).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   TUBO [Human B-cell 10IHW]

AC   CVCL_E858

DR   dbMHC; 49048

DR   ECACC; 88052045

DR   IHW; IHW9045

DR   IMGT/HLA; 11502

WW   http://bioinformatics.hsanmartino.it/ecbr/cl45.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   TUBO [Mouse mammary tumor]

AC   CVCL_2A33

SY   Turin-Bologna

DR   EFO; EFO_0006306

RX   PubMed=11046045;

WW   https://cancermodels.nci.nih.gov/camod/ViewModelAction.do?unprotected_method=populateCellLines&aModelID=448

CC   Breed/subspecies: BALB-neuT.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   TUBO-P2J

AC   CVCL_2A34

RX   PubMed=25179116;

WW   http://www.ifmsa.org/About-Us/Our-Members/Asia-Pacific/KMSA/Projects/Characterization-of-Novel-Mouse-Breast-Cancer-Cell-Line-for-Spontaneous-Metatasis-focused-on-EMT

CC   Breed/subspecies: BALB-neuT.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2A33 ! TUBO [Mouse mammary tumor]

SX   Female

CA   Cancer cell line

//

ID   Tucker-HSA

AC   CVCL_0D01

SY   TUCKER

RX   PubMed=19461996;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C122783; Canine hemangiosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   TuD-1

AC   CVCL_5638

SY   TuD1

DR   IFO; IFO50103

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-1

AC   CVCL_M862

SY   TuD1-1

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-10

AC   CVCL_M871

SY   TuD1-10

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-2

AC   CVCL_M868

SY   TuD1-2

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-3

AC   CVCL_5639

SY   TuD1-3

DR   IFO; IFO50152

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-5

AC   CVCL_5640

SY   TuD1-5

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-7

AC   CVCL_M869

SY   TuD1-7

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TuD-1-9

AC   CVCL_M870

SY   TuD1-9

RX   PubMed=2384449;

CC   Breed/subspecies: ACI/NM.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5638 ! TuD-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   TUHR10TKB

AC   CVCL_5952

SY   TUHR-10TKB

DR   BTO; BTO:0003732

DR   CLO; CLO_0050896

DR   BioSample; SAMN03472180

DR   CCLE; TUHR10TKB_KIDNEY

DR   GEO; GSM887715

DR   GEO; GSM888808

DR   RCB; RCB1275

RX   PubMed=17284252;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 14

ST   D16S539: 13

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TUHR14TKB

AC   CVCL_5953

SY   TUHR-14TKB; 14T

DR   BTO; BTO:0003730

DR   CLO; CLO_0050897

DR   BioSample; SAMN03472133

DR   CCLE; TUHR14TKB_KIDNEY

DR   GEO; GSM887716

DR   GEO; GSM888809

DR   RCB; RCB1383

RX   PubMed=14534724;

RX   PubMed=15604581;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TUHR16TKB

AC   CVCL_5954

SY   TUHR-16TKB

DR   BTO; BTO:0003733

RX   PubMed=17284252;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TUHR25TKB

AC   CVCL_5955

SY   TUHR-25TKB

DR   BTO; BTO:0003735

DR   RCB; RCB1680

RX   PubMed=17284252;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TUHR3TKB

AC   CVCL_5956

SY   TUHR-3TKB

DR   CLO; CLO_0050895

DR   BioSample; SAMN03472175

DR   RCB; RCB1187

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D16S539: 10,12

ST   D5S818: 10,11

ST   D7S820: 9,10

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 18,19

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TUHR4TKB

AC   CVCL_5957

SY   TUHR-4TKB; 4TUHR; 4T

DR   BTO; BTO:0003729

DR   CLO; CLO_0050898

DR   BioSample; SAMN03472178

DR   CCLE; TUHR4TKB_KIDNEY

DR   GEO; GSM887717

DR   GEO; GSM888810

DR   RCB; RCB1198

RX   PubMed=14534724;

RX   PubMed=15604581;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 12,13

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TUR

AC   CVCL_1775

SY   TPA-U937-resistant

DR   CLO; CLO_0009447

DR   ATCC; CRL-2367

DR   BioSample; SAMN03471833

DR   ChEMBL-Cells; CHEMBL3308519

DR   ChEMBL-Targets; CHEMBL2366218

DR   Cosmic; 683549

DR   Cosmic; 909773

DR   Cosmic-CLP; 909773

DR   GDSC; 909773

DR   GEO; GSM186464

DR   GEO; GSM1670551

RX   PubMed=7720732;

RX   PubMed=8398907;

RX   PubMed=27397505;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   TuWi

AC   CVCL_8275

SY   Tu Wi

DR   ATCC; CCL-31

DR   BioSample; SAMN03151763

RX   PubMed=566722;

RX   PubMed=1246601;

RX   PubMed=6451928;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a Wilms tumor.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Discontinued: ATCC; CCL-31; true.

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   TV-1

AC   CVCL_R817

SY   Turbot Vigo-1

RX   CelloPub=CLPUB00121;

CC   Group: Fish cell line.

OX   NCBI_TaxID=52904; ! Scophthalmus maximus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   TVGH-iPSC-01-04

AC   CVCL_GT31

DR   BCRC; SC81032

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   TVGH-iPSC-02-07

AC   CVCL_GT32

DR   BCRC; SC81033

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TVMBO

AC   CVCL_M220

RX   PubMed=11121133;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TW

AC   CVCL_F585

SY   TER253

DR   IMGT/HLA; 11856

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   TW-EBV-LCL

AC   CVCL_J444

DR   CLO; CLO_0050984

DR   BioSample; SAMN03472141

DR   RCB; RCB1438

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 10,14

ST   D7S820: 11,12

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   TW1

AC   CVCL_Y013

SY   hESC-TW1

DR   BCRC; hESC-TW1

DR   BCRC; SC81001

RX   PubMed=18765016;

CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   TW2

AC   CVCL_Y014

RX   PubMed=18765016;

CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   TW2.6

AC   CVCL_GZ05

RX   PubMed=17070096;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TW3

AC   CVCL_Y015

DR   BCRC; SC81003

RX   PubMed=18765016;

CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   TW4

AC   CVCL_Y016

RX   PubMed=18765016;

CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   TW5

AC   CVCL_Y017

DR   BCRC; SC81005

RX   PubMed=18765016;

CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   TWERC

AC   CVCL_7704

DR   CLO; CLO_0009448

DR   CLDB; cl4574

RX   PubMed=4107530;

CC   Transformant: NCBI_TaxID; 11888; Rous sarcoma virus (strain Prague C).

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_7881 ! WERC

CA   Transformed cell line

//

ID   Twin-DS-iPSC

AC   CVCL_W088

RX   PubMed=24375627;

CC   Miscellaneous: Twin-DS-iPSC and Twin-N-iPSC (CVCL_W087) originate from monozygotic twins discordant for trisomy 21.

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   Twin-N-iPSC

AC   CVCL_W087

RX   PubMed=24375627;

CC   Miscellaneous: Twin-DS-iPSC (CVCL_W088) and Twin-N-iPSC originate from monozygotic twins discordant for trisomy 21.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   TWNT-1

AC   CVCL_J364

DR   JCRB; JCRB1582

RX   PubMed=12811248;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P42212; GFP.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 12

ST   D16S539: 9,10

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3800; Epithelioid hemangioendothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0390 ! LI90

SX   Female

CA   Telomerase immortalized cell line

//

ID   TWNT-4

AC   CVCL_W296

RX   PubMed=12953924;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C3800; Epithelioid hemangioendothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0390 ! LI90

SX   Female

CA   Telomerase immortalized cell line

//

ID   TX-7F

AC   CVCL_K256

DR   CLO; CLO_0050324

DR   RCB; RCB1856

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   TX-LY-172h

AC   CVCL_AQ50

RX   PubMed=26080839;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TX3.833

AC   CVCL_U756

SY   TX3-833

DR   ATCC; CRL-13013

RX   PubMed=11854497;

CC   Discontinued: ATCC; CRL-13013; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Tx3095

AC   CVCL_6853

SY   TX3095

RX   PubMed=16061850;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Tx3868

AC   CVCL_6854

SY   TX3868

DR   BTO; BTO:0002128

RX   PubMed=8882887;

RX   PubMed=16061850;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TXM-1

AC   CVCL_5643

SY   TXM1

DR   Cosmic; 932705

DR   KCLB; 80028

RX   PubMed=1826230;

CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.

CC   Discontinued: KCLB; 80028; probable.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TXM-13

AC   CVCL_5645

SY   TXM13

DR   BTO; BTO:0003728

DR   Cosmic; 932706

DR   KCLB; 80029

RX   PubMed=1826230;

RX   PubMed=10987313;

RX   PubMed=16462895;

CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.

CC   Derived from metastatic site: Brain.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8

ST   FGA: 22.2,25

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TXM-18

AC   CVCL_5646

SY   TXM18

DR   BTO; BTO:0003983

DR   Cosmic; 932707

DR   Cosmic; 1238112

DR   KCLB; 80030

RX   PubMed=1826230;

CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.

CC   Derived from metastatic site: Brain.

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D3S1358: 16,19

ST   D5S818: 13

ST   D7S820: 7,9

ST   FGA: 20

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TXM-34

AC   CVCL_5647

SY   TXM34

RX   PubMed=1826230;

CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.

CC   Derived from metastatic site: Brain.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TXM-40

AC   CVCL_5648

SY   TXM40

DR   KCLB; 80031

RX   PubMed=1826230;

CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.

CC   Derived from metastatic site: Brain.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TY-1

AC   CVCL_DG42

SY   TY1

DR   Cosmic; 1588565

DR   GEO; GSM634740

DR   GEO; GSM710425

DR   GEO; GSM710441

RX   PubMed=10421407;

RX   PubMed=21685375;

CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).

DI   NCIt; C6915; Primary effusion lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ty-82

AC   CVCL_3220

SY   TY-82

DR   GEO; GSM577206

DR   JCRB; JCRB1330

DR   JCRB; NIHS0541

RX   PubMed=1730520;

CC   Discontinued: JCRB; NIHS0541 ; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 9,11

ST   D7S820: 12,13

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C7569; Thymic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TY-E

AC   CVCL_9V43

RX   PubMed=9815546;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   TY-ES

AC   CVCL_S804

RX   CelloPub=CLPUB00122;

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TY08

AC   CVCL_F712

RX   PubMed=20458752;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Conditionally immortalized cell line

//

ID   TY09

AC   CVCL_U943

RX   DOI=10.1111/cen3.12001;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F712 ! TY08

CA   Conditionally immortalized cell line

//

ID   TY25

AC   CVCL_CW90

RX   PubMed=12421930;

RX   PubMed=14515261;

CC   Monoclonal antibody target: UniProtKB; Q9WUL5; Mouse Pdcd1lg2/Cd273.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   TYBDC-1

AC   CVCL_4W80

DR   JCRB; JCRB1501

CC   Derived from metastatic site: Liver.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 11,13

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 7,9

ST   TPOX: 8,12

ST   vWA: 19

DI   NCIt; C27813; Bile duct adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYGBK-1

AC   CVCL_J034

DR   Cosmic; 2038290

DR   JCRB; JCRB1499

RX   PubMed=22843894;

CC   Doubling time: ~48 hours(PubMed=22843894).

CC   Derived from metastatic site: Lymph node.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 10

ST   D16S539: 9

ST   D5S818: 11,14

ST   D7S820: 8

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYGBK-8

AC   CVCL_4W81

DR   JCRB; JCRB1590

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYHPC-1

AC   CVCL_4W82

DR   JCRB; JCRB1520

CC   Derived from metastatic site: Liver.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3087; Hemangiopericytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TYK-nu

AC   CVCL_1776

SY   TYK-NU; TYKnu; TYKNU

DR   EFO; EFO_0006766

DR   BioSample; SAMN03471005

DR   CCLE; TYKNU_OVARY

DR   CGH-DB; 9359-4

DR   ChEMBL-Cells; CHEMBL3308805

DR   ChEMBL-Targets; CHEMBL1075601

DR   Cosmic; 909774

DR   Cosmic; 931359

DR   Cosmic; 948288

DR   Cosmic; 1077283

DR   Cosmic; 2582803

DR   Cosmic-CLP; 909774

DR   GDSC; 909774

DR   GEO; GSM659409

DR   GEO; GSM851946

DR   GEO; GSM887718

DR   GEO; GSM888811

DR   GEO; GSM1670552

DR   JCRB; JCRB0234.0

RX   PubMed=3782955;

RX   PubMed=9290701;

RX   PubMed=11330945;

RX   PubMed=12417041;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=23839242;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=27561551;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-312.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 45 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 9,10

ST   D18S51: 13

ST   D21S11: 32.2

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 10

ST   D8S1179: 10,15

ST   FGA: 24

ST   Penta D: 12

ST   Penta E: 16

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14,16

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYK-nu.CP-r

AC   CVCL_3221

SY   TYK-nu (R); TYKNU CPR

DR   EFO; EFO_0006767

DR   CGH-DB; 383-2

DR   CGH-DB; 9360-4

DR   JCRB; JCRB0234.1

RX   PubMed=2647872;

RX   PubMed=11330945;

RX   PubMed=12417041;

RX   PubMed=25485619;

RX   PubMed=27561551;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Caution: It is possible that TYK-nu.CP-r and TYK-nu-CisR (CVCL_EQ58) are the same cell line.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14,16

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1776 ! TYK-nu

SX   Female

CA   Cancer cell line

//

ID   TYK-nu-CisR

AC   CVCL_EQ58

SY   Tyk-nu-cisR; TYKnuCisR; TyknuCisR

DR   GEO; GSM851947

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Transcriptome analysis.

CC   Caution: It is possible that TYK-nu.CP-r (CVCL_3221) and TYK-nu-CisR are the same cell line.

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1776 ! TYK-nu

SX   Female

CA   Cancer cell line

//

ID   TYLMS-1

AC   CVCL_4W83

DR   JCRB; JCRB1521

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C27904; Retroperitoneal leiomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYPK-1

AC   CVCL_4V78

DR   JCRB; JCRB1500

RX   PubMed=26124327;

CC   Caution: Indicated as being from a male patient in PubMed=26124327 and from a female patient in JCRB.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 9,12

ST   D5S818: 10

ST   D7S820: 8,14

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 16

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TYPK-2

AC   CVCL_4V79

RX   PubMed=26124327;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TYR1-hiPSC1

AC   CVCL_C361

SY   TYR.1.H.iPSC.1; RIi005-A

DR   hPSCreg; RIi005-A

DR   ISCR; 1411

DR   RSCB; RSCB0067

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C366 ! TYR1-hiPSC6

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC2

AC   CVCL_C362

SY   TYR.1.H.iPSC.2

DR   RSCB; RSCB0068

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C366 ! TYR1-hiPSC6

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC3

AC   CVCL_C363

SY   TYR.1.H.iPSC.3

DR   RSCB; RSCB0069

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C366 ! TYR1-hiPSC6

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC4

AC   CVCL_C364

SY   TYR.1.H.iPSC.4

DR   RSCB; RSCB0070

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C366 ! TYR1-hiPSC6

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC5

AC   CVCL_C365

SY   TYR.1.H.iPSC.5

DR   RSCB; RSCB0071

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C366 ! TYR1-hiPSC6

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC6

AC   CVCL_C366

SY   TYR.1.H.iPSC.6

DR   RSCB; RSCB0072

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C367 ! TYR1-hiPSC7

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYR1-hiPSC7

AC   CVCL_C367

SY   TYR.1.H.iPSC.7

DR   RSCB; RSCB0073

RX   PubMed=20821352;

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C98641; Type I tyrosinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C361 ! TYR1-hiPSC1

OI   CVCL_C362 ! TYR1-hiPSC2

OI   CVCL_C363 ! TYR1-hiPSC3

OI   CVCL_C364 ! TYR1-hiPSC4

OI   CVCL_C365 ! TYR1-hiPSC5

OI   CVCL_C366 ! TYR1-hiPSC6

SX   Female

CA   Induced pluripotent stem cell

//

ID   TYS

AC   CVCL_5G91

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=2429552;

CC   Doubling time: 44.4 hours (PubMed=2429552).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TYUC-1

AC   CVCL_4W84

DR   JCRB; JCRB1512

RX   PubMed=25667451;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C6762; Esophageal small cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   TZ-1

AC   CVCL_R882

DR   Cosmic; 2391883

RX   PubMed=16826222;

DI   NCIt; C7171; Acute monoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   TZDR03

AC   CVCL_V386

DR   IMGT/HLA; 14467

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   TZM-bl

AC   CVCL_B478

SY   TZM; JC53-bl; JC53BL-13; JC.53bl-13; JC53-bl clone 13

DR   BTO; BTO:0005059

DR   ChEMBL-Cells; CHEMBL3307662

DR   ChEMBL-Targets; CHEMBL614612

DR   NIH-ARP; 8129-442

RX   PubMed=18842727;

RX   PubMed=19474095;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Misspelling: Occasionally 'TZM-b1'.

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   TZM-bl/FcalphaR

AC   CVCL_1F83

RX   DOI=10.1186/1742-4690-6-S3-P152;

CC   Transfected with: HGNC; 3608; FCAR.

CC   Transfected with: HGNC; 3611; FCER1G.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZM-bl/FcgammaRI

AC   CVCL_1E18

DR   NIH-ARP; 11798-376

RX   PubMed=19458010;

RX   PubMed=23408628;

CC   Transfected with: HGNC; 3613; FCGR1A.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZM-bl/FcgammaRIIa

AC   CVCL_1E19

DR   NIH-ARP; 11795-314

RX   PubMed=19458010;

CC   Transfected with: HGNC; 3616; FCGR2A.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZM-bl/FcgammaRIIb

AC   CVCL_1E20

DR   NIH-ARP; 11797-375

RX   PubMed=19458010;

CC   Transfected with: HGNC; 3618; FCGR2B.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZM-bl/FcgammaRIIIa

AC   CVCL_1E21

DR   NIH-ARP; 11796-374

RX   PubMed=19458010;

CC   Transfected with: HGNC; 3619; FCGR3A.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZM-tfLC3B

AC   CVCL_0A24

RX   PubMed=25241145;

CC   Transfected with: HGNC; 13352; MAP1LC3B.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B478 ! TZM-bl

SX   Female

CA   Cancer cell line

//

ID   TZR

AC   CVCL_4Y62

RX   PubMed=9328141;

CC   Selected for resistance to: ChEBI; CHEBI:90239; Tiazofurine.

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0382 ! L1210

SX   Female

CA   Cancer cell line

//

ID   U-105MG

AC   CVCL_5903

SY   U-105 MG; U105MG; 105 MG; 105MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=608846;

RX   PubMed=833871;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4337530;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=9220028;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D18S51: 14,18

ST   D19S433: 13,14

ST   D21S11: 29,30

ST   D2S1338: 17,26

ST   D3S1358: 17,18

ST   D5S818: 7,13

ST   D7S820: 8,11

ST   D8S1179: 12,14

ST   FGA: 18,20

ST   Penta D: 8,12

ST   Penta E: 5,14

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1073MG

AC   CVCL_GR52

SY   U1073MG; 1073 MG

RX   PubMed=608846;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 13

ST   D16S539: 13,15

ST   D18S51: 13,16

ST   D19S433: 13.2,14

ST   D21S11: 29

ST   D2S1338: 19,20

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,13

ST   D8S1179: 15

ST   FGA: 21,23

ST   Penta D: 9,13

ST   TH01: 6

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1176MG

AC   CVCL_GR53

SY   U1176MG

RX   PubMed=27582061;

CC   Miscellaneous: Gender from personal communication of Westermark B.

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 12,15

ST   D19S433: 15

ST   D21S11: 28,30

ST   D2S1338: 19,25

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 15

ST   FGA: 21.2

ST   Penta D: 9,10

ST   Penta E: 7,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-118MG

AC   CVCL_0633

SY   U-118 MG; U-118-MG; U118-MG; U118MG; U118; 118 MG; 118MG

DR   BTO; BTO:0004605

DR   CLO; CLO_0009451

DR   ATCC; HTB-15

DR   ATCC; CRL-7712

DR   BioSample; SAMN03151974

DR   BioSample; SAMN03472723

DR   CCLE; U118MG_CENTRAL_NERVOUS_SYSTEM

DR   CCRID; 3131C0001001200022

DR   ChEMBL-Cells; CHEMBL3308793

DR   ChEMBL-Targets; CHEMBL1075602

DR   CLS; 300362/p4581_U-118_MG

DR   Cosmic; 687588

DR   Cosmic; 849852

DR   Cosmic; 849878

DR   Cosmic; 920817

DR   Cosmic; 1175822

DR   Cosmic; 1217672

DR   Cosmic; 1571919

DR   Cosmic; 1610738

DR   Cosmic; 2301554

DR   Cosmic; 2367553

DR   Cosmic; 2550362

DR   Cosmic-CLP; 687588

DR   GDSC; 687588

DR   GEO; GSM888812

DR   GEO; GSM1374968

DR   GEO; GSM1374969

DR   GEO; GSM1670554

DR   KCB; KCB 201302YJ

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2253244;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4337530;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=7459858;

RX   PubMed=9220028;

RX   PubMed=11414198;

RX   PubMed=19365568;

RX   PubMed=19435942;

RX   PubMed=20143388;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=27397505;

RX   PubMed=27582061;

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=75

WW   http://www.atcc.org/support/faqs/931ae/U118%20MG%20ATCC%20HTB15%20U138%20MG%20ATCC%20HTB16-1056.aspx

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u118/u118cells.html

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Characteristics: Has no IDH1 mutation.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-7712; true.

ST   Source(s): ATCC; CLS; Cosmic-CLP; PubMed=22570425; PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9 (ATCC; Cosmic-CLP)

ST   D13S317: 9,11 (CLS; PubMed=22570425; PubMed=27582061)

ST   D16S539: 12,13

ST   D18S51: 13

ST   D19S433: 13

ST   D21S11: 27,32.2

ST   D2S1338: 23,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 14,15

ST   FGA: 23 (CLS; PubMed=22570425)

ST   FGA: 18,23 (PubMed=27582061)

ST   Penta D: 13 (CLS)

ST   Penta D: 10,13 (PubMed=22570425; PubMed=27582061)

ST   Penta E: 7 (CLS; PubMed=22570425)

ST   Penta E: 7,13 (PubMed=27582061)

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0020 ! U-138MG

SX   Male

CA   Cancer cell line

//

ID   U-120MG

AC   CVCL_T446

SY   120MG

RX   PubMed=4337530;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   U-1231MG

AC   CVCL_5G55

SY   U-1231 MG; U1231MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 14,15

ST   D21S11: 29

ST   D2S1338: 18,25

ST   D3S1358: 18,19

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   D8S1179: 11,13

ST   FGA: 20,24

ST   Penta D: 9,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1240MG

AC   CVCL_5G54

SY   U-1240 MG; U1240MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11,13

ST   D16S539: 11,13

ST   D18S51: 16

ST   D19S433: 13.2

ST   D21S11: 29,30.2

ST   D2S1338: 17

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   D8S1179: 10,12

ST   FGA: 21

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1242MG

AC   CVCL_F841

SY   U-1242 MG; U1242MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=27582061;

CC   Miscellaneous: Gender from personal communication of Westermark B.

ST   Source(s): PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 13

ST   D18S51: 16

ST   D19S433: 14

ST   D21S11: 28,31

ST   D2S1338: 17,18

ST   D3S1358: 17,19

ST   D5S818: 9,11

ST   D7S820: 9,11

ST   D8S1179: 12

ST   FGA: 19,22

ST   Penta D: 17,19

ST   Penta E: 13,15

ST   TH01: 9,10

ST   TPOX: 8,10

ST   vWA: 15

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-1285

AC   CVCL_7153

SY   U1285

DR   BTO; BTO:0002389

RX   PubMed=2983887;

RX   PubMed=6285665;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1285dox

AC   CVCL_7154

SY   U-1285dox(900)

DR   BTO; BTO:0002391

RX   PubMed=12766562;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7153 ! U-1285

SX   Male

CA   Cancer cell line

//

ID   U-138MG

AC   CVCL_0020

SY   U-138 MG; U-138-MG; U138-MG; U 138 MG; U138MG; U138; 138 MG; 138MG

DR   BTO; BTO:0002127

DR   CLO; CLO_0009452

DR   CLO; CLO_0009453

DR   CLDB; cl4577

DR   ATCC; HTB-16

DR   BCRJ; 0239

DR   BioSample; SAMN01821604

DR   BioSample; SAMN01821668

DR   BioSample; SAMN03472727

DR   CCLE; U138MG_CENTRAL_NERVOUS_SYSTEM

DR   CLS; 300363/p511_U-138_MG

DR   Cosmic; 755288

DR   Cosmic; 850744

DR   Cosmic; 1571920

DR   Cosmic; 1610739

DR   Cosmic; 1746952

DR   Cosmic; 2060806

DR   Cosmic; 2301555

DR   Cosmic; 2302317

DR   DSMZ; ACC-291

DR   GEO; GSM326234

DR   GEO; GSM887719

DR   GEO; GSM888813

DR   IGRhCellID; U138MG

DR   Lonza; 104

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=833871;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4313504;

RX   PubMed=4337530;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=6582512;

RX   PubMed=19365568;

RX   PubMed=19435942;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=27582061;

WW   http://www.atcc.org/support/faqs/931ae/U118%20MG%20ATCC%20HTB15%20U138%20MG%20ATCC%20HTB16-1056.aspx

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0028&theme=default

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: Has no IDH1 mutation.

CC   Doubling time: ~70 hours (DSMZ).

CC   Omics: CNV analysis.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; DSMZ; PubMed=22570425; PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 12 (ATCC; CLS; DSMZ; PubMed=22570425)

ST   CSF1PO: 11,12 (PubMed=27582061)

ST   D13S317: 9,11

ST   D16S539: 12,13

ST   D18S51: 13

ST   D19S433: 13

ST   D21S11: 27,32.2

ST   D2S1338: 23,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 14,15

ST   FGA: 18,23

ST   Penta D: 9,13 (CLS; PubMed=22570425)

ST   Penta D: 10,13 (PubMed=27582061)

ST   Penta E: 7 (CLS; PubMed=22570425)

ST   Penta E: 7,13 (PubMed=27582061)

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1568

AC   CVCL_7155

SY   U1568

DR   BTO; BTO:0002390

RX   PubMed=6285665;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1690

AC   CVCL_D055

SY   U1690

RX   PubMed=2983887;

RX   PubMed=2990154;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1752

AC   CVCL_0565

SY   U1752

DR   BTO; BTO:0005386

DR   MCCL; MCC:0000467

DR   Cosmic; 953988

DR   Cosmic; 1006541

RX   PubMed=2983887;

RX   PubMed=6178358;

RX   PubMed=9551745;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   U-1761

AC   CVCL_W848

SY   U1761

RX   PubMed=2990154;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-178MG

AC   CVCL_A758

SY   U-178-MG; U-178 MG; U178-MG; U 178 MG; U178MG; MG 178; U-178; 178 MG; 178MG

DR   CCLE; U178_CENTRAL_NERVOUS_SYSTEM

DR   Cosmic; 849851

DR   Cosmic; 849879

DR   Cosmic; 1610740

DR   Cosmic; 2516041

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=833871;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4139097;

RX   PubMed=4369403;

RX   PubMed=19435942;

RX   PubMed=22570425;

RX   PubMed=25984343;

RX   PubMed=27582061;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: Has no IDH1 mutation.

CC   Doubling time: 45 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

ST   Source(s): PubMed=22570425; PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11 (PubMed=22570425)

ST   D13S317: 10,11 (PubMed=27582061)

ST   D16S539: 10,13

ST   D18S51: 14,15

ST   D19S433: 14,15

ST   D21S11: 28,30

ST   D2S1338: 14,15

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 10 (PubMed=22570425)

ST   D7S820: 8,10 (PubMed=27582061)

ST   D8S1179: 13,14

ST   FGA: 22,26

ST   Penta D: 7,12

ST   Penta E: 7,12

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1796MG

AC   CVCL_5G61

SY   U-1796 MG; U1796MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

RX   PubMed=27582061;

CC   Miscellaneous: Gender from personal communication of Westermark B.

ST   Source(s): PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 12

ST   D18S51: 13,18

ST   D19S433: 14,15

ST   D21S11: 32.2,33.2

ST   D2S1338: 17

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 20,21

ST   Penta D: 12,13

ST   Penta E: 11,14

ST   TH01: 9,9.3

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-1810

AC   CVCL_D054

SY   U1810

DR   BTO; BTO:0003727

RX   PubMed=2983887;

RX   PubMed=2990154;

RX   PubMed=9551745;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1906

AC   CVCL_D075

SY   U1906

RX   PubMed=2983887;

RX   PubMed=2990154;

RX   PubMed=9551745;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-1957

AC   CVCL_M493

RX   PubMed=3580570;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M494 ! U-1958

SX   Male

CA   Cancer cell line

//

ID   U-1958

AC   CVCL_M494

RX   PubMed=3580570;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M493 ! U-1957

SX   Male

CA   Cancer cell line

//

ID   U-1996

AC   CVCL_M495

RX   PubMed=3580570;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-2 OS R1

AC   CVCL_T429

RX   PubMed=17096323;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0042 ! U2OS

SX   Female

CA   Cancer cell line

//

ID   U-2 OS R2

AC   CVCL_T430

SY   U-2OSR2

RX   PubMed=17096323;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T429 ! U-2 OS R1

SX   Female

CA   Cancer cell line

//

ID   U-2020

AC   CVCL_D076

SY   U2020

RX   PubMed=2983887;

RX   PubMed=2990154;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-2030

AC   CVCL_M581

RX   PubMed=3583453;

RX   PubMed=10936422;

CC   Miscellaneous: Cell line has been lost (PubMed=10936422).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M585 ! U-2031

CA   Cancer cell line

//

ID   U-2030 TG

AC   CVCL_M582

RX   PubMed=3583453;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M581 ! U-2030

CA   Cancer cell line

//

ID   U-2031

AC   CVCL_M585

RX   PubMed=3583453;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M581 ! U-2030

CA   Transformed cell line

//

ID   U-2050

AC   CVCL_D077

SY   U2050

RX   PubMed=2990154;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-2149

AC   CVCL_W019

SY   U2149

RX   PubMed=2556928;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0043 ! U-2197

SX   Male

CA   Cancer cell line

//

ID   U-2197

AC   CVCL_0043

SY   U2197

DR   CLO; CLO_0009455

DR   BioSample; SAMN03473584

DR   Cosmic; 1933189

DR   DSMZ; ACC-406

RX   PubMed=2556928;

WW   http://www.proteinatlas.org/learn/cellines

CC   Doubling time: ~100-120 hours (DSMZ).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 10,13

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 6,9.3

ST   TPOX: 10,11

ST   vWA: 17,18

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W019 ! U-2149

SX   Male

CA   Cancer cell line

//

ID   U-251 MG-Luc

AC   CVCL_J269

DR   JCRB; JCRB1386

DR   JCRB; NIHS0645

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0645; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U-251MG

AC   CVCL_0021

SY   U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG

DR   BTO; BTO:0002035

DR   CLO; CLO_0009456

DR   EFO; EFO_0006498

DR   CLDB; cl4583

DR   CCLE; U251MG_CENTRAL_NERVOUS_SYSTEM

DR   CCRID; 3111C0001CCC000058

DR   CCRID; 3131C0001000700058

DR   CCRID; 3142C0001000000112

DR   CGH-DB; 155-1

DR   ChEMBL-Cells; CHEMBL3307756

DR   ChEMBL-Targets; CHEMBL615021

DR   ChEMBL-Targets; CHEMBL615022

DR   CLS; 300385/p534_U251_MG

DR   Cosmic; 687451

DR   Cosmic; 848340

DR   Cosmic; 849850

DR   Cosmic; 850742

DR   Cosmic; 875896

DR   Cosmic; 897440

DR   Cosmic; 905983

DR   Cosmic; 920818

DR   Cosmic; 923899

DR   Cosmic; 970094

DR   Cosmic; 974243

DR   Cosmic; 1044250

DR   Cosmic; 1066235

DR   Cosmic; 1092644

DR   Cosmic; 1171225

DR   Cosmic; 1175823

DR   Cosmic; 1217673

DR   Cosmic; 1312345

DR   Cosmic; 1436038

DR   Cosmic; 1610741

DR   Cosmic; 1998487

DR   Cosmic; 2367502

DR   Cosmic; 2367554

DR   Cosmic; 2516042

DR   Cosmic; 2550363

DR   Cosmic-CLP; 905983

DR   ECACC; 09063001

DR   GDSC; 905983

DR   GEO; GSM50180

DR   GEO; GSM50244

DR   GEO; GSM750795

DR   GEO; GSM799328

DR   GEO; GSM799391

DR   GEO; GSM847166

DR   GEO; GSM844718

DR   GEO; GSM844719

DR   GEO; GSM887720

DR   GEO; GSM888814

DR   GEO; GSM1153398

DR   GEO; GSM1181247

DR   GEO; GSM1181342

DR   GEO; GSM1670555

DR   ICLC; HTL99014

DR   IFO; IFO50288

DR   KCB; KCB 200965YJ

DR   Lonza; 105

DR   Lonza; 1007

DR   PRIDE; PXD000589

DR   RCB; RCB0461

DR   SKY/M-FISH/CGH; 2825

DR   TOKU-E; 4005

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=608846;

RX   PubMed=833871;

RX   PubMed=2041050;

RX   PubMed=4134536;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=6582512;

RX   PubMed=9220028;

RX   PubMed=16232199;

RX   PubMed=16391870;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19435942;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24810477;

RX   PubMed=25894527;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=27582061;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=57

WW   https://www.kerafast.com/product/1790/u-251-mg-glioblastoma-cell-line

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-313.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Characteristics: Has no IDH1 mutation.

CC   Doubling time: 24 hours (PubMed=25984343); 23.8 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Cell surface proteome.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB0461; true.

ST   Source(s): CLS; Cosmic-CLP; ECACC; JCRB; PubMed=19372543; PubMed=22570425; PubMed=24810477; PubMed=27582061

ST   Amelogenin: X,Y

ST   Amelogenin: X (PubMed=24810477_some_subclones)

ST   CSF1PO: 11,12 (CLS; Cosmic-CLP; ECACC; JCRB; PubMed=22570425; PubMed=27582061)

ST   CSF1PO: 12,13 (PubMed=19372543)

ST   D13S317: 10,11

ST   D16S539: 12

ST   D18S51: 13,15

ST   D18S51: 13 (CLS; PubMed=22570425; PubMed=24810477_some_subclones)

ST   D19S433: 13,15

ST   D21S11: 29,30

ST   D21S11: 29 (PubMed=22570425; PubMed=24810477_some_subclones)

ST   D2S1338: 24 (CLS)

ST   D2S1338: 22,24 (PubMed=27582061)

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D5S818: 11 (PubMed=24810477_some_subclones)

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 21,25

ST   FGA: 20,21,25 (PubMed=24810477_some_subclones)

ST   Penta D: 10,12 (CLS; PubMed=27582061)

ST   Penta D: 12 (PubMed=22570425)

ST   Penta E: 7,10 (CLS)

ST   Penta E: 7 (PubMed=22570425; PubMed=27582061)

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-251MG (KO)

AC   CVCL_2809

SY   U-251 MG (KO)

DR   BioSample; SAMN03472772

DR   IFO; IFO50285

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U-251MG AgCl1

AC   CVCL_5G63

SY   U-251 MG AgCl1; U-251 MGAgCl1

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U-251MG sp

AC   CVCL_5G56

SY   U-251 MG sp; U-251 MGsp; U-251SP

DR   BTO; BTO:0005865

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=6260907;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U-266/70

AC   CVCL_0015

WW   http://www.proteinatlas.org/learn/cellines

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U-266/84

AC   CVCL_0016

RX   PubMed=3133230;

WW   http://www.proteinatlas.org/learn/cellines

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U-2904

AC   CVCL_X504

SY   U 2904

DR   DSMZ; ACC-768

RX   PubMed=7591289;

RX   PubMed=17926183;

CC   Doubling time: ~25-35 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 12

ST   D16S539: 11,13

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-2932

AC   CVCL_1896

SY   U2932

DR   EFO; EFO_0006499

DR   BioSample; SAMN03473452

DR   Cosmic; 1487546

DR   Cosmic; 1517654

DR   Cosmic; 1945196

DR   DSMZ; ACC-633

DR   GEO; GSM1059802

DR   GEO; GSM1374971

DR   PRIDE; PXD000589

RX   PubMed=12533045;

RX   PubMed=23295736;

RX   PubMed=23292937;

RX   PubMed=25485619;

RX   PubMed=25894527;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 48 hours (PubMed=12533045); ~50 hours (DSMZ).

CC   Omics: Cell surface proteome.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,13

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 14,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-2940

AC   CVCL_1897

SY   U2940

DR   BioSample; SAMN03473453

DR   Cosmic; 2437272

DR   Cosmic; 2479246

DR   DSMZ; ACC-634

DR   GEO; GSM1374972

DR   Lonza; 1539

RX   PubMed=16106419;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~50 hours (DSMZ).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,10

ST   D16S539: 10,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 7,9.3

ST   TPOX: 8,12

ST   vWA: 17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-2946

AC   CVCL_X503

DR   DSMZ; ACC-795

RX   PubMed=17926183;

RX   PubMed=27907212;

CC   Doubling time: 48 hours (PubMed=27907212); ~20-30 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,9.3

ST   TPOX: 9,12

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-2973

AC   CVCL_1898

DR   BioSample; SAMN03473456

DR   DSMZ; ACC-642

RX   PubMed=18510704;

RX   PubMed=23171647;

CC   Doubling time: ~35 hours (DSMZ).

CC   Omics: Genome sequenced.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 10,11

ST   D16S539: 11,13

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17,20

DI   NCIt; C80291; B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-2987-P3

AC   CVCL_S469

RX   PubMed=19543319;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S468 ! U-2987MG

SX   Male

CA   Cancer cell line

//

ID   U-2987-P6

AC   CVCL_S470

RX   PubMed=19543319;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S468 ! U-2987MG

SX   Male

CA   Cancer cell line

//

ID   U-2987MG

AC   CVCL_S468

RX   PubMed=16547494;

RX   PubMed=19543319;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-343MG

AC   CVCL_S471

SY   U-343 MG; U-343-MG; U343MG; U-343; U343; 343 MG; 343MG

DR   Cosmic; 849880

DR   Cosmic; 2367503

DR   Cosmic; 2491104

DR   Cosmic; 2516043

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4142792;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=11351043;

RX   PubMed=21406405;

RX   PubMed=22570425;

RX   PubMed=25984343;

RX   PubMed=26496030;

RX   PubMed=27582061;

CC   Doubling time: 45 hours (PubMed=25984343).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: shRNA library screening.

ST   Source(s): PubMed=22570425; PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,13

ST   D16S539: 9,12

ST   D18S51: 23 (PubMed=22570425)

ST   D18S51: 21,23 (PubMed=27582061)

ST   D19S433: 13,14

ST   D21S11: 31,33.2

ST   D2S1338: 22,24

ST   D3S1358: 15,17

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 19,20

ST   Penta D: 9,10

ST   Penta E: 10,12

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17 (PubMed=22570425)

ST   vWA: 17,18 (PubMed=27582061)

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4773 ! U-343MGa

SX   Male

CA   Cancer cell line

//

ID   U-343MGa

AC   CVCL_4773

SY   U-343 MG-A; U-343-MG-A; U343-MG-A; U-343 MGa; U343 MGa; U343MGa; U343

DR   BTO; BTO:0003218

DR   CLO; CLO_0009459

DR   CLDB; cl4586

DR   CCLE; U343_CENTRAL_NERVOUS_SYSTEM

DR   CLS; 300365/p542_U-343_MGa

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=3497714;

RX   PubMed=10709103;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

ST   Source(s): CLS

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,13

ST   D16S539: 9,12

ST   D18S51: 23

ST   D21S11: 31,33.2

ST   D3S1358: 15,17

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 19,20

ST   Penta D: 9,10

ST   Penta E: 10,12

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S471 ! U-343MG

SX   Male

CA   Cancer cell line

//

ID   U-343MGa 31L

AC   CVCL_S472

SY   U-343 MGa 31L

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=3497714;

RX   PubMed=10709103;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4773 ! U-343MGa

SX   Male

CA   Cancer cell line

//

ID   U-343MGa Cl2

AC   CVCL_S474

SY   U-343 MGa Cl2; U-343 MGa Cl 2

RX   PubMed=2998609;

RX   PubMed=3497714;

RX   PubMed=6296418;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4773 ! U-343MGa

SX   Male

CA   Cancer cell line

//

ID   U-343MGa Cl2:6

AC   CVCL_S473

SY   U-343 MGa Cl2:6; U-Cl2:6MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=2998609;

RX   PubMed=3497714;

RX   PubMed=10709103;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S474 ! U-343MGa Cl2

SX   Male

CA   Cancer cell line

//

ID   U-343MGa Cl3

AC   CVCL_S475

SY   U-343 MGa Cl3; U-343 MGa Cl 3

RX   PubMed=2998609;

RX   PubMed=6296418;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4773 ! U-343MGa

SX   Male

CA   Cancer cell line

//

ID   U-372MG

AC   CVCL_5G60

SY   U-372 MG; U372MG; 372 MG

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=608846;

RX   PubMed=2454731;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D18S51: 13,15

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 17,18

ST   D3S1358: 17,18

ST   D5S818: 9,11

ST   D7S820: 9

ST   D8S1179: 13

ST   FGA: 22,23

ST   Penta D: 12,14

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-373MG ATCC

AC   CVCL_2219

SY   U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG

DR   BTO; BTO:0002126

DR   CLO; CLO_0009460

DR   CLO; CLO_0009461

DR   EFO; EFO_0001255

DR   CLDB; cl4587

DR   CLDB; cl4589

DR   CLDB; cl4964

DR   ATCC; HTB-17

DR   CCLV; CCLV-RIE 0675

DR   CGH-DB; 320-1

DR   ChEMBL-Cells; CHEMBL3307474

DR   ChEMBL-Targets; CHEMBL615024

DR   Cosmic; 687589

DR   Cosmic; 849849

DR   Cosmic; 850825

DR   Cosmic; 920819

DR   Cosmic; 970093

DR   Cosmic; 1066236

DR   Cosmic; 1171226

DR   Cosmic; 1175824

DR   Cosmic; 1217674

DR   Cosmic; 1294952

DR   Cosmic; 1610742

DR   Cosmic; 2367504

DR   Cosmic; 2491105

DR   ECACC; 89081403

DR   GEO; GSM827314

DR   IZSLER; BS TCL 89

DR   JCRB; NIHS0295

DR   Lonza; 334

DR   Lonza; 1006

DR   KCLB; 30017

DR   NCBI_Iran; C455

DR   PRIDE; PXD000430

DR   TOKU-E; 3660

RX   PubMed=833871;

RX   PubMed=2253244;

RX   PubMed=6260907;

RX   PubMed=6582512;

RX   PubMed=9220028;

RX   PubMed=10074188;

RX   PubMed=11351043;

RX   PubMed=11414198;

RX   PubMed=16232199;

RX   PubMed=21406405;

RX   PubMed=22570425;

RX   PubMed=26496030;

WW   http://www.atcc.org/support/faqs/cf245/U373%20MG%20ATCC%20HTB17-1055.aspx

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=76

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0029&theme=default

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-510.html

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated/misidentified. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (CVCL_2818) for the original U-373MG cell line.

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Misspelling: '373MG' in Cosmic 970093.

CC   Discontinued: ECACC; 89081403; probable.

CC   Discontinued: JCRB; NIHS0295; true.

ST   Source(s): ATCC; JCRB; KCLB; PubMed=22570425

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 10,11

ST   D16S539: 12

ST   D18S51: 13

ST   D21S11: 29,30

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 21,25

ST   Penta D: 10,12

ST   Penta E: 7,10

ST   TH01: 9.3 (ATCC; KCLB; PubMed=22570425)

ST   TH01: 9.3,11 (JCRB)

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U-373MG Uppsala

AC   CVCL_2818

SY   U-373 MG Uppsala; U-373 MG (Uppsala); U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG

DR   BioSample; SAMN03471311

DR   ECACC; 08061901

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4369403;

RX   PubMed=19435942;

RX   PubMed=27582061;

CC   Characteristics: Has no IDH1 mutation.

CC   Caution: This is the original U-373MG cell line established in 1973 at the University of Uppsala. The cell line distributed by most cell collections is a different cell line.

ST   Source(s): ECACC; PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 12,13

ST   D18S51: 14,22

ST   D19S433: 13,14

ST   D21S11: 28,32.2

ST   D2S1338: 17,25

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 8.2,12 (ECACC)

ST   D7S820: 8,12 (PubMed=27582061)

ST   D8S1179: 13,16

ST   FGA: 20

ST   Penta D: 9,13

ST   Penta E: 11,13

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-399MG

AC   CVCL_1E96

SY   U-399 MG; U399MG; 399 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

RX   PubMed=4369403;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D18S51: 14,15

ST   D19S433: 14

ST   D21S11: 29,31

ST   D2S1338: 17,20

ST   D3S1358: 15,18

ST   D5S818: 9,13

ST   D7S820: 8,11

ST   D8S1179: 10,13

ST   FGA: 22,25

ST   Penta D: 10,12

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-410MG

AC   CVCL_W020

SY   U-410 MG; U410MG; 410 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2253244;

RX   PubMed=2454731;

RX   PubMed=4369403;

RX   PubMed=6260907;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 11

ST   D18S51: 13,18

ST   D19S433: 14,16.2

ST   D21S11: 28,31.2

ST   D2S1338: 18,20

ST   D3S1358: 15,18

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 10,13

ST   FGA: 20,22

ST   Penta D: 9

ST   Penta E: 7,11

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-47703 BL

AC   CVCL_IW55

RX   PubMed=165156;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   U-489MG

AC   CVCL_1E97

SY   U-489 MG; 489 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

RX   PubMed=4369403;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-495MG

AC   CVCL_1E98

SY   U-495 MG; 495 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   PubMed=4369403;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-539MG

AC   CVCL_1E99

SY   U-539 MG; U539MG; 539 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

RX   PubMed=4369403;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 15,17

ST   D19S433: 13,15

ST   D21S11: 29,30

ST   D2S1338: 20,25

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 21,23

ST   Penta D: 12,14

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-563MG

AC   CVCL_A757

SY   U-563 MG; U563 MG; U-563-MG; U563MG; 563 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1847665;

RX   PubMed=2454731;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 16,17

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 19,21

ST   D3S1358: 17

ST   D5S818: 13

ST   D7S820: 8,9

ST   D8S1179: 13,15

ST   FGA: 21,25

ST   Penta D: 9,11

ST   Penta E: 10,16

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-692 MG

AC   CVCL_1F00

SY   692 MG

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   PubMed=4369403;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-698-M

AC   CVCL_0017

SY   U-698 M; U-698M; U698-M; U698M; U-698; U698

DR   CLO; CLO_0009462

DR   EFO; EFO_0006768

DR   CLDB; cl4591

DR   BioSample; SAMN03471071

DR   ChEMBL-Cells; CHEMBL3308280

DR   ChEMBL-Targets; CHEMBL2366098

DR   Cosmic; 909777

DR   Cosmic-CLP; 909777

DR   DSMZ; ACC-4

DR   GDSC; 909777

DR   GEO; GSM1374973

DR   GEO; GSM1670558

RX   PubMed=4136723;

RX   PubMed=4369887;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.proteinatlas.org/learn/cellines

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 15,18

ST   D21S11: 29,30

ST   D3S1358: 14,15

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   D8S1179: 11,13

ST   FGA: 22,24

ST   Penta D: 11,12

ST   Penta E: 11,12

ST   TH01: 6,10

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C9360; Lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-706MG

AC   CVCL_5G70

SY   U-706M; U706MG

RX   PubMed=7319677;

RX   PubMed=27582061;

ST   Source(s): PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D18S51: 13,14

ST   D19S433: 14,16

ST   D21S11: 30,32.2

ST   D2S1338: 16,20

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 12,14

ST   FGA: 22,26

ST   Penta D: 9,14

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5G71 ! U-706S

SX   Female

CA   Cancer cell line

//

ID   U-706S

AC   CVCL_5G71

SY   U-706 S

RX   PubMed=2454731;

RX   PubMed=7319677;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5G70 ! U-706MG

SX   Female

CA   Cancer cell line

//

ID   U-715-M

AC   CVCL_4T89

SY   U-715 M; U-715M; U-715; U715

RX   PubMed=4136723;

RX   PubMed=4369887;

DI   NCIt; C9360; Lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-87 MG-luc2

AC   CVCL_5J15

SY   U87MG-luc2

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 124577.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U-87MG ATCC

AC   CVCL_0022

SY   U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG

DR   BTO; BTO:0002036

DR   CLO; CLO_0009463

DR   CLO; CLO_0009464

DR   EFO; EFO_0005237

DR   MCCL; MCC:0000469

DR   CLDB; cl4592

DR   CLDB; cl4594

DR   CLDB; cl4595

DR   CLDB; cl7166

DR   ATCC; HTB-14

DR   BCRC; 60360

DR   BCRJ; 0241

DR   BioSample; SAMN03472715

DR   BioSample; SAMN03473126

DR   CCLE; U87MG_CENTRAL_NERVOUS_SYSTEM

DR   CCRID; 3111C0001CCC000208

DR   CCRID; 3131C0001000700138

DR   CGH-DB; 157-1

DR   ChEMBL-Cells; CHEMBL3307575

DR   ChEMBL-Targets; CHEMBL614247

DR   CLS; 300367/p658_U-87_MG

DR   Cosmic; 687590

DR   Cosmic; 849853

DR   Cosmic; 850741

DR   Cosmic; 850822

DR   Cosmic; 920816

DR   Cosmic; 1036336

DR   Cosmic; 1064099

DR   Cosmic; 1066234

DR   Cosmic; 1171224

DR   Cosmic; 1175825

DR   Cosmic; 1198263

DR   Cosmic; 1217671

DR   Cosmic; 1219449

DR   Cosmic; 1237542

DR   Cosmic; 1294951

DR   Cosmic; 1610737

DR   Cosmic; 1746951

DR   Cosmic; 1945859

DR   Cosmic; 2302316

DR   Cosmic; 2367555

DR   Cosmic; 2491106

DR   Cosmic; 2516044

DR   Cosmic; 2550364

DR   Cosmic; 2568870

DR   Cosmic-CLP; 687590

DR   ECACC; 89081402

DR   ENCODE; ENCBS424ENC

DR   GDSC; 687590

DR   GEO; GSM326243

DR   GEO; GSM481417

DR   GEO; GSM500897

DR   GEO; GSM887723

DR   GEO; GSM888817

DR   GEO; GSM923437

DR   GEO; GSM1374974

DR   GEO; GSM1670559

DR   ICLC; HTL00013

DR   IZSLER; BS TCL 189

DR   KCB; KCB 2011101YJ

DR   KCLB; 30014

DR   LINCS; 50868

DR   Lonza; 37

DR   Lonza; 808

DR   NCBI_Iran; C531

DR   NIH-ARP; 2188-324

DR   PRIDE; PXD000589

DR   PRIDE; PXD001565

DR   RCB; RCB0419

DR   TOKU-E; 3381

DR   Wikidata; Q7863603

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=7459858;

RX   PubMed=10074188;

RX   PubMed=11414198;

RX   PubMed=11966317;

RX   PubMed=16232199;

RX   PubMed=19365568;

RX   PubMed=19435942;

RX   PubMed=20126413;

RX   PubMed=21406405;

RX   PubMed=22460905;

RX   PubMed=22570425;

RX   PubMed=23325432;

RX   PubMed=25894527;

RX   PubMed=25984343;

RX   PubMed=26496030;

RX   PubMed=27397505;

RX   PubMed=27582061;

WW   https://en.wikipedia.org/wiki/U87

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=58

WW   http://www.proteinatlas.org/learn/cellines

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/U-87_Myers_protocol.pdf

WW   http://www.addexbio.com/productdetail?pid=71

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-314.html

CC   Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Characteristics: Has no IDH1 mutation.

CC   Doubling time: 72 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Cell surface proteome.

CC   Omics: CNV analysis.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB0419; true.

ST   Source(s): AddexBio; ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP; KCLB)

ST   Amelogenin: X (AddexBio; CLS; ECACC; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061)

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 12

ST   D18S51: 13 (CLS; PubMed=22570425)

ST   D18S51: 13,14 (PubMed=11416159; PubMed=25877200)

ST   D19S433: 15,15.2

ST   D21S11: 28,32.2

ST   D2S1338: 20,23

ST   D3S1358: 16,17

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   D8S1179: 10,11

ST   FGA: 18,24

ST   Penta D: 9,14

ST   Penta E: 7,14

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-87MG Uppsala

AC   CVCL_GP63

SY   U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG

DR   Wikidata; Q28575999

RX   DOI=10.1007/978-1-4757-1647-4_7;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2454731;

RX   PubMed=4134536;

RX   PubMed=4313504;

RX   PubMed=4337530;

RX   PubMed=4369403;

RX   PubMed=27582061;

WW   https://en.wikipedia.org/wiki/U87

CC   Caution: This is the original U-87MG cell line established in 1968 at the University of Uppsala. The cell line distributed by most cell collections (including ATCC, CLS, ECACC, etc.) is a different cell line whose origin is not yet clear (PubMed=27582061). See U-87MG ATCC (CVCL_0022) for the cell line used by most research groups.

ST   Source(s): PubMed=27582061

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D19S433: 14,15

ST   D21S11: 28,30

ST   D2S1338: 17,20

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   D8S1179: 13,14

ST   FGA: 20,24

ST   Penta D: 11

ST   Penta E: 7,13

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 15,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-937

AC   CVCL_0007

SY   U937; U 937

DR   BTO; BTO:0001412

DR   CLO; CLO_0009450

DR   CLO; CLO_0009465

DR   EFO; EFO_0001257

DR   MCCL; MCC:0000470

DR   CLDB; cl4597

DR   CLDB; cl4599

DR   CLDB; cl4600

DR   CLDB; cl4601

DR   CLDB; cl4602

DR   CLDB; cl4603

DR   CLDB; cl4604

DR   CLDB; cl4605

DR   CLDB; cl4606

DR   CLDB; cl4608

DR   ATCC; CRL-1593

DR   ATCC; CRL-1593.2

DR   BCRC; 60435

DR   BCRJ; 0242

DR   BioSample; SAMN03472409

DR   BioSample; SAMN03473173

DR   BioSample; SAMN03473567

DR   CCLE; U937_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CCRID; 3111C0001CCC000059

DR   CCRID; 3131C0001000700059

DR   CCRID; 3131C0001000700159

DR   CCRID; 3142C0001000000078

DR   ChEMBL-Cells; CHEMBL3308006

DR   ChEMBL-Targets; CHEMBL612794

DR   CLS; 300368/p474_U-937

DR   Cosmic; 787483

DR   Cosmic; 798666

DR   Cosmic; 821044

DR   Cosmic; 852000

DR   Cosmic; 919123

DR   Cosmic; 922162

DR   Cosmic; 932770

DR   Cosmic; 975307

DR   Cosmic; 991558

DR   Cosmic; 994178

DR   Cosmic; 999781

DR   Cosmic; 1012127

DR   Cosmic; 1019837

DR   Cosmic; 1067446

DR   Cosmic; 1070690

DR   Cosmic; 1078726

DR   Cosmic; 1082516

DR   Cosmic; 1086353

DR   Cosmic; 1089523

DR   Cosmic; 1107178

DR   Cosmic; 1127260

DR   Cosmic; 1150904

DR   Cosmic; 1176581

DR   Cosmic; 1181605

DR   Cosmic; 1191692

DR   Cosmic; 1465967

DR   Cosmic; 1523828

DR   Cosmic; 1524826

DR   Cosmic; 1582388

DR   Cosmic; 1601066

DR   Cosmic; 1995661

DR   Cosmic; 2301570

DR   Cosmic; 2361376

DR   DSMZ; ACC-5

DR   ECACC; 85011440

DR   GEO; GSM2020

DR   GEO; GSM236809

DR   GEO; GSM236845

DR   GEO; GSM482491

DR   GEO; GSM887724

DR   GEO; GSM888818

DR   GEO; GSM1028244

DR   GEO; GSM1028245

DR   GEO; GSM1374975

DR   GEO; GSM1670560

DR   ICLC; HTL94002

DR   IFO; IFO50038

DR   IMGT/HLA; 11507

DR   IZSLER; BS TCL 73

DR   JCRB; JCRB9021

DR   KCB; KCB 200676YJ

DR   KCLB; 21593.1

DR   LINCS; 50869

DR   Lonza; 135

DR   MeSH; D020298

DR   NCBI_Iran; C130

DR   PRIDE; PXD001521

DR   PRIDE; PXD001522

DR   PRIDE; PXD001523

DR   RCB; RCB1978

DR   TOKU-E; 3382

DR   Wikidata; Q7863610

RX   PubMed=178611;

RX   PubMed=1083890;

RX   PubMed=6091813;

RX   PubMed=6582512;

RX   PubMed=8547074;

RX   PubMed=8643484;

RX   PubMed=9685479;

RX   PubMed=9738977;

RX   PubMed=10676951;

RX   PubMed=11701946;

RX   PubMed=12393283;

RX   PubMed=15637111;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=20801507;

RX   PubMed=21269460;

RX   PubMed=22460905;

RX   PubMed=25485619;

WW   https://en.wikipedia.org/wiki/U937_cells

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=U937

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

WW   http://www.addexbio.com/productdetail?pid=72

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-315.html

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0012&theme=default

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA).

CC   Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-1593; true.

CC   Discontinued: RCB; RCB1978; true.

ST   Source(s): ATCC; CLS; COG; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 12 (ATCC; CLS; COG; ECACC; JCRB; KCLB; PubMed=25877200; RCB)

ST   CSF1PO: 10,12 (DSMZ; PubMed=15637111)

ST   D13S317: 10,12

ST   D16S539: 12

ST   D18S51: 13,14

ST   D19S433: 14,16

ST   D21S11: 27,29 (CLS; COG; PubMed=25877200)

ST   D21S11: 27 (PubMed=15637111)

ST   D2S1338: 17,20

ST   D3S1358: 16

ST   D5S818: 12 (ATCC; CLS; COG; ECACC; JCRB; KCLB; PubMed=25877200; RCB)

ST   D5S818: 10,12 (PubMed=15637111)

ST   D5S818: 10,12,13 (DSMZ)

ST   D7S820: 9,11

ST   D8S1179: 12,13

ST   FGA: 22,25

ST   Penta D: 12,13 (CLS; COG; PubMed=25877200)

ST   Penta D: 13 (PubMed=15637111)

ST   Penta E: 13

ST   TH01: 6,9.3 (ATCC; CLS; COG; DSMZ; ECACC; JCRB_IFO50038; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB)

ST   TH01: 6,10 (JCRB_JCRB9021)

ST   TH01: 9.3 (KCLB)

ST   TPOX: 8,11

ST   vWA: 15 (ATCC; KCLB)

ST   vWA: 14,15 (CLS; COG; DSMZ; ECACC; JCRB; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB)

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-937 cl1-14

AC   CVCL_2810

SY   U937 cl1-14

DR   JCRB; JCRB0116.1

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U-937 cl1-22

AC   CVCL_2811

SY   U937 cl1-22

DR   JCRB; JCRB0116.2

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U-937 DE-4

AC   CVCL_8765

DR   CLO; CLO_0050122

DR   BioSample; SAMN03472308

DR   RCB; RCB0435

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U-937 GTB

AC   CVCL_U631

SY   U-937-GTB; U-937/GTB; U937/GTB; U937-GTB

DR   ChEMBL-Cells; CHEMBL3308007

DR   ChEMBL-Targets; CHEMBL612795

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U-937-AG

AC   CVCL_X000

SY   U-937 AG

RX   PubMed=6748730;

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U-BLC1

AC   CVCL_2738

SY   UBLC1

DR   CCLE; UBLC1_URINARY_TRACT

DR   Cosmic; 2050467

DR   Cosmic; 2212693

DR   ECACC; 06013102

RX   PubMed=10074925;

RX   PubMed=24367658;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-CH1

AC   CVCL_4988

SY   UCH-1; UCH1

DR   EFO; EFO_0004389

DR   ATCC; CRL-3217

DR   DSMZ; ACC-748

DR   ENCODE; ENCBS267AAA

DR   GDSC; 1503374

RX   PubMed=11579460;

RX   PubMed=20461036;

RX   PubMed=21253487;

RX   PubMed=23325432;

RX   PubMed=26183925;

RX   PubMed=27102572;

WW   https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch1/

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Doubling time: ~1 week, but can be significantly longer after recovery from liquid nitrogen freezing (DSMZ); 2 days (PubMed=26183925).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

ST   Source(s): ATCC; DSMZ; PubMed=21253487; PubMed=26183925; PubMed=27102572

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D10S1248: 15

ST   D12S391: 17,22

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D18S51: 15

ST   D19S433: 14

ST   D1S1656: 16,16.3

ST   D21S11: 28,29

ST   D22S1045: 16

ST   D2S1338: 17,18

ST   D2S441: 12,14

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,12

ST   D8S1179: 10,15

ST   FGA: 20,21

ST   Penta D: 11

ST   Penta E: 7,10

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-CH1-N

AC   CVCL_4990

SY   U-CH1-NIRS

RX   PubMed=21914223;

CC   Doubling time: ~3 days (PubMed=21914223).

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4988 ! U-CH1

SX   Male

CA   Cancer cell line

//

ID   U-CH10

AC   CVCL_1D66

SY   UCH10

RX   PubMed=26183925;

RX   PubMed=27102572;

WW   https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch10/

CC   Doubling time: 14 days (PubMed=26183925).

ST   Source(s): PubMed=26183925; PubMed=27102572

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,13

ST   D16S539: 11,13

ST   D18S51: 13

ST   D19S433: 13,15

ST   D21S11: 29,31

ST   D2S1338: 19

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 9,10 (PubMed=26183925)

ST   D7S820: 10 (PubMed=27102572)

ST   D8S1179: 8,13

ST   FGA: 24

ST   Penta D: 9,13

ST   Penta E: 18

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-CH11

AC   CVCL_1D67

SY   UCH11

RX   PubMed=26183925;

WW   https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch11-2/

CC   Doubling time: 10 days (PubMed=26183925).

ST   Source(s): PubMed=26183925

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 14

ST   D16S539: 9,11

ST   D18S51: 14

ST   D3S1358: 15

ST   D7S820: 9,10

ST   D8S1179: 13,16

ST   Penta D: 9,12

ST   Penta E: 7,14

ST   TH01: 6,9.3

ST   TPOX: 8

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-CH12

AC   CVCL_IR27

SY   UCH12

RX   PubMed=26183925;

CC   Doubling time: 7 days (PubMed=26183925).

ST   Source(s): PubMed=26183925

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D10S1248: 14,16

ST   D12S391: 19,19.3

ST   D13S317: 12,13

ST   D16S539: 15

ST   D18S51: 17,18

ST   D19S433: 12,15

ST   D1S1656: 13,16

ST   D21S11: 27,32.2

ST   D22S1045: 15

ST   D2S1338: 22,23

ST   D2S441: 11

ST   D3S1358: 14,19

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   D8S1179: 14

ST   FGA: 23,24

ST   Penta D: 12

ST   Penta E: 12,15

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-CH2

AC   CVCL_4989

SY   UCH2

DR   ATCC; CRL-3218

DR   Cosmic-CLP; 1503373

DR   DSMZ; ACC-749

DR   GEO; GSM1670565

RX   PubMed=21253487;

RX   PubMed=26183925;

RX   PubMed=27102572;

RX   PubMed=27397505;

WW   https://www.chordomafoundation.org/reagents-data/cell-line-repository/u-ch2/

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf

CC   Doubling time: 4 days (PubMed=26183925); Doubling time: ~5-7 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=21253487; PubMed=26183925; PubMed=27102572

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D10S1248: 13,16

ST   D12S391: 18,19

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 12,18

ST   D19S433: 15.2,17

ST   D1S1656: 14.3,15

ST   D21S11: 29,30

ST   D22S1045: 15

ST   D2S1338: 24

ST   D2S441: 10,11.3

ST   D3S1358: 17

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   D8S1179: 13

ST   FGA: 21,22.2

ST   Penta D: 12,13

ST   Penta E: 12,15

ST   TH01: 9.3 (ATCC; DSMZ; PubMed=26183925; PubMed=27102572)

ST   TH01: 6 (Cosmic-CLP)

ST   TH01: 6,9.3 (PubMed=21253487)

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-CH3

AC   CVCL_IR25

SY   UCH3

RX   PubMed=26183925;

CC   Doubling time: 8 days (PubMed=26183925).

ST   Source(s): PubMed=26183925

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D10S1248: 15

ST   D12S391: 17,18

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 17

ST   D19S433: 13,14

ST   D1S1656: 15,17

ST   D21S11: 30

ST   D22S1045: 11

ST   D2S1338: 18,22

ST   D2S441: 10,11

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 16

ST   FGA: 26

ST   Penta D: 10

ST   Penta E: 7,14

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U-CH6

AC   CVCL_IR26

SY   UCH6

RX   PubMed=26183925;

CC   Doubling time: 14 days (PubMed=26183925).

CC   Derived from metastatic site: Skin.

ST   Source(s): PubMed=26183925

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D10S1248: 17

ST   D12S391: 18

ST   D13S317: 8

ST   D16S539: 12

ST   D18S51: 15

ST   D19S433: 13,16.2

ST   D1S1656: 17

ST   D21S11: 29

ST   D22S1045: 15

ST   D2S1338: 18,20

ST   D2S441: 11

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 12

ST   FGA: 19,21

ST   Penta D: 12

ST   Penta E: 13,20

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-CH7

AC   CVCL_IR23

SY   UCH7

RX   PubMed=26183925;

RX   PubMed=27102572;

CC   Doubling time: 7 days (PubMed=26183925).

ST   Source(s): PubMed=26183925; PubMed=27102572

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D10S1248: 13

ST   D12S391: 15,19

ST   D13S317: 10 (PubMed=27102572)

ST   D13S317: 10,12 (PubMed=26183925)

ST   D16S539: 10,12

ST   D18S51: 16

ST   D19S433: 13,14

ST   D1S1656: 17.3

ST   D21S11: 30,33.2

ST   D22S1045: 15

ST   D2S1338: 23

ST   D2S441: 10,14

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   D8S1179: 14,16

ST   FGA: 22,24

ST   Penta D: 12,13

ST   Penta E: 12,15

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C129927; Sacral chordoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U-HO1

AC   CVCL_2220

SY   U-H01

DR   BioSample; SAMN03473507

DR   Cosmic; 1289702

DR   Cosmic; 1432042

DR   DSMZ; ACC-626

DR   GEO; GSM381299

DR   IGRhCellID; U-HO1

RX   PubMed=18253030;

RX   PubMed=18820924;

CC   Doubling time: ~100 hours (DSMZ).

CC   Anecdotal: Andreas Mader, the first author of the paper (PubMed=18253030) describing this cell line is the patient that donated the cell line. As it is not frequent to see a patient 'acknowledged' by being an author this fact should be emphasized.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D5S818: 11

ST   D7S820: 8,10

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 18

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U1/HIV-1

AC   CVCL_M769

SY   U1

DR   NIH-ARP; 165-432

RX   PubMed=2449497;

RX   PubMed=3313729;

CC   Characteristics: Contains two copies of the HIV-1 proviral genome (strain HIV-NY5) per cell.

CC   Doubling time: 36 hours (NIH-ARP).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U14

AC   CVCL_9U56

RX   DOI=10.1007/s11805-008-0044-0;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: Kunming.

DI   NCIt; C24068; Mouse cervical carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_9U22 ! L10-90

OI   CVCL_9U43 ! P11-90

SX   Female

CA   Cancer cell line

//

ID   U14-GFP

AC   CVCL_9U57

RX   DOI=10.1007/s11805-008-0044-0;

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: Kunming.

DI   NCIt; C24068; Mouse cervical carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9U56 ! U14

SX   Female

CA   Cancer cell line

//

ID   U1I

AC   CVCL_IW88

RX   PubMed=6773878;

CC   Doubling time: 27.2 hours (PubMed=6773878).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Spontaneously immortalized cell line

//

ID   U2-OS Tet-On

AC   CVCL_V335

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0042 ! U2OS

SX   Female

CA   Cancer cell line

//

ID   U2-OS-Luc Tet-On

AC   CVCL_V336

SY   U-2 OS-Luc teT-on; U2OSLUC Tet ON

DR   CCRID; 3111C0001CCC000270

WW   http://www.clontech.com/xxclt_ibcGetAttachment.jsp?cItemId=26894&minisite=10020&secItmId=16274

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V335 ! U2-OS Tet-On

SX   Female

CA   Cancer cell line

//

ID   U251-TR3

AC   CVCL_1G29

SY   A172TR3; TR3

DR   Cosmic; 1236361

RX   DOI=10.1158/1078-0432.CCR-13-1821;

RX   PubMed=19584161;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought (PubMed=19584161) to be a A-172 (CVCL_0131) derivative but shown to be a U-251MG derivative (DOI 10.1158/1078-0432.CCR-13-1821).

CC   Selected for resistance to: ChEBI; CHEBI:72564; Temozolomide (TMZ).

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0021 ! U-251MG

SX   Male

CA   Cancer cell line

//

ID   U266/ADM

AC   CVCL_GZ72

RX   PubMed=26045737;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U266/velR

AC   CVCL_T031

RX   PubMed=24286313;

CC   Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U266B1

AC   CVCL_0566

SY   U266-B1; U266 B1; U-266; U 266; U266; U266S; U266BL; U266 Bl; 266 Bl

DR   BTO; BTO:0001594

DR   CLO; CLO_0009457

DR   CLO; CLO_0009458

DR   EFO; EFO_0001254

DR   MCCL; MCC:0000471

DR   CLDB; cl4584

DR   CLDB; cl4609

DR   ATCC; TIB-196

DR   BCRC; 60437

DR   BCRJ; 0240

DR   BioSample; SAMN01821605

DR   BioSample; SAMN01821669

DR   BioSample; SAMN03472935

DR   CCLE; U266B1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CGH-DB; 37-1

DR   CGH-DB; 9155-4

DR   ChEMBL-Cells; CHEMBL3308535

DR   ChEMBL-Targets; CHEMBL2366315

DR   Cosmic; 720795

DR   Cosmic; 742953

DR   Cosmic; 753615

DR   Cosmic; 759903

DR   Cosmic; 759912

DR   Cosmic; 760401

DR   Cosmic; 760647

DR   Cosmic; 886087

DR   Cosmic; 888019

DR   Cosmic; 991555

DR   Cosmic; 1424220

DR   Cosmic; 1483078

DR   Cosmic; 1762463

DR   Cosmic; 1889513

DR   Cosmic; 2081409

DR   Cosmic; 2367281

DR   Cosmic; 2391806

DR   Cosmic-CLP; 753615

DR   DSMZ; ACC-9

DR   ECACC; 85051003

DR   GDSC; 753615

DR   GEO; GSM143345

DR   GEO; GSM545498

DR   GEO; GSM545499

DR   GEO; GSM827442

DR   GEO; GSM887721

DR   GEO; GSM888815

DR   GEO; GSM1374970

DR   GEO; GSM1670556

DR   IGRhCellID; U266B1

DR   IZSLER; BS TCL 233

DR   KCB; KCB 2013024YJ

DR   Lonza; 807

DR   NCBI_Iran; C151

RX   PubMed=1643757;

RX   PubMed=2537114;

RX   PubMed=4097745;

RX   PubMed=8943038;

RX   PubMed=9685479;

RX   PubMed=10087940;

RX   PubMed=10557056;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=11429052;

RX   PubMed=15215163;

RX   PubMed=16956823;

RX   PubMed=17171682;

RX   PubMed=21173094;

RX   PubMed=22460905;

RX   PubMed=23074853;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Group: Hybridoma fusion partner cell line.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~55 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: BCRJ; 0240; probable.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 12,14

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 13

ST   FGA: 18

ST   Penta D: 10,13

ST   Penta E: 10,12

ST   TH01: 5,7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W412 ! U268

SX   Male

CA   Cancer cell line

//

ID   U266R

AC   CVCL_C828

RX   PubMed=8307198;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U268

AC   CVCL_W412

SY   U-268; 268 Bm

RX   PubMed=4097745;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0566 ! U266B1

SX   Male

CA   Cancer cell line

//

ID   U28

AC   CVCL_J093

DR   ECACC; 93022518

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   U2OS

AC   CVCL_0042

AS   CVCL_L856

SY   U-2 OS; U-2OS; U-2-OS; U2-OS; U20-S; U20S; 2T

DR   BTO; BTO:0001938

DR   CLO; CLO_0001272

DR   CLO; CLO_0009454

DR   EFO; EFO_0002869

DR   MCCL; MCC:0000468

DR   CLDB; cl53

DR   CLDB; cl4579

DR   CLDB; cl4580

DR   CLDB; cl4581

DR   CLDB; cl7217

DR   ATCC; HTB-96

DR   BCRC; 60187

DR   BCRJ; 0304

DR   BioSample; SAMN03472549

DR   BioSample; SAMN03472766

DR   CCLE; U2OS_BONE

DR   CCRID; 3111C0001CCC000028

DR   CCRID; 3131C0001000700088

DR   ChEMBL-Cells; CHEMBL3307757

DR   ChEMBL-Targets; CHEMBL615023

DR   CLS; 300364/p489_U-2_OS

DR   Cosmic; 687934

DR   Cosmic; 755312

DR   Cosmic; 909776

DR   Cosmic; 931038

DR   Cosmic; 931909

DR   Cosmic; 1044081

DR   Cosmic; 1044268

DR   Cosmic; 1066238

DR   Cosmic; 1074397

DR   Cosmic; 1078392

DR   Cosmic; 1082493

DR   Cosmic; 1097758

DR   Cosmic; 1529905

DR   Cosmic; 1733128

DR   Cosmic; 2009542

DR   Cosmic; 2301583

DR   Cosmic; 2440477

DR   Cosmic-CLP; 909776

DR   DSMZ; ACC-785

DR   ECACC; 92022711

DR   ENCODE; ENCBS200HLU

DR   ENCODE; ENCBS266AAA

DR   ENCODE; ENCBS953RZO

DR   GDSC; 909776

DR   GEO; GSE54820

DR   GEO; GSM170250

DR   GEO; GSM185160

DR   GEO; GSM185161

DR   GEO; GSM287989

DR   GEO; GSM287990

DR   GEO; GSM320831

DR   GEO; GSM827583

DR   GEO; GSM879223

DR   GEO; GSM887722

DR   GEO; GSM888816

DR   GEO; GSM1231597

DR   GEO; GSM1231598

DR   GEO; GSM1231599

DR   GEO; GSM1231600

DR   GEO; GSM1231601

DR   GEO; GSM1231602

DR   GEO; GSM1231603

DR   GEO; GSM1231604

DR   GEO; GSM1231605

DR   GEO; GSM1231606

DR   GEO; GSM1231607

DR   GEO; GSM1231608

DR   GEO; GSM1231609

DR   GEO; GSM1231610

DR   GEO; GSM1356565

DR   GEO; GSM1356566

DR   GEO; GSM1356567

DR   GEO; GSM1356568

DR   GEO; GSM1356569

DR   GEO; GSM1356570

DR   GEO; GSM1356571

DR   GEO; GSM1356572

DR   GEO; GSM1356573

DR   GEO; GSM1356574

DR   GEO; GSM1356575

DR   GEO; GSM1356576

DR   GEO; GSM1356577

DR   GEO; GSM1356578

DR   GEO; GSM1356579

DR   GEO; GSM1356580

DR   GEO; GSM1356581

DR   GEO; GSM1356582

DR   GEO; GSM1356583

DR   GEO; GSM1356584

DR   GEO; GSM1356585

DR   GEO; GSM1356586

DR   GEO; GSM1356587

DR   GEO; GSM1670557

DR   GEO; GSM1676324

DR   GEO; GSM1701657

DR   ICLC; HTL11001

DR   KCB; KCB 200962YJ

DR   KCLB; 30096

DR   Lonza; 676

DR   PRIDE; PRD000118

DR   PRIDE; PXD000157

DR   PRIDE; PXD000589

DR   PRIDE; PXD001220

DR   PRIDE; PXD002073

DR   PRIDE; PXD002117

DR   PRIDE; PXD002395

DR   PRIDE; PXD003754

DR   TOKU-E; 3379

DR   Wikidata; Q28473037

RX   PubMed=833871;

RX   PubMed=2823272;

RX   PubMed=6081590;

RX   PubMed=8275086;

RX   PubMed=8617485;

RX   PubMed=12645653;

RX   PubMed=15150091;

RX   PubMed=15736406;

RX   PubMed=18359981;

RX   PubMed=19787792;

RX   PubMed=21519327;

RX   PubMed=22068332;

RX   PubMed=22278370;

RX   PubMed=22460905;

RX   PubMed=24618588;

RX   PubMed=25485619;

RX   PubMed=25894527;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://141.61.102.20/mxdb/project/show/9191407937500

WW   http://www.proteinatlas.org/learn/cellines

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=U2-OS

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u2/u2cells.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-92.html

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/U2OS_Farnham_protocol.pdf

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ENCODE project common cell types; tier 3.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~25-30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Cell surface proteome.

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using proteomics.

CC   Misspelling: Occasionally 'U-205'.

CC   Misspelling: Occasionally 'U205'.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)

ST   CSF1PO: 12,13 (CLS; DSMZ)

ST   D13S317: 13 (ATCC; Cosmic-CLP; DSMZ; ECACC; KCLB; PubMed=25877200)

ST   D13S317: 11,13 (CLS)

ST   D16S539: 11,12

ST   D18S51: 12,14 (CLS)

ST   D18S51: 14 (PubMed=25877200)

ST   D21S11: 31

ST   D3S1358: 16

ST   D5S818: 11 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)

ST   D5S818: 8,11 (CLS; DSMZ)

ST   D7S820: 11,12 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; KCLB)

ST   D7S820: 12 (PubMed=25877200)

ST   D8S1179: 12,14

ST   FGA: 20

ST   Penta D: 9

ST   Penta E: 10,13

ST   TH01: 6,9.3

ST   TPOX: 11,12

ST   vWA: 14,18

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3002MG

AC   CVCL_IR56

SY   U3002-MG; U3002

DR   GEO; GSM1857567

DR   GEO; GSM1857783

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3004MG

AC   CVCL_IR57

SY   U3004-MG; U3004

DR   GEO; GSM1857568

DR   GEO; GSM1857784

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D18S51: 16,19

ST   D19S433: 15.2,16.2

ST   D21S11: 29,31.2

ST   D2S1338: 19,24

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 20,23

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3005MG

AC   CVCL_IR58

SY   U3005-MG; U3005

DR   GEO; GSM1857569

DR   GEO; GSM1857785

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3008MG

AC   CVCL_IR59

SY   U3008-MG; U3008

DR   GEO; GSM1857570

DR   GEO; GSM1857786

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D18S51: 14,18

ST   D19S433: 15

ST   D21S11: 30,33.2

ST   D2S1338: 19,25

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 11,15

ST   FGA: 21,25

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3009MG

AC   CVCL_IR60

SY   U3009-MG; U3009

DR   GEO; GSM1857571

DR   GEO; GSM1857787

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 9

ST   D18S51: 13,15

ST   D19S433: 14,15

ST   D21S11: 29,31

ST   D2S1338: 19,25

ST   D3S1358: 16,17

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 14

ST   FGA: 19,22.2

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3013MG

AC   CVCL_IR61

SY   U3013-MG; U3013

DR   GEO; GSM1857572

DR   GEO; GSM1857788

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 14

ST   D16S539: 10

ST   D18S51: 13,14

ST   D19S433: 14

ST   D21S11: 31.2,32.2

ST   D2S1338: 25,26

ST   D3S1358: 17,19

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 18,24

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3016MG

AC   CVCL_IR62

SY   U3016-MG; U3016

DR   GEO; GSM1857573

DR   GEO; GSM1857789

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3017MG

AC   CVCL_IR63

SY   U3017-MG; U3017

DR   GEO; GSM1857574

DR   GEO; GSM1857790

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,12

ST   D18S51: 14,18

ST   D19S433: 14,16.2

ST   D21S11: 29,31.2

ST   D2S1338: 20,25

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 10,15

ST   FGA: 20,26

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3019MG

AC   CVCL_IR64

SY   U3019-MG; U3019

DR   GEO; GSM1857575

DR   GEO; GSM1857791

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 14

ST   D16S539: 10

ST   D18S51: 13,14

ST   D19S433: 14

ST   D21S11: 31.2,32.2

ST   D3S1358: 17,19

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 13,14

ST   FGA: 18,24

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3020MG

AC   CVCL_IR65

SY   U3020-MG; U3020

DR   GEO; GSM1857576

DR   GEO; GSM1857792

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 11,13

ST   D18S51: 16

ST   D19S433: 13,15

ST   D21S11: 31.2

ST   D2S1338: 23,24

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   D8S1179: 12,13

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 8,11

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3021MG

AC   CVCL_IR66

SY   U3021-MG; U3021

DR   GEO; GSM1857577

DR   GEO; GSM1857793

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 13,15

ST   D19S433: 14,15

ST   D21S11: 28,29

ST   D2S1338: 17,23

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21,25

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3024MG

AC   CVCL_IR67

SY   U3024-MG; U3024

DR   GEO; GSM1857578

DR   GEO; GSM1857794

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 14

ST   D16S539: 12,13

ST   D18S51: 15,17

ST   D19S433: 14,15

ST   D21S11: 32.2

ST   D2S1338: 17

ST   D3S1358: 15,18

ST   D5S818: 10,12

ST   D7S820: 8,12

ST   D8S1179: 12,15

ST   FGA: 19,23

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3027MG

AC   CVCL_IR68

SY   U3027-MG; U3027

DR   GEO; GSM1857579

DR   GEO; GSM1857795

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 12

ST   D18S51: 16,18

ST   D19S433: 13,14

ST   D21S11: 30,31.2

ST   D2S1338: 21,24

ST   D3S1358: 17,18

ST   D5S818: 11,12

ST   D7S820: 9,12

ST   D8S1179: 12,14

ST   FGA: 22,23

ST   TH01: 6,7

ST   TPOX: 8,10

ST   vWA: 18,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3028MG

AC   CVCL_IR69

SY   U3028-MG; U3028

DR   GEO; GSM1857580

DR   GEO; GSM1857796

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3029MG

AC   CVCL_IR70

SY   U3029-MG; U3029

DR   GEO; GSM1857581

DR   GEO; GSM1857797

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 12,14

ST   D19S433: 14,15

ST   D21S11: 29,30

ST   D2S1338: 17,18

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 8

ST   D8S1179: 13,15

ST   FGA: 21,23

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3031MG

AC   CVCL_IR71

SY   U3031-MG; U3031

DR   GEO; GSM1857582

DR   GEO; GSM1857798

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 14,18

ST   D19S433: 14.2

ST   D21S11: 30,33.2

ST   D2S1338: 18,19

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 22,24

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 18,20

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3033MG

AC   CVCL_IR72

SY   U3033-MG; U3033

DR   GEO; GSM1857583

DR   GEO; GSM1857799

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 10,12

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 29,32.2

ST   D2S1338: 16,24

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 12,14

ST   FGA: 22

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3034MG

AC   CVCL_IR73

SY   U3034-MG; U3034

DR   GEO; GSM1857584

DR   GEO; GSM1857800

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,14

ST   D18S51: 13,16

ST   D19S433: 13,13.2

ST   D21S11: 27,28

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 15,16

ST   FGA: 19,22

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3035MG

AC   CVCL_IR74

SY   U3035-MG; U3035

DR   GEO; GSM1857585

DR   GEO; GSM1857801

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11,14

ST   D18S51: 14,18

ST   D19S433: 14,15

ST   D21S11: 28,30.2

ST   D2S1338: 17

ST   D3S1358: 16,17

ST   D5S818: 10,11

ST   D7S820: 10

ST   D8S1179: 11,12

ST   FGA: 21,25

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3037MG

AC   CVCL_IR75

SY   U3037-MG; U3037

DR   GEO; GSM1857586

DR   GEO; GSM1857802

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 11,14

ST   D18S51: 12,16

ST   D19S433: 15

ST   D21S11: 30,31.2

ST   D2S1338: 25

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 21,25

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3039MG

AC   CVCL_IR76

SY   U3039-MG; U3039

DR   GEO; GSM1857587

DR   GEO; GSM1857803

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 12,14

ST   D13S317: 9,13

ST   D16S539: 11

ST   D18S51: 12,14

ST   D19S433: 12,15

ST   D21S11: 29,33.2

ST   D2S1338: 17,20

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   D8S1179: 11,14

ST   FGA: 21,22

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3042MG

AC   CVCL_IR77

SY   U3042-MG; U3042

DR   GEO; GSM1857588

DR   GEO; GSM1857804

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D16S539: 12,13

ST   D18S51: 16,19

ST   D19S433: 14,15

ST   D21S11: 31

ST   D2S1338: 17,20

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 9,10

ST   D8S1179: 13

ST   FGA: 21,23

ST   TH01: 6,7

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3046MG

AC   CVCL_IR78

SY   U3046-MG; U3046

DR   GEO; GSM1857589

DR   GEO; GSM1857805

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 14,16

ST   D19S433: 13,14

ST   D21S11: 28,31

ST   D2S1338: 20,22

ST   D3S1358: 14,18

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 23,25

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3047MG

AC   CVCL_IR79

SY   U3047-MG; U3047

DR   GEO; GSM1857590

DR   GEO; GSM1857806

RX   PubMed=25510230;

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,13

ST   D16S539: 9

ST   D18S51: 14,20

ST   D19S433: 14,15.2

ST   D21S11: 28,31

ST   D2S1338: 23

ST   D3S1358: 16,17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 21,23

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 14,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3048MG

AC   CVCL_IR80

SY   U3048-MG; U3048

DR   GEO; GSM1857591

DR   GEO; GSM1857807

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 11,13

ST   D18S51: 13,18

ST   D19S433: 15,15.2

ST   D21S11: 30,31

ST   D2S1338: 23

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 9

ST   D8S1179: 13,14

ST   FGA: 23

ST   TH01: 7,9.3

ST   TPOX: 8,12

ST   vWA: 14,16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3051MG

AC   CVCL_IR81

SY   U3051-MG; U3051

DR   GEO; GSM1857592

DR   GEO; GSM1857808

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3053MG

AC   CVCL_IR82

SY   U3053-MG; U3053

DR   GEO; GSM1857593

DR   GEO; GSM1857809

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D18S51: 14,18

ST   D19S433: 14,15

ST   D21S11: 28,31

ST   D2S1338: 16,24

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 10,12

ST   FGA: 21,22

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3054MG

AC   CVCL_IR83

SY   U3054-MG; U3054

DR   GEO; GSM1857594

DR   GEO; GSM1857810

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 9,12

ST   D18S51: 12

ST   D19S433: 14,14.2

ST   D21S11: 31,32.2

ST   D2S1338: 23

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 13,17

ST   FGA: 21,23

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3056MG

AC   CVCL_IR84

SY   U3056-MG; U3056

DR   GEO; GSM1857595

DR   GEO; GSM1857811

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3060MG

AC   CVCL_IR85

SY   U3060-MG; U3060

DR   GEO; GSM1857596

DR   GEO; GSM1857812

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 11,13

ST   D18S51: 17,18

ST   D19S433: 14,15

ST   D21S11: 28,29

ST   D2S1338: 17,24

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 8,9

ST   D8S1179: 10,14

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3062MG

AC   CVCL_IR86

SY   U3062-MG; U3062

DR   GEO; GSM1857597

DR   GEO; GSM1857813

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3065MG

AC   CVCL_IR87

SY   U3065-MG; U3065

DR   GEO; GSM1857598

DR   GEO; GSM1857814

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 8,10

ST   D16S539: 11,12

ST   D18S51: 12,15

ST   D19S433: 13

ST   D21S11: 28,30.2

ST   D2S1338: 19,21

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 8,11

ST   D8S1179: 14,15

ST   FGA: 21,25

ST   TH01: 9.3

ST   TPOX: 8,12

ST   vWA: 14,16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3067MG

AC   CVCL_IR88

SY   U3067-MG; U3067

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 14,17

ST   D19S433: 13,14

ST   D21S11: 27,29

ST   D2S1338: 17,18

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 14

ST   FGA: 23

ST   TH01: 9,10

ST   TPOX: 8,9

ST   vWA: 19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3068MG

AC   CVCL_IR89

SY   U3068-MG; U3068

DR   GEO; GSM1857599

DR   GEO; GSM1857815

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3071MG

AC   CVCL_IR90

SY   U3071-MG; U3071

DR   GEO; GSM1857600

DR   GEO; GSM1857816

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 9

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 15

ST   D19S433: 14,14.2

ST   D21S11: 30.2,31

ST   D2S1338: 20,23

ST   D3S1358: 16,18

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 19,23

ST   TH01: 9.3,10

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3073MG

AC   CVCL_IR91

SY   U3073-MG; U3073

DR   GEO; GSM1857601

DR   GEO; GSM1857817

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 12

ST   D18S51: 12,16

ST   D19S433: 13,15

ST   D21S11: 29,30.2

ST   D2S1338: 20,25

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10,12

ST   FGA: 19,21

ST   TH01: 6,8

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3078MG

AC   CVCL_IR92

SY   U3078-MG; U3078

DR   GEO; GSM1857602

DR   GEO; GSM1857818

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D18S51: 14,15

ST   D19S433: 13,15

ST   D21S11: 28,29

ST   D2S1338: 17,24

ST   D3S1358: 14,17

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 23,25

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3082MG

AC   CVCL_IR93

SY   U3082-MG; U3082

DR   GEO; GSM1857603

DR   GEO; GSM1857819

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 9,12

ST   D16S539: 12,13

ST   D18S51: 12

ST   D19S433: 14,15

ST   D21S11: 28,31.2

ST   D2S1338: 16,19

ST   D3S1358: 15,16

ST   D5S818: 9,12

ST   D7S820: 9,13

ST   D8S1179: 12,13

ST   FGA: 22,25

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3084MG

AC   CVCL_IR94

SY   U3084-MG; U3084

DR   GEO; GSM1857604

DR   GEO; GSM1857820

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 11,14

ST   D18S51: 12,18

ST   D19S433: 13

ST   D21S11: 29,30

ST   D2S1338: 17,20

ST   D3S1358: 15,17

ST   D5S818: 11,14

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 22

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IR96 ! U3086MG

SX   Male

CA   Cancer cell line

//

ID   U3085MG

AC   CVCL_IR95

SY   U3085-MG; U3085

DR   GEO; GSM1857605

DR   GEO; GSM1857821

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 12,14

ST   D19S433: 14

ST   D21S11: 28,30

ST   D2S1338: 17,18

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 12,15

ST   FGA: 21,24

ST   TH01: 6,9.3

ST   TPOX: 10,11

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3086MG

AC   CVCL_IR96

SY   U3086-MG; U3086

DR   GEO; GSM1857606

DR   GEO; GSM1857822

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 11,14

ST   D18S51: 12,18

ST   D19S433: 13

ST   D21S11: 29,30

ST   D2S1338: 17,20

ST   D3S1358: 15,17

ST   D5S818: 11,14

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 22

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IR94 ! U3084MG

SX   Male

CA   Cancer cell line

//

ID   U3088MG

AC   CVCL_IR97

SY   U3088-MG; U3088

DR   GEO; GSM1857607

DR   GEO; GSM1857823

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26629530

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 17,18

ST   D19S433: 15,16.2

ST   D21S11: 27,30

ST   D2S1338: 19,24

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 23,24

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3101MG

AC   CVCL_IR98

SY   U3101-MG; U3101

DR   GEO; GSM1857608

DR   GEO; GSM1857824

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3110MG

AC   CVCL_IR99

SY   U3110-MG; U3110

DR   GEO; GSM1857609

DR   GEO; GSM1857825

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   U3117MG

AC   CVCL_IS00

SY   U3117-MG; U3117

DR   GEO; GSM1857610

DR   GEO; GSM1857826

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IS01 ! U3118MG

SX   Male

CA   Cancer cell line

//

ID   U3118MG

AC   CVCL_IS01

SY   U3118-MG; U3118

DR   GEO; GSM1857611

DR   GEO; GSM1857827

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IS00 ! U3117MG

SX   Male

CA   Cancer cell line

//

ID   U3121MG

AC   CVCL_IS02

SY   U3121-MG; U3121

DR   GEO; GSM1857612

DR   GEO; GSM1857828

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3123MG

AC   CVCL_IS03

SY   U3123-MG; U3123

DR   GEO; GSM1857613

DR   GEO; GSM1857829

RX   PubMed=26629530;

WW   http://www.hgcc.se/

CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   U3129MG

AC   CVCL_IS04

SY   U3129-MG; U3129

DR   GEO; GSM1857614

CC   Omics: SNP array analysis.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   U373-MAGI

AC   CVCL_1F84

SY   U373-CD4

DR   NIH-ARP; 3595-281

RX   PubMed=7690415;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2219 ! U-373MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U373-MAGI-CCR5

AC   CVCL_1F85

SY   U373-MAGI-CCR5E

DR   NIH-ARP; 3597-204

RX   PubMed=9201229;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1606; CCR5.

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1F84 ! U373-MAGI

SX   Male

CA   Cancer cell line

//

ID   U373-MAGI-CXCR4

AC   CVCL_1F86

SY   U373-MAGI-CXCR4CEM

DR   NIH-ARP; 3596-40

RX   PubMed=9201229;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 2561; CXCR4.

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1F84 ! U373-MAGI

SX   Male

CA   Cancer cell line

//

ID   U38

AC   CVCL_M770

DR   NIH-ARP; 1297-125

RX   PubMed=3422113;

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U4.4

AC   CVCL_Z820

SY   u4.4

RX   PubMed=3951024;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7160; ! Aedes albopictus

HI   CVCL_Z223 ! ATC-15

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   U87 MG-Red-FLuc

AC   CVCL_5J12

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW124577

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87-CD4 Clone 2

AC   CVCL_X702

SY   U87MG clone 2

DR   NIH-ARP; 2187-19

RX   PubMed=2293663;

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87-MG/Pt

AC   CVCL_4V16

DR   Cosmic; 1198264

RX   CelloPub=CLPUB00268;

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87/DK

AC   CVCL_3428

SY   U87-DK; U87DK; U87 dead kinase; U87MG.deltaEGFR

DR   CLDB; cl7208

DR   ICLC; HTL08003

RX   PubMed=9006938;

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

CC   Transfected with: HGNC; 3236; EGFR (truncated extracellular mutant with M-745).

ST   Source(s): ICLC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 12

ST   D21S11: 28.2,32.2

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87/WT

AC   CVCL_3429

DR   CLDB; cl7209

DR   ICLC; HTL08004

CC   Problematic cell line: Contaminated/misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.

ST   Source(s): ICLC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,11

ST   D16S539: 12

ST   D21S11: 28.2,32.2

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87.CD4

AC   CVCL_X626

SY   U87/CD4; U87MG.CD4

DR   NIH-ARP; 4031-20

RX   PubMed=9311827;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0022 ! U-87MG ATCC

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CCR1

AC   CVCL_X627

SY   U87.CD4-CCR1

DR   NIH-ARP; 4032-23

RX   PubMed=9311827;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default

CC   Transfected with: HGNC; 1602; CCR1.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CCR2

AC   CVCL_X628

SY   U87.CD4.CCR2b; U87.CD4-CCR2b

DR   NIH-ARP; 4033-24

RX   PubMed=9311827;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0070&theme=default

CC   Transfected with: HGNC; 1603; CCR2.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CCR3

AC   CVCL_X629

SY   U87.CD4-CCR3

DR   NIH-ARP; 4034-26

RX   PubMed=9311827;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0071&theme=default

CC   Transfected with: HGNC; 1604; CCR3.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CCR5

AC   CVCL_X630

SY   U87.CD4-CCR5

DR   NIH-ARP; 4035-332

RX   PubMed=9311827;

RX   PubMed=15169555;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0072&theme=default

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1606; CCR5.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CCR5.CXCR4

AC   CVCL_X631

RX   PubMed=15169555;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1606; CCR5.

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U87.CD4.CXCR4

AC   CVCL_X632

SY   U87.CD4-CXCR4; U87 CD4+ CXCR4+

DR   NIH-ARP; 4036-455

RX   PubMed=9311827;

RX   PubMed=15169555;

WW   http://www.nibsc.org/Default.aspx?pageid=597&id=0073&theme=default

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X626 ! U87.CD4

SX   Male

CA   Cancer cell line

//

ID   U937-DC-SIGN

AC   CVCL_2Z95

DR   ATCC; CRL-3253

RX   PubMed=17804661;

CC   Transfected with: HGNC; 1641; CD209.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/ara-C

AC   CVCL_4V23

RX   PubMed=21290089;

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/clone21

AC   CVCL_Y170

DR   CGH-DB; 9116-4

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/clone36

AC   CVCL_Y171

DR   CGH-DB; 9117-4

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/clone41

AC   CVCL_Y172

DR   CGH-DB; 9118-4

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/clone49

AC   CVCL_Y173

DR   CGH-DB; 9119-4

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/HIV-2MS

AC   CVCL_X608

DR   NIH-ARP; 127-109

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/UK110

AC   CVCL_Y174

SY   UK110

RX   PubMed=8845304;

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937/UK711

AC   CVCL_Y175

SY   UK711

DR   CGH-DB; 9120-4

RX   PubMed=7957669;

RX   PubMed=14973057;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937(CD59-)

AC   CVCL_8932

SY   CD59- U937

RX   PubMed=7518799;

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   U937(CD59+)

AC   CVCL_8927

SY   CD59+ U937

DR   CLO; CLO_0009466

DR   CLDB; cl682

DR   ECACC; 95102435

RX   PubMed=7518799;

CC   Discontinued: ECACC; 95102435; probable.

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   UA-S2

AC   CVCL_E859

SY   BUA

DR   dbMHC; 49049

DR   ECACC; 94071430

DR   IHW; IHW9328

DR   IMGT/HLA; 11508

WW   http://bioinformatics.hsanmartino.it/ecbr/cl328.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   UACC-1012

AC   CVCL_M448

SY   UACC 1012; UACC1012; University of Arizona Cell Culture-1012

RX   PubMed=10952317;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-1022

AC   CVCL_4035

SY   UACC 1022; UACC1022; University of Arizona Cell Culture-1022

RX   PubMed=10952317;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-1097

AC   CVCL_M449

SY   UACC 1097; UACC1097; University of Arizona Cell Culture-1097

RX   PubMed=10952317;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-1118

AC   CVCL_DG48

SY   UACC 1118; UACC1118; University of Arizona Cell Culture-1118

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-1179

AC   CVCL_4036

SY   UACC 1179; UACC1179; University of Arizona Cell Culture-1179

DR   ATCC; CRL-3127

RX   PubMed=9778046;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 10,13

ST   D5S818: 12

ST   D7S820: 8,11

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-1227

AC   CVCL_4037

SY   UACC 1227; UACC1227; University of Arizona Cell Culture-1227

RX   PubMed=12115485;

RX   PubMed=19383853;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-1237

AC   CVCL_4038

SY   UACC 1237; UACC1237; University of Arizona Cell Culture-1237

RX   PubMed=12115485;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-1256

AC   CVCL_M450

SY   UACC1256

RX   PubMed=10952317;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-1273

AC   CVCL_G297

SY   UACC 1273; UACC1273; University of Arizona Cell Culture-1273

RX   PubMed=10952317;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-1273EV

AC   CVCL_4039

SY   UACC 1273EV; UACC1273EV

DR   BTO; BTO:0005064

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_G297 ! UACC-1273

SX   Male

CA   Cancer cell line

//

ID   UACC-1308

AC   CVCL_DG39

SY   UACC 1308; UACC1308; University of Arizona Cell Culture-1308

DR   BTO; BTO:0005895

RX   PubMed=23039341;

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-1529

AC   CVCL_M451

SY   UACC 1529; UACC1529; University of Arizona Cell Culture-1529

RX   PubMed=10952317;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-1598

AC   CVCL_4040

SY   UACC 1598; UACC1598; University of Arizona Cell Culture-1598

DR   ATCC; CRL-3128

DR   BioSample; SAMN03471713

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 13

ST   D16S539: 11,12

ST   D5S818: 13

ST   D7S820: 7,9

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-182

AC   CVCL_S728

SY   UACC 182; UACC182; University of Arizona Cell Culture-182

DR   Cosmic; 1020265

RX   PubMed=10918183;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-1940

AC   CVCL_IN96

SY   UACC 1940; UACC1940; University of Arizona Cell Culture-1940

DR   BTO; BTO:0005896

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-2087

AC   CVCL_4041

SY   UACC 2087; UACC2087; University of Arizona Cell Culture-2087

DR   ATCC; CRL-3180

RX   PubMed=9778046;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,10

ST   D16S539: 11

ST   D7S820: 10,12

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-239

AC   CVCL_S729

SY   UACC 239 UACC239; University of Arizona Cell Culture-239

DR   Cosmic; 1020266

RX   PubMed=10918183;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-2534

AC   CVCL_M452

SY   UACC 2534; UACC2534; University of Arizona Cell Culture-2534

DR   BTO; BTO:0005897

DR   Cosmic; 1211155

RX   PubMed=10952317;

RX   PubMed=23039341;

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-2561

AC   CVCL_E116

SY   UACC 2561; UACC2561; University of Arizona Cell Culture-2561

DR   Cosmic; 730330

RX   PubMed=8050085;

DI   NCIt; C45543; Lung carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-2565

AC   CVCL_M453

SY   UACC 2565; UACC2565; University of Arizona Cell Culture-2565

RX   PubMed=19383853;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-257

AC   CVCL_1779

SY   UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257

DR   BTO; BTO:0004233

DR   EFO; EFO_0005376

DR   BioSample; SAMN03473125

DR   CCLE; UACC257_SKIN

DR   ChEMBL-Cells; CHEMBL3308008

DR   ChEMBL-Targets; CHEMBL612796

DR   Cosmic; 686478

DR   Cosmic; 688056

DR   Cosmic; 875890

DR   Cosmic; 905977

DR   Cosmic; 974070

DR   Cosmic; 974259

DR   Cosmic; 1054854

DR   Cosmic; 1092645

DR   Cosmic; 1175874

DR   Cosmic; 1303058

DR   Cosmic; 1305370

DR   Cosmic; 1507612

DR   Cosmic; 1998488

DR   Cosmic; 2233682

DR   Cosmic-CLP; 905977

DR   GDSC; 905977

DR   GEO; GSM50207

DR   GEO; GSM50269

DR   GEO; GSM188228

DR   GEO; GSM188258

DR   GEO; GSM188317

DR   GEO; GSM750818

DR   GEO; GSM799359

DR   GEO; GSM799422

DR   GEO; GSM847167

DR   GEO; GSM844720

DR   GEO; GSM844721

DR   GEO; GSM887725

DR   GEO; GSM888819

DR   GEO; GSM1153430

DR   GEO; GSM1181338

DR   GEO; GSM1181360

DR   GEO; GSM1670561

DR   SKY/M-FISH/CGH; 2826

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=17308088;

RX   PubMed=19372543;

RX   PubMed=22460905;

RX   PubMed=23039341;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24879157;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=50

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 38.5 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,13

ST   D16S539: 9,11

ST   D18S51: 15

ST   D19S433: 12,15

ST   D21S11: 30,31.2

ST   D2S1338: 17,25

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   D8S1179: 13,15

ST   FGA: 22

ST   Penta D: 9,12

ST   Penta E: 10

ST   TH01: 8

ST   TPOX: 9,12

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   UACC-2648

AC   CVCL_W021

SY   UACC 2648; UACC2648; University of Arizona Cell Culture-2648

DR   ATCC; CRL-3121

RX   PubMed=9778046;

CC   Discontinued: ATCC; CRL-3121; probable.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 8

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 14,15

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-2837

AC   CVCL_DG40

SY   UACC 2837; UACC2837; University of Arizona Cell Culture-2837

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-2972

AC   CVCL_1G28

SY   UACC 2972; UACC2972; University of Arizona Cell Culture-2972

RX   PubMed=12115485;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-2973

AC   CVCL_M454

SY   UACC 2973; UACC2973; University of Arizona Cell Culture-2973

RX   PubMed=10952317;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-2996

AC   CVCL_W092

SY   UACC 2996; UACC2996; University of Arizona Cell Culture-2996

DR   ATCC; CRL-3123

CC   Discontinued: ATCC; CRL-3123; probable.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-3074

AC   CVCL_M455

SY   UACC 3074; UACC3074; University of Arizona Cell Culture-3074

RX   PubMed=19383853;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-3093

AC   CVCL_A692

SY   UACC 3093; UACC3093; University of Arizona Cell Culture-3093

DR   Cosmic; 1211163

RX   PubMed=10952317;

RX   PubMed=23039341;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-3133

AC   CVCL_B221

SY   UACC 3133; UACC3133; University of Arizona Cell Culture-3133

DR   ATCC; CRL-2988

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 9,11

ST   D7S820: 8,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C7950; Invasive lobular breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-3149

AC   CVCL_M456

SY   UACC 3149; UACC3149; University of Arizona Cell Culture-3149

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-3199

AC   CVCL_4042

SY   UACC 3199; UACC3199; University of Arizona Cell Culture-3199

DR   ATCC; CRL-2983

DR   BioSample; SAMN03471703

DR   GEO; GSM481329

RX   PubMed=9778046;

CC   Derived from metastatic site: Axillary lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 13

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 10,13

ST   vWA: 15,17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-325

AC   CVCL_4043

SY   UACC 325; UACC325; University of Arizona Cell Culture-325

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-3247

AC   CVCL_W091

SY   UACC 3247; UACC3247; University of Arizona Cell Culture-3247

DR   ATCC; CRL-3124

CC   Discontinued: ATCC; CRL-3124; probable.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-3291

AC   CVCL_IN97

SY   UACC 3291; UACC3291; University of Arizona Cell Culture-3291

DR   BTO; BTO:0005883

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-375

AC   CVCL_M457

SY   UACC 375; UACC375; University of Arizona Cell Culture-375

DR   ChEMBL-Cells; CHEMBL3307880

DR   ChEMBL-Targets; CHEMBL614127

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-383

AC   CVCL_4044

SY   UACC 383; UACC383; University of Arizona Cell Culture-383

RX   PubMed=1371813;

RX   PubMed=10952317;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-456

AC   CVCL_4045

SY   UACC 456; UACC456; University of Arizona Cell Culture-456

RX   PubMed=1371813;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-457

AC   CVCL_4046

SY   UACC 457; UACC457; University of Arizona Cell Culture-457

RX   PubMed=10952317;

RX   PubMed=19383853;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-462

AC   CVCL_4047

SY   UACC 462; UACC462; University of Arizona Cell Culture-462

DR   ATCC; CRL-2989

RX   PubMed=3014534;

CC   Derived from metastatic site: Peritoneum.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 13

ST   D5S818: 12,13

ST   D7S820: 12

ST   TH01: 9,9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-502

AC   CVCL_M458

SY   UACC 502; UACC502; University of Arizona Cell Culture-502

DR   BTO; BTO:0005898

RX   PubMed=10952317;

RX   PubMed=12115485;

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-537

AC   CVCL_S730

SY   UACC 537; UACC537; University of Arizona Cell Culture-537

DR   Cosmic; 1020267

RX   PubMed=10918183;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-558

AC   CVCL_DG41

SY   UACC 558; UACC558; University of Arizona Cell Culture-558

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-608

AC   CVCL_4048

SY   UACC 608; UACC608; University of Arizona Cell Culture-608

RX   PubMed=1371813;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-62

AC   CVCL_1780

SY   UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62

DR   BTO; BTO:0004152

DR   EFO; EFO_0005377

DR   BioSample; SAMN03473228

DR   CCLE; UACC62_SKIN

DR   ChEMBL-Cells; CHEMBL3307660

DR   ChEMBL-Targets; CHEMBL614610

DR   Cosmic; 686477

DR   Cosmic; 687447

DR   Cosmic; 875888

DR   Cosmic; 897469

DR   Cosmic; 905976

DR   Cosmic; 974067

DR   Cosmic; 974260

DR   Cosmic; 1044267

DR   Cosmic; 1092646

DR   Cosmic; 1132590

DR   Cosmic; 1175875

DR   Cosmic; 1303059

DR   Cosmic; 1305371

DR   Cosmic; 1312352

DR   Cosmic; 1537484

DR   Cosmic; 1888915

DR   Cosmic; 1998489

DR   Cosmic-CLP; 905976

DR   GDSC; 905976

DR   GEO; GSM50208

DR   GEO; GSM50271

DR   GEO; GSM188229

DR   GEO; GSM188259

DR   GEO; GSM188318

DR   GEO; GSM750828

DR   GEO; GSM799360

DR   GEO; GSM799423

DR   GEO; GSM847168

DR   GEO; GSM844722

DR   GEO; GSM887726

DR   GEO; GSM888820

DR   GEO; GSM1153431

DR   GEO; GSM1181275

DR   GEO; GSM1181277

DR   GEO; GSM1670562

DR   SKY/M-FISH/CGH; 2827

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19727395;

RX   PubMed=20041153;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=49

WW   http://www.addexbio.com/productdetail?pid=414

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 31.3 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9,12

ST   D18S51: 15

ST   D19S433: 15

ST   D21S11: 28,31

ST   D2S1338: 18,20

ST   D3S1358: 15

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   D8S1179: 10,13

ST   FGA: 23

ST   Penta D: 11,12

ST   Penta E: 5,14

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   UACC-647

AC   CVCL_4049

SY   UACC 647; UACC647; University of Arizona Cell Culture-647

DR   BTO; BTO:0005063

DR   Cosmic; 1020270

RX   PubMed=10952317;

RX   PubMed=23039341;

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-732

AC   CVCL_4050

SY   UACC 732; UACC732; University of Arizona Cell Culture-732

DR   ATCC; CRL-3166

DR   Cosmic; 1348960

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,12

ST   D16S539: 9,10

ST   D5S818: 13,14

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-793

AC   CVCL_S731

SY   UACC 793; UACC793; University of Arizona Cell Culture-793

DR   Cosmic; 1020268

RX   PubMed=10918183;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UACC-812

AC   CVCL_1781

SY   UACC 812; UACC812; University of Arizona Cell Culture-812

DR   CLO; CLO_0009467

DR   EFO; EFO_0001258

DR   ATCC; CRL-1897

DR   BioSample; SAMN03471261

DR   BioSample; SAMN03471377

DR   CCLE; UACC812_BREAST

DR   CCRID; 3111C0001CCC000119

DR   ChEMBL-Cells; CHEMBL3308475

DR   ChEMBL-Targets; CHEMBL1075604

DR   Cosmic; 687501

DR   Cosmic; 871158

DR   Cosmic; 894093

DR   Cosmic; 904396

DR   Cosmic; 910910

DR   Cosmic; 997926

DR   Cosmic; 1046963

DR   Cosmic; 1136361

DR   Cosmic; 1287902

DR   Cosmic; 1289419

DR   Cosmic; 1523774

DR   Cosmic; 1603227

DR   Cosmic; 2165014

DR   Cosmic-CLP; 910910

DR   GDSC; 910910

DR   GEO; GSM1717

DR   GEO; GSM73722

DR   GEO; GSM115104

DR   GEO; GSM217606

DR   GEO; GSM344359

DR   GEO; GSM344409

DR   GEO; GSM350516

DR   GEO; GSM481327

DR   GEO; GSM783969

DR   GEO; GSM847441

DR   GEO; GSM847508

DR   GEO; GSM844723

DR   GEO; GSM887727

DR   GEO; GSM888821

DR   GEO; GSM1008920

DR   GEO; GSM1215270

DR   GEO; GSM1670563

DR   IGRhCellID; UACC812

DR   LINCS; 50556

RX   PubMed=1674877;

RX   PubMed=10862037;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 100 hours (PubMed=1674877).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 8,11

ST   D18S51: 14,20

ST   D21S11: 29,32.2

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 9,12 (ATCC; Cosmic-CLP)

ST   D7S820: 9 (PubMed=25877200)

ST   D8S1179: 12,15

ST   FGA: 25

ST   Penta D: 10,11

ST   Penta E: 14,18

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-827

AC   CVCL_4051

SY   UACC 827; UACC827; University of Arizona Cell Culture-827

RX   PubMed=1371813;

RX   PubMed=10952317;

RX   PubMed=12115485;

RX   PubMed=19383853;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-893

AC   CVCL_1782

SY   UACC 893; UACC893; University of Arizona Cell Culture-893

DR   BTO; BTO:0003443

DR   CLO; CLO_0009468

DR   EFO; EFO_0002385

DR   ATCC; CRL-1902

DR   BioSample; SAMN03472115

DR   CCLE; UACC893_BREAST

DR   ChEMBL-Cells; CHEMBL3308807

DR   ChEMBL-Targets; CHEMBL1075605

DR   Cosmic; 687502

DR   Cosmic; 871151

DR   Cosmic; 894092

DR   Cosmic; 897416

DR   Cosmic; 904397

DR   Cosmic; 909778

DR   Cosmic; 1017162

DR   Cosmic; 1018469

DR   Cosmic; 1046943

DR   Cosmic; 1044233

DR   Cosmic; 1047718

DR   Cosmic; 1136362

DR   Cosmic; 1287903

DR   Cosmic; 1289420

DR   Cosmic; 1523773

DR   Cosmic; 1603228

DR   Cosmic; 2165015

DR   Cosmic-CLP; 909778

DR   GDSC; 909778

DR   GEO; GSM69197

DR   GEO; GSM73728

DR   GEO; GSM344384

DR   GEO; GSM344434

DR   GEO; GSM350529

DR   GEO; GSM481326

DR   GEO; GSM783959

DR   GEO; GSM887728

DR   GEO; GSM888822

DR   GEO; GSM1215273

DR   GEO; GSM1670564

DR   IGRhCellID; UACC893

DR   LINCS; 50557

RX   PubMed=1674877;

RX   PubMed=9778046;

RX   PubMed=10862037;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=24162158;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 120 hours (PubMed=1674877).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9,13

ST   D18S51: 17,18

ST   D21S11: 28,30.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 22,25

ST   Penta D: 9,12

ST   Penta E: 13,17

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UACC-903

AC   CVCL_4052

SY   UACC 903; UACC903; University of Arizona Cell Culture-903

DR   BTO; BTO:0005060

DR   ChEMBL-Cells; CHEMBL3307961

DR   ChEMBL-Targets; CHEMBL612446

DR   Cosmic; 706103

DR   Cosmic; 888843

DR   Cosmic; 897489

DR   Cosmic; 905860

DR   Cosmic; 1020269

DR   Lonza; 39

RX   PubMed=2068080;

RX   PubMed=2300817;

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=10952317;

RX   PubMed=12115485;

RX   PubMed=15009714;

RX   PubMed=19383853;

RX   PubMed=23039341;

RX   PubMed=24879157;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-91

AC   CVCL_M447

SY   UACC 91; UACC91; UACC-091; UACC 091; UACC091; University of Arizona Cell Culture-91

DR   BTO; BTO:0005899

RX   PubMed=2300817;

RX   PubMed=10952317;

RX   PubMed=23039341;

RX   PubMed=24879157;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-929

AC   CVCL_M459

SY   UACC 929; UACC929; University of Arizona Cell Culture-929

RX   PubMed=19383853;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UACC-930

AC   CVCL_4053

SY   UACC 930; UACC930; University of Arizona Cell Culture-930

RX   PubMed=10952317;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UAMS-32

AC   CVCL_D624

SY   UAMS32

DR   BTO; BTO:0005307

RX   PubMed=10383440;

CC   Breed/subspecies: SAMR1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   UAMS-33

AC   CVCL_D625

SY   U-33

RX   PubMed=10412038;

CC   Breed/subspecies: SAMR1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   UB/OC-1

AC   CVCL_9636

SY   University Bristol/Organ of Corti-1; UBOC-1; UBOC1

DR   EFO; EFO_0001259

RX   PubMed=9753783;

RX   PubMed=12382283;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UB/OC-2

AC   CVCL_D790

SY   University Bristol/Organ of Corti-2

RX   PubMed=9753783;

RX   PubMed=12382283;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   UB/UE-1

AC   CVCL_D807

RX   PubMed=10531448;

RX   PubMed=12382283;

WW   http://www.fusioniplicensing.co.uk/NR/rdonlyres/36B43469-4160-423C-A438-421D3395BB0E/0/Materialsalesopportunity27008C.pdf

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   UBE6T-15

AC   CVCL_3222

SY   UBET-15

DR   CLO; CLO_0051558

DR   BioSample; SAMN03472472

DR   JCRB; JCRB1159

DR   JCRB; NIHS0456

DR   RCB; RCB2162

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

CC   Discontinued: JCRB; NIHS0456; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBE6T-6

AC   CVCL_3223

SY   UBET-6

DR   CLO; CLO_0051552

DR   JCRB; JCRB1140

DR   JCRB; NIHS0450

DR   RCB; RCB2156

RX   PubMed=15923633;

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

CC   Discontinued: JCRB; NIHS0450; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBE6T-7

AC   CVCL_3224

SY   UBET-7

DR   CLO; CLO_0051553

DR   BioSample; SAMN03472463

DR   JCRB; JCRB1143

DR   JCRB; NIHS0451

DR   RCB; RCB2157

RX   PubMed=15293342;

RX   PubMed=15923633;

RX   PubMed=21155951;

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

CC   Discontinued: JCRB; NIHS0451; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBE6T-8

AC   CVCL_6F33

SY   UBET-8

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBM12218693

AC   CVCL_F586

SY   TER291; TER371; TER451

DR   IMGT/HLA; 11509

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UBM13129406

AC   CVCL_F587

SY   29036; TER185; TER352

DR   IMGT/HLA; 11510

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   UBT-10

AC   CVCL_6F38

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBT-14

AC   CVCL_B971

SY   UBT-15

RX   PubMed=15923633;

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UBT-5

AC   CVCL_B972

RX   PubMed=15293342;

RX   PubMed=15923633;

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Telomerase immortalized cell line

//

ID   UC 729-6

AC   CVCL_D039

SY   UC729-6; UC729.6

DR   ATCC; CRL-8061

RX   DOI=10.1007/BF01404489;

RX   Patent=US4451570;

RX   PubMed=6604917;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-447.html

CC   Group: Hybridoma fusion partner cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-8061; probable.

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   UC-11MG

AC   CVCL_M421

SY   UC-11 MG; UC11MG

RX   PubMed=2566365;

RX   PubMed=3007688;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UC-302MG

AC   CVCL_M422

RX   PubMed=3007688;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UC10-4F10-11

AC   CVCL_8977

DR   CLO; CLO_0009469

DR   ATCC; HB-304

RX   PubMed=7882171;

CC   Monoclonal antibody target: UniProtKB; P09793; Mouse Ctla4/Cd152.

OX   NCBI_TaxID=10032; ! Cricetulus migratorius

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   UC11

AC   CVCL_M872

SY   UC 11

DR   ATCC; HB-9756

RX   Patent=US5292667;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   UC1B

AC   CVCL_6462

DR   CLO; CLO_0009470

DR   ATCC; CRL-6465

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0184 ! BALB/3T3 clone A31

CA   Spontaneously immortalized cell line

//

ID   UC1BC1

AC   CVCL_6463

DR   CLO; CLO_0009471

DR   ATCC; CRL-6460

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6460; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6462 ! UC1B

CA   Spontaneously immortalized cell line

//

ID   UC1BC2

AC   CVCL_6464

DR   CLO; CLO_0009472

DR   ATCC; CRL-6461

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6461; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6462 ! UC1B

CA   Spontaneously immortalized cell line

//

ID   UC1BC3

AC   CVCL_6465

DR   CLO; CLO_0009473

DR   ATCC; CRL-6462

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6462; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6462 ! UC1B

CA   Spontaneously immortalized cell line

//

ID   UC1BC4

AC   CVCL_6466

DR   CLO; CLO_0009474

DR   ATCC; CRL-6463

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6463; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6462 ! UC1B

CA   Spontaneously immortalized cell line

//

ID   UC1BC5

AC   CVCL_6467

DR   CLO; CLO_0009475

DR   ATCC; CRL-6464

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6464; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6462 ! UC1B

CA   Spontaneously immortalized cell line

//

ID   UC3-10A6

AC   CVCL_8978

DR   CLO; CLO_0009476

DR   ATCC; CRL-1988

RX   PubMed=7882171;

OX   NCBI_TaxID=10032; ! Cricetulus migratorius

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   UC7

AC   CVCL_F801

SY   UC 7

DR   CLO; CLO_0009477

DR   ATCC; HB-9753

RX   Patent=US5292667;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   UC7-13D5

AC   CVCL_8979

DR   CLO; CLO_0009478

DR   ATCC; CRL-1989

OX   NCBI_TaxID=10032; ! Cricetulus migratorius

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   UC701

AC   CVCL_3225

DR   JCRB; JCRB1218

DR   JCRB; NIHS0549

CC   Discontinued: JCRB; NIHS0549; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,10

ST   D16S539: 10,11

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   UC702

AC   CVCL_3226

DR   BioSample; SAMN03472445

DR   JCRB; JCRB1220

DR   JCRB; NIHS0550

CC   Discontinued: JCRB; NIHS0550; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   UC704

AC   CVCL_3227

DR   BioSample; SAMN03472447

DR   JCRB; JCRB1224

DR   JCRB; NIHS0551

CC   Discontinued: JCRB; NIHS0551; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 9,11

ST   D5S818: 8,13

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   UC705

AC   CVCL_8315

DR   JCRB; JCRB1227

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   UC706

AC   CVCL_T842

DR   SKIP; SKIP000169

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   UC8-1B9

AC   CVCL_8980

SY   UC81B9

DR   CLO; CLO_0009479

DR   ATCC; CRL-1968

CC   Monoclonal antibody target: ChEBI; CHEBI:53018; 2,4-dinitrophenyl (DNP).

OX   NCBI_TaxID=10032; ! Cricetulus migratorius

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   UCA

AC   CVCL_1M77

SY   GM08604

DR   CLO; CLO_0010608

DR   Coriell; GM08604

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   UCB302MSCs

AC   CVCL_3228

SY   UCB302

DR   BioSample; SAMN03472509

DR   JCRB; JCRB1106

DR   JCRB; NIHS0410

DR   SKIP; SKIP000284

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0410; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 11

ST   D5S818: 12,14

ST   D7S820: 10

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   UCB408E6E7-31

AC   CVCL_3229

DR   BioSample; SAMN03472450

DR   JCRB; JCRB1108

DR   JCRB; NIHS0412

DR   SKIP; SKIP000286

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0412; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 9,10

ST   D5S818: 9,13

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3231 ! UCB408E6E7TERT-33

OI   CVCL_3230 ! UCB408E7-32

OI   CVCL_4W85 ! UCB408E7TERT-34

SX   Male

CA   Transformed cell line

//

ID   UCB408E6E7TERT-33

AC   CVCL_3231

DR   CLO; CLO_0050434

DR   JCRB; JCRB1110

DR   JCRB; NIHS0414

DR   RCB; RCB2080

DR   SKIP; SKIP000288

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0414; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 9,10

ST   D5S818: 9,13

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3229 ! UCB408E6E7-31

OI   CVCL_3230 ! UCB408E7-32

OI   CVCL_4W85 ! UCB408E7TERT-34

SX   Male

CA   Transformed cell line

//

ID   UCB408E7-32

AC   CVCL_3230

DR   JCRB; JCRB1109

DR   JCRB; NIHS0413

DR   SKIP; SKIP000287

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

CC   Discontinued: JCRB; NIHS0413; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 9,10

ST   D5S818: 9,13

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3229 ! UCB408E6E7-31

OI   CVCL_3231 ! UCB408E6E7TERT-33

OI   CVCL_4W85 ! UCB408E7TERT-34

SX   Male

CA   Transformed cell line

//

ID   UCB408E7TERT-34

AC   CVCL_4W85

SY   UCB408E7-TERT34

DR   JCRB; JCRB1546

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 9,10

ST   D5S818: 9,13

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3229 ! UCB408E6E7-31

OI   CVCL_3231 ! UCB408E6E7TERT-33

OI   CVCL_3230 ! UCB408E7-32

SX   Male

CA   Transformed cell line

//

ID   UCBiPS7

AC   CVCL_0H61

DR   SKIP; SKIP000585

RX   PubMed=23326500;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   UCBTERT-21

AC   CVCL_3232

SY   UCB-TERT-21

DR   CLO; CLO_0050433

DR   BioSample; SAMN01821720

DR   JCRB; JCRB1107

DR   JCRB; NIHS0411

DR   RCB; RCB2079

DR   SKIP; SKIP000285

RX   PubMed=15647378;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0411; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 11

ST   D5S818: 12,14

ST   D7S820: 10

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Telomerase immortalized cell line

//

ID   UCCA-21

AC   CVCL_W502

RX   PubMed=15016319;

CC   Doubling time: 63.6 hours (PubMed=15016319).

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W503 ! UCCA-22

OI   CVCL_W504 ! UCCA-23

OI   CVCL_W505 ! UCCA-24

OI   CVCL_W506 ! UCCA-25

SX   Female

CA   Cancer cell line

//

ID   UCCA-22

AC   CVCL_W503

RX   PubMed=15016319;

CC   Doubling time: 43.8 hours (PubMed=15016319).

CC   Microsatellite instability: Stable (MSS) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W502 ! UCCA-21

OI   CVCL_W504 ! UCCA-23

OI   CVCL_W505 ! UCCA-24

OI   CVCL_W506 ! UCCA-25

SX   Female

CA   Cancer cell line

//

ID   UCCA-23

AC   CVCL_W504

RX   PubMed=15016319;

CC   Doubling time: 44.4 hours (PubMed=15016319).

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W502 ! UCCA-21

OI   CVCL_W503 ! UCCA-22

OI   CVCL_W505 ! UCCA-24

OI   CVCL_W506 ! UCCA-25

SX   Female

CA   Cancer cell line

//

ID   UCCA-24

AC   CVCL_W505

RX   PubMed=15016319;

CC   Doubling time: 37.3 hours (PubMed=15016319).

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W502 ! UCCA-21

OI   CVCL_W503 ! UCCA-22

OI   CVCL_W504 ! UCCA-23

OI   CVCL_W506 ! UCCA-25

SX   Female

CA   Cancer cell line

//

ID   UCCA-25

AC   CVCL_W506

RX   PubMed=15016319;

CC   Doubling time: 40.5 hours (PubMed=15016319).

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W502 ! UCCA-21

OI   CVCL_W503 ! UCCA-22

OI   CVCL_W504 ! UCCA-23

OI   CVCL_W505 ! UCCA-24

SX   Female

CA   Cancer cell line

//

ID   UCCA-3

AC   CVCL_W507

RX   PubMed=15016319;

CC   Doubling time: 56.9 hours (PubMed=15016319).

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCD-Dm-mei-218-1

AC   CVCL_Z920

SY   mei-218-1; mei-218

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   DOI=10.1007/BF02618446;

RX   PubMed=826452;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-mei-41-1

AC   CVCL_Z921

SY   mei-41-1

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   DOI=10.1007/BF02618446;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-mei-9-1

AC   CVCL_Z922

SY   mei-9-1; mei-9a-1

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   PubMed=826452;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-mei-9-2

AC   CVCL_Z923

SY   UCD Dm mei-9-2; mei-9-2; mei-9a-2; Mei9a

DR   ECACC; 90070553

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   DOI=10.1007/BF02618446;

RX   PubMed=826452;

RX   PubMed=3141801;

CC   Group: Insect cell line.

CC   Caution: It is uncertain whether ECACC Mei9a is UCD-Dm-mei-9-2 or UCD-Dm-mei-9-1. We believe it is the first one based on its use by many investigators.

CC   Discontinued: ECACC; 90070553; probable.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-mus103-1

AC   CVCL_Z924

SY   mus103-1

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   DOI=10.1007/BF02618446;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-mus104-1

AC   CVCL_Z925

SY   mus104-1

RX   DOI=10.1007/BF02618446;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD-Dm-w-1

AC   CVCL_Z873

SY   w-1

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   DOI=10.1007/BF02618446;

RX   PubMed=826452;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCD/AB 6.01

AC   CVCL_F802

SY   UCD/AB6.01

DR   CLO; CLO_0009480

DR   ATCC; HB-8693

RX   Patent=US4775620;

CC   Monoclonal antibody target: UniProtKB; P05787; Human KRT8.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   UCD/AB 6.11

AC   CVCL_F803

DR   CLO; CLO_0009481

DR   ATCC; HB-8458

RX   Patent=US4775620;

CC   Discontinued: ATCC; HB-8458; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   UCD/PR 10.11

AC   CVCL_F804

SY   UCD/PR10.11

DR   CLO; CLO_0009482

DR   ATCC; HB-8694

RX   Patent=US4775620;

CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.

CC   Monoclonal antibody target: UniProtKB; P05787; Human KRT8.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   UCDK9B1

AC   CVCL_GY10

RX   PubMed=22136758;

CC   Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a female Bullmastiff.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UCDK9B2

AC   CVCL_GY11

RX   PubMed=22136758;

CC   Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male German Shorthaired Pointer.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UCDK9B3

AC   CVCL_GY12

RX   PubMed=22136758;

CC   Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Labrador Retriever.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UCDK9B4

AC   CVCL_GY13

RX   PubMed=22136758;

CC   Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Basset Hound.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UCDK9B5

AC   CVCL_GY14

RX   PubMed=22136758;

CC   Problematic cell line: Contaminated. Originally thought to be of dog origin but found to be from human (from personal communication of Kent M.S.). Was originally thought to originate from a lymphoma from a male Greyhound.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   UCDK9M1

AC   CVCL_0C77

RX   PubMed=21722969;

RX   PubMed=22901430;

CC   Miscellaneous: Breed and gender from personal communication of Kent M.S.

CC   Derived from metastatic site: Skin.

CC   Breed/subspecies: Miniature Poodle.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UCDK9M2

AC   CVCL_0C78

RX   PubMed=21722969;

RX   PubMed=22901430;

CC   Miscellaneous: Breed and gender from personal communication of Kent M.S.

CC   Derived from metastatic site: Lymph node.

CC   Breed/subspecies: Irish Terrier.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UCDK9M3

AC   CVCL_0C79

RX   PubMed=21722969;

RX   PubMed=22901430;

CC   Miscellaneous: Breed and gender from personal communication of Kent M.S.

CC   Breed/subspecies: Springer Spaniel x Chow.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   UCDK9M4

AC   CVCL_0C80

RX   PubMed=21722969;

RX   PubMed=22901430;

CC   Miscellaneous: Breed and gender from personal communication of Kent M.S.

CC   Breed/subspecies: German Shorthaired Pointer.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   UCDK9M5

AC   CVCL_0C81

RX   PubMed=21722969;

RX   PubMed=22901430;

CC   Miscellaneous: Breed and gender from personal communication of Kent M.S.

CC   Derived from metastatic site: Lymph node.

CC   Breed/subspecies: Cocker Spaniel.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   UCH1

AC   CVCL_4991

DR   Cosmic; 1529013

RX   PubMed=17454636;

DI   NCIt; C4341; Marginal zone lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCHCC1

AC   CVCL_9W59

RX   Patent=US8337829;

RX   PubMed=2418922;

CC   Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Transformed cell line

//

ID   UCHT1

AC   CVCL_9W35

RX   Patent=US8337829;

RX   PubMed=954652;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2535.

CC   Doubling time: ~24 hours (PubMed=954652).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60369; Rat C-cell carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   UCI 101

AC   CVCL_5380

SY   UCI-101; UCI101

DR   BTO; BTO:0002630

RX   PubMed=8428692;

RX   PubMed=11314036;

RX   PubMed=12080474;

RX   PubMed=15677628;

CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCI 107

AC   CVCL_5381

SY   UCI-107; UCI107

DR   BTO; BTO:0004036

DR   Cosmic; 1113281

DR   GEO; GSM459738

RX   PubMed=7672698;

RX   PubMed=11314036;

RX   PubMed=12080474;

RX   PubMed=15677628;

CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCI-VULV-1

AC   CVCL_S961

RX   PubMed=7729733;

CC   Doubling time: 60 hours (PubMed=7729733).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCLA # 1

AC   CVCL_M586

RX   PubMed=9639523;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   UCLA 1

AC   CVCL_9951

SY   UCLA1

DR   ISCR; 1412

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=395

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0058.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 10

AC   CVCL_9952

DR   ISCR; 1902

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=494

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0146.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   UCLA 11

AC   CVCL_C941

DR   ISCR; 2240

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=576

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0185.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 12

AC   CVCL_C942

DR   ISCR; 2241

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=577

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0186.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 13

AC   CVCL_W013

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=689

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0293.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 14

AC   CVCL_W014

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=690

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0294.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 15

AC   CVCL_W015

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=691

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0295.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 16

AC   CVCL_W016

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=692

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0296.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 17

AC   CVCL_W017

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=707

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0297.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 18

AC   CVCL_W018

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=708

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0298.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 19n

AC   CVCL_IS73

SY   UCLA19n

RX   PubMed=26853856;

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 20n

AC   CVCL_IS74

SY   UCLA20n

RX   PubMed=26853856;

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCLA 2

AC   CVCL_9953

SY   UCLA2

DR   ISCR; 1413

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=396

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0059.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   UCLA 3

AC   CVCL_9954

SY   UCLA3

DR   ISCR; 1414

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=397

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0060.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 4

AC   CVCL_9955

SY   UCLA4

DR   ISCR; 1774

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=462

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0087.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 5

AC   CVCL_9956

SY   UCLA5

DR   ISCR; 1775

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=463

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0088.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 6

AC   CVCL_9957

SY   UCLA6

DR   ISCR; 1776

RX   PubMed=22058289;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=464

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0089.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   UCLA 7

AC   CVCL_9958

DR   ISCR; 1903

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=491

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0143.

DI   NCIt; C36529; Trisomy 13

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 8

AC   CVCL_9959

DR   ISCR; 1904

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=492

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0144.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA 9

AC   CVCL_9960

DR   ISCR; 1905

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=493

CC   From: University of California, Los Angeles; Los Angeles; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0145.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCLA-P3

AC   CVCL_N513

AS   CVCL_7211

SY   UCLA P3; UCLA P-3; UCP-3; UCP3

DR   BTO; BTO:0004841

DR   ChEMBL-Cells; CHEMBL3307243

DR   ChEMBL-Targets; CHEMBL612797

RX   PubMed=3596831;

RX   PubMed=6362852;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCLC11

AC   CVCL_S741

SY   UCLC-11

DR   Cosmic; 844588

DR   Cosmic; 877399

DR   Cosmic; 1152494

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCLi001-A

AC   CVCL_9S54

SY   HHItC9S-V19

DR   BioSamples; SAMEA3174455

DR   EBiSC; UCLi001-A

DR   ECACC; 66540028

DR   hPSCreg; UCLi001-A

CC   From: University College London; London; UK.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCLi002-A

AC   CVCL_9S55

SY   HHItC9D-V34; DN19

DR   BioSamples; SAMEA3174461

DR   EBiSC; UCLi002-A

DR   ECACC; 66540029

DR   hPSCreg; UCLi002-A

CC   From: University College London; London; UK.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCLi003-A

AC   CVCL_9S56

SY   TSM(Exon10+16)V97

DR   BioSamples; SAMEA3174519

DR   EBiSC; UCLi003-A

DR   ECACC; 66540027

DR   hPSCreg; UCLi003-A

CC   From: University College London; London; UK.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCLi004-A

AC   CVCL_II89

SY   RCi173; RCFB60c6

DR   BioSamples; SAMEA3964268

DR   EBiSC; UCLi004-A

DR   ECACC; 66540123

CC   From: University College London; London; UK.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE26 ! UCLi004-B

OI   CVCL_II90 ! UCLi004-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCLi004-B

AC   CVCL_EE26

SY   RCi177; RCFB60c7

DR   BioSamples; SAMEA4084285

DR   EBiSC; UCLi004-B

DR   ECACC; 66540154

CC   From: University College London; London; UK.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_II89 ! UCLi004-A

OI   CVCL_II90 ! UCLi004-C

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCLi004-C

AC   CVCL_II90

SY   RCi172; RCFB60c2

DR   BioSamples; SAMEA4085372

DR   EBiSC; UCLi004-C

DR   ECACC; 66540165

CC   From: University College London; London; UK.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_II89 ! UCLi004-A

OI   CVCL_EE26 ! UCLi004-B

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCLi005-A

AC   CVCL_9S57

SY   LGMD2D #4; LGMD2D Pt. 4; LGMD2D Pt.4

DR   hPSCreg; UCLi005-A

RX   PubMed=22745439;

CC   From: University College London; London; UK.

DI   NCIt; C84828; Limb-girdle muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCO-Mel-2

AC   CVCL_C264

SY   UCO-Mel2

DR   ESTDAB; ESTDAB-188

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCONN-L2

AC   CVCL_A693

SY   UCONN-2

DR   Cosmic; 1086005

DR   Cosmic; 1086368

DR   Cosmic; 1152616

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   UCR-SE-1

AC   CVCL_Z311

SY   UCR-Se-1

RX   DOI=10.1016/0022-2011(86)90124-2;

RX   PubMed=1367489;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7107; ! Spodoptera exigua

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCR-SE-1a

AC   CVCL_Z312

SY   UCR-SE-1A; UCR-SE1a; SE-UCR-1A

RX   DOI=10.1016/0022-1910(94)90067-1;

RX   PubMed=1367489;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7107; ! Spodoptera exigua

HI   CVCL_Z311 ! UCR-SE-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCR-SE-1C

AC   CVCL_Z313

RX   PubMed=8799737;

RX   DOI=10.3923/jas.2007.4040.4043;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7107; ! Spodoptera exigua

HI   CVCL_Z311 ! UCR-SE-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCRU-BL-12

AC   CVCL_M874

SY   BL-12

DR   Cosmic; 735764

RX   PubMed=2418959;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCRU-BL-13

AC   CVCL_M873

SY   UCRU-BL-13 CL; UCRU BL 13/0; UCRU-BL-13/0 CL; BL-13; BL13

DR   Cosmic; 735765

DR   Cosmic; 928827

DR   Cosmic; 1927310

RX   PubMed=2418959;

RX   PubMed=2685375;

RX   PubMed=2759734;

RX   PubMed=8873383;

RX   PubMed=9246190;

RX   PubMed=23401075;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCRU-BL-17

AC   CVCL_M007

SY   UCRU-BL-17-CL; UCRU-BL-17CL; UCRU BL 17CL; UCRU-BL 17; BL-17; BL17

DR   Cosmic; 735768

DR   Cosmic; 928828

DR   Cosmic; 1927311

RX   Patent=US5622836;

RX   PubMed=2328200;

RX   PubMed=2418959;

RX   PubMed=2685375;

RX   PubMed=3335421;

RX   PubMed=8635192;

RX   PubMed=8873383;

RX   PubMed=9246190;

RX   PubMed=23401075;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCRU-BL-23

AC   CVCL_M008

SY   UCRU-BL-23/3; BL-23; BL23; UCRU-BL-17/23alpha

DR   Cosmic; 735773

RX   Patent=US5622836;

RX   PubMed=2685375;

RX   PubMed=8635192;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M007 ! UCRU-BL-17

SX   Female

CA   Cancer cell line

//

ID   UCRU-BL-28

AC   CVCL_4904

SY   UCRU-BL 28; BL-28; BL28

DR   Cosmic; 735774

DR   Cosmic; 928829

DR   Cosmic; 1927312

RX   PubMed=8345582;

RX   PubMed=8873383;

RX   PubMed=9246190;

RX   PubMed=23401075;

CC   Misspelling: 'BL-128' in Cosmic 1927312.

CC   Misspelling: 'BL128' in PubMed=23401075.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCRU-Pr-2

AC   CVCL_4905

SY   UCRU-PR-2

RX   PubMed=2833415;

WW   http://capcelllines.ca/details.asp?id=115

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCS

AC   CVCL_1G59

SY   Ussuri Catfish Skin

RX   PubMed=24794839;

CC   Group: Fish cell line.

OX   NCBI_TaxID=78871; ! Tachysurus ussuriensis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UCS-2

AC   CVCL_W508

RX   PubMed=12237927;

DI   NCIt; C9118; Sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCS-4

AC   CVCL_W509

RX   PubMed=12237927;

CC   Derived from metastatic site: Lung.

DI   NCIt; C9118; Sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UCS-5

AC   CVCL_W510

RX   PubMed=12237927;

CC   Derived from metastatic site: Lung.

DI   NCIt; C9118; Sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCSD-242L

AC   CVCL_M009

SY   UCSD-242l; UCSD 242L

DR   EFO; EFO_0006769

DR   BioSample; SAMN03473115

DR   Cosmic; 1303060

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,10

ST   D16S539: 9,12,13

ST   D18S51: 14,16

ST   D21S11: 28,31.2

ST   D3S1358: 16,17

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 10,12

ST   FGA: 20,21,23

ST   Penta D: 10,12

ST   Penta E: 8,10

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCSD-354L

AC   CVCL_M010

SY   UCSD 354L

DR   Cosmic; 1303061

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCSD-AML1

AC   CVCL_1853

SY   UCSD/AML1; UCSD/AML-1; UCSD/AML 1

DR   BioSample; SAMN03473441

DR   Cosmic; 787484

DR   Cosmic; 975308

DR   Cosmic; 1281358

DR   Cosmic; 2306242

DR   Cosmic; 2378089

DR   DSMZ; ACC-691

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Misspelling: 'UCSC-AML1' in Cosmic 1281358.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 8,12

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 7,8

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCSD001i-5-1

AC   CVCL_EM44

SY   NextGen_5_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD001i-5-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-71d8-e25b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34449; Hypertrophic cardiomyopathy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD002i-16-1

AC   CVCL_EM45

SY   NextGen_16_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD002i-16-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-81f2-270b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD003i-16-2

AC   CVCL_EM46

SY   NextGen_16_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD003i-16-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-81f5-cd58-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C84735; Glycogen storage disease type IIb

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD004i-42-1

AC   CVCL_EM47

SY   NextGen_42_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD004i-42-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a57c-9429-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C99544; Left ventricular non-compaction syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD005i-43-1

AC   CVCL_EM48

SY   NextGen_43_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD005i-43-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a59c-95e4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C99544; Left ventricular non-compaction syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD006i-21-1

AC   CVCL_EM49

SY   NextGen_21_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD006i-21-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9058-9935-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD007i-21-2

AC   CVCL_EM50

SY   NextGen_21_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD007i-21-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9068-a878-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD008i-44-1

AC   CVCL_EM51

SY   NextGen_44_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD008i-44-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a59e-a357-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C99544; Left ventricular non-compaction syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD009i-5-2

AC   CVCL_EM52

SY   NextGen_5_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD009i-5-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-7211-7dfa-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD010i-5-3

AC   CVCL_EM53

SY   NextGen_5_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD010i-5-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-721e-80a2-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD011i-5-4

AC   CVCL_EM54

SY   NextGen_5_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD011i-5-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-7225-aaa9-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD012i-5-5

AC   CVCL_EM55

SY   NextGen_5_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD012i-5-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-7234-a6a9-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD013i-16-3

AC   CVCL_EM56

SY   NextGen_16_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD013i-16-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-81d6-bcfb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C84735; Glycogen storage disease type IIb

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD014i-21-3

AC   CVCL_EM57

SY   NextGen_21_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD014i-21-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-9080-3509-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C84673; Dilated cardiomyopathy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD015i-3-3

AC   CVCL_EM58

SY   NextGen_3_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD015i-3-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d6e-bd21-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD016i-3-4

AC   CVCL_EM59

SY   NextGen_3_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD016i-3-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-715f-35bc-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD017i-3-5

AC   CVCL_EM60

SY   NextGen_3_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD017i-3-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-7174-e91d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD018i-3-6

AC   CVCL_EM61

SY   NextGen_3_6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD018i-3-6.cmsx

WW   http://shared.eagle-i.net/i/00000150-717f-ba8e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD019i-3-7

AC   CVCL_EM62

SY   NextGen_3_7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD019i-3-7.cmsx

WW   http://shared.eagle-i.net/i/00000150-71bf-4a09-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD020i-3-8

AC   CVCL_EM63

SY   NextGen_3_8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD020i-3-8.cmsx

WW   http://shared.eagle-i.net/i/00000150-718a-7c5c-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD021i-3-9

AC   CVCL_EM64

SY   NextGen_3_9

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD021i-3-9.cmsx

WW   http://shared.eagle-i.net/i/00000150-71bb-1862-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD022i-8-3

AC   CVCL_EM65

SY   NextGen_8_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD022i-8-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-8104-0cbd-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD023i-8-4

AC   CVCL_EM66

SY   NextGen_8_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD023i-8-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-80ff-7208-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD024i-13-3

AC   CVCL_EM67

SY   NextGen_13_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD024i-13-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-81b4-2131-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD025i-13-4

AC   CVCL_EM68

SY   NextGen_13_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD025i-13-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-81b0-bf98-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD026i-9-1

AC   CVCL_EM69

SY   NextGen_9_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD026i-9-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-810e-a070-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD027i-9-2

AC   CVCL_EM70

SY   NextGen_9_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD027i-9-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-8112-1735-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD028i-9-3

AC   CVCL_EM71

SY   NextGen_9_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD028i-9-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-8119-f549-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD029i-9-4

AC   CVCL_EM72

SY   NextGen_9_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD029i-9-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-8120-3467-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD030i-23-2

AC   CVCL_EM73

SY   NextGen_23_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD030i-23-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-90b7-4764-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD031i-45-1

AC   CVCL_EM74

SY   NextGen_45_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD031i-45-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5b0-e036-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD032i-41-1

AC   CVCL_EM75

SY   NextGen_41_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD032i-41-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a575-3cf0-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD033i-41-2

AC   CVCL_EM76

SY   NextGen_41_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD033i-41-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-a578-cf16-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD034i-4-3

AC   CVCL_EM77

SY   NextGen_4_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD034i-4-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-71ce-b3a8-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD035i-4-4

AC   CVCL_EM78

SY   NextGen_4_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD035i-4-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-71d2-3cf2-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD036i-4-5

AC   CVCL_EM79

SY   NextGen_4_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD036i-4-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-71d4-f8fb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD037i-26-2

AC   CVCL_EM80

SY   NextGen_26_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD037i-26-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-912b-0c15-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD038i-24-2

AC   CVCL_EM81

SY   NextGen_24_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD038i-24-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-90c0-c9ea-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD039i-14-3

AC   CVCL_EM82

SY   NextGen_14_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD039i-14-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-81c0-535e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD040i-33-1

AC   CVCL_EM83

SY   NextGen_33_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD040i-33-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9639-6274-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD041i-33-2

AC   CVCL_EM84

SY   NextGen_33_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD041i-33-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-963d-797d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD042i-46-1

AC   CVCL_EM85

SY   NextGen_46_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD042i-46-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5b7-c353-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50802; Ventricular tachycardia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD043i-47-1

AC   CVCL_EM86

SY   NextGen_47_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD043i-47-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5d4-78ef-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD044i-48-1

AC   CVCL_EM87

SY   NextGen_48_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD044i-48-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5d8-3fb1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD045i-49-1

AC   CVCL_EM88

SY   NextGen_49_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD045i-49-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5dc-82c8-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD046i-50-1

AC   CVCL_EM89

SY   NextGen_50_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD046i-50-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5df-d802-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD047i-51-1

AC   CVCL_EM90

SY   NextGen_51_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD047i-51-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5e1-f7db-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD048i-52-1

AC   CVCL_EM91

SY   NextGen_52_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD048i-52-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a5e5-f551-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C26732; Coronary artery disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD049i-53-1

AC   CVCL_EM92

SY   NextGen_53_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD049i-53-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a9ee-bf8b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD050i-54-1

AC   CVCL_EM93

SY   NextGen_54_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD050i-54-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa5b-cfa6-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD051i-55-1

AC   CVCL_EM94

SY   NextGen_55_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD051i-55-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa60-36dc-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD052i-56-1

AC   CVCL_EM95

SY   NextGen_56_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD052i-56-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa62-a613-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD053i-57-1

AC   CVCL_EM96

SY   NextGen_57_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD053i-57-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa65-aa65-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD054i-58-1

AC   CVCL_EM97

SY   NextGen_58_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD054i-58-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa69-6720-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD055i-59-1

AC   CVCL_EM98

SY   NextGen_59_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD055i-59-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa6e-9590-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34830; Cardiomyopathy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD056i-60-1

AC   CVCL_EM99

SY   NextGen_60_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD056i-60-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa76-a729-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34830; Cardiomyopathy

DI   NCIt; C50802; Ventricular tachycardia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD057i-61-1

AC   CVCL_EN00

SY   NextGen_61_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD057i-61-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa83-391f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD058i-62-1

AC   CVCL_EN01

SY   NextGen_62_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD058i-62-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aa8b-9c34-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50802; Ventricular tachycardia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD059i-63-1

AC   CVCL_EN02

SY   NextGen_63_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD059i-63-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aaab-acb4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C50466; Atrial fibrillation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD060i-64-1

AC   CVCL_EN03

SY   NextGen_64_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD060i-64-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aac2-b9cb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C54936; Premature ventricular contraction adverse event

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD061i-65-1

AC   CVCL_EN04

SY   NextGen_65_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD061i-65-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aac6-0405-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C3080; Congestive heart failure

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD062i-66-1

AC   CVCL_EN05

SY   NextGen_66_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD062i-66-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aaca-8c8a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD063i-20-1

AC   CVCL_EN06

SY   NextGen_20_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD063i-20-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-86e5-8b3f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD064i-20-2

AC   CVCL_EN07

SY   NextGen_20_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD064i-20-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-86f2-4119-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD065i-20-3

AC   CVCL_EN08

SY   NextGen_20_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD065i-20-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-86f9-37ca-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD066i-67-1

AC   CVCL_EN09

SY   NextGen_67_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD066i-67-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aacd-fc1a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD067i-19-1

AC   CVCL_EN10

SY   NextGen_19_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD067i-19-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-8680-30af-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD068i-19-2

AC   CVCL_EN11

SY   NextGen_19_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD068i-19-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-869d-d452-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD069i-19-3

AC   CVCL_EN12

SY   NextGen_19_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD069i-19-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-86a6-96a1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD070i-1-1

AC   CVCL_EN13

SY   NextGen_1_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD070i-1-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c30-ddaf-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD071i-1-2

AC   CVCL_EN14

SY   NextGen_1_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD071i-1-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c6d-0234-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD072i-1-3

AC   CVCL_EN15

SY   NextGen_1_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD072i-1-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c7a-ef65-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD073i-1-4

AC   CVCL_EN16

SY   NextGen_1_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD073i-1-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-6812-9962-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD074i-1-5

AC   CVCL_EN17

SY   NextGen_1_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD074i-1-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c90-82e1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD075i-1-6

AC   CVCL_EN18

SY   NextGen_1_6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD075i-1-6.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c96-54bb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD076i-1-7

AC   CVCL_EN19

SY   NextGen_1_7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD076i-1-7.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c9a-4330-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD077i-1-8

AC   CVCL_EN20

SY   NextGen_1_8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD077i-1-8.cmsx

WW   http://shared.eagle-i.net/i/00000150-6c9e-ba19-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD078i-1-9

AC   CVCL_EN21

SY   NextGen_1_9

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD078i-1-9.cmsx

WW   http://shared.eagle-i.net/i/00000150-6ca2-db4d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD079i-1-12

AC   CVCL_EN22

SY   NextGen_1_12

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD079i-1-12.cmsx

WW   http://shared.eagle-i.net/i/00000150-6ca9-3fc3-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD080i-1-13

AC   CVCL_EN23

SY   NextGen_1_13

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD080i-1-13.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cbe-4e86-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD081i-1-14

AC   CVCL_EN24

SY   NextGen_1_14

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD081i-1-14.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cb6-daf3-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD082i-40-1

AC   CVCL_EN25

SY   NextGen_40_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD082i-40-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-a56e-b74a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD083i-40-2

AC   CVCL_EN26

SY   NextGen_40_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD083i-40-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-a572-9029-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD084i-6-1

AC   CVCL_EN27

SY   NextGen_6_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD084i-6-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-7247-eb0f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD085i-6-2

AC   CVCL_EN28

SY   NextGen_6_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD085i-6-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-724c-8fbc-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD086i-6-3

AC   CVCL_EN29

SY   NextGen_6_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD086i-6-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-724f-7a9d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD087i-6-4

AC   CVCL_EN30

SY   NextGen_6_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD087i-6-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-723d-be75-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD088i-6-5

AC   CVCL_EN31

SY   NextGen_6_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD088i-6-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-7238-3510-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD089i-15-1

AC   CVCL_EN32

SY   NextGen_15_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD089i-15-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-81cd-7113-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD090i-15-2

AC   CVCL_EN33

SY   NextGen_15_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD090i-15-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-81d0-2a57-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD091i-15-3

AC   CVCL_EN34

SY   NextGen_15_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD091i-15-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-81d4-2730-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD092i-1-10

AC   CVCL_EN35

SY   NextGen_1_10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD092i-1-10.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cad-981e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD093i-1-11

AC   CVCL_EN36

SY   NextGen_1_11

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD093i-1-11.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cb2-ee42-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD094i-25-1

AC   CVCL_EN37

SY   NextGen_25_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD094i-25-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-90e6-ac34-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD095i-25-2

AC   CVCL_EN38

SY   NextGen_25_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD095i-25-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9108-d34b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD096i-34-1

AC   CVCL_EN39

SY   NextGen_34_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD096i-34-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9641-bef7-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD097i-34-2

AC   CVCL_EN40

SY   NextGen_34_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD097i-34-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9645-faea-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD098i-35-1

AC   CVCL_EN41

SY   NextGen_35_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD098i-35-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9652-1fff-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD099i-35-2

AC   CVCL_EN42

SY   NextGen_35_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD099i-35-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-965a-9467-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD100i-36-1

AC   CVCL_EN43

SY   NextGen_36_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD100i-36-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-965f-42e5-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD101i-36-2

AC   CVCL_EN44

SY   NextGen_36_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD101i-36-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9667-45a2-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD102i-2-1

AC   CVCL_EN45

SY   NextGen_2_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD102i-2-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d50-46c7-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD103i-2-2

AC   CVCL_EN46

SY   NextGen_2_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD103i-2-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d56-8d15-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD104i-2-3

AC   CVCL_EN47

SY   NextGen_2_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD104i-2-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d4b-4969-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD105i-2-4

AC   CVCL_EN48

SY   NextGen_2_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD105i-2-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d3c-00df-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD106i-2-5

AC   CVCL_EN49

SY   NextGen_2_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD106i-2-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d27-3737-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD107i-2-6

AC   CVCL_EN50

SY   NextGen_2_6

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD107i-2-6.cmsx

WW   http://shared.eagle-i.net/i/00000150-6ce6-a30b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD108i-2-7

AC   CVCL_EN51

SY   NextGen_2_7

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD108i-2-7.cmsx

WW   http://shared.eagle-i.net/i/00000150-6ccd-2f31-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD109i-2-8

AC   CVCL_EN52

SY   NextGen_2_8

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD109i-2-8.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d1d-68da-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD110i-2-9

AC   CVCL_EN53

SY   NextGen_2_9

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD110i-2-9.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cef-6c41-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD111i-2-10

AC   CVCL_EN54

SY   NextGen_2_10

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD111i-2-10.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d11-5b3c-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD112i-2-11

AC   CVCL_EN55

SY   NextGen_2_11

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD112i-2-11.cmsx

WW   http://shared.eagle-i.net/i/00000150-6cf8-8315-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD113i-68-1

AC   CVCL_EN56

SY   NextGen_68_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD113i-68-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aad1-ac77-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD114i-69-1

AC   CVCL_EN57

SY   NextGen_69_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD114i-69-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aad5-19c1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD115i-70-1

AC   CVCL_EN58

SY   NextGen_70_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD115i-70-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-aae1-9289-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD116i-71-1

AC   CVCL_EN59

SY   NextGen_71_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD116i-71-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab05-9565-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD117i-72-1

AC   CVCL_EN60

SY   NextGen_72_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD117i-72-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab08-9a2e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD118i-38-1

AC   CVCL_EN61

SY   NextGen_38_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD118i-38-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9674-be79-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD119i-38-2

AC   CVCL_EN62

SY   NextGen_38_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD119i-38-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-967f-3849-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD120i-39-1

AC   CVCL_EN63

SY   NextGen_39_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD120i-39-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9682-759f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD121i-39-2

AC   CVCL_EN64

SY   NextGen_39_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD121i-39-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-a56b-1e9e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD122i-73-1

AC   CVCL_EN65

SY   NextGen_73_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD122i-73-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab0b-57d9-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD123i-74-1

AC   CVCL_EN66

SY   NextGen_74_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD123i-74-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab0e-e3d5-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD124i-7-1

AC   CVCL_EN67

SY   NextGen_7_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD124i-7-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-7261-f4c0-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD125i-7-2

AC   CVCL_EN68

SY   NextGen_7_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD125i-7-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-725d-b905-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD126i-7-3

AC   CVCL_EN69

SY   NextGen_7_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD126i-7-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-7257-3494-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD127i-7-4

AC   CVCL_EN70

SY   NextGen_7_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD127i-7-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-7268-5d1d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD128i-7-5

AC   CVCL_EN71

SY   NextGen_7_5

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD128i-7-5.cmsx

WW   http://shared.eagle-i.net/i/00000150-7275-cf88-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD129i-75-1

AC   CVCL_EN72

SY   NextGen_75_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD129i-75-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab11-42dc-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD130i-76-1

AC   CVCL_EN73

SY   NextGen_76_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD130i-76-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab14-8809-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD131i-77-1

AC   CVCL_EN74

SY   NextGen_77_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD131i-77-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab17-5dd4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD132i-78-1

AC   CVCL_EN75

SY   NextGen_78_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD132i-78-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab1a-31cd-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD133i-79-1

AC   CVCL_EN76

SY   NextGen_79_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD133i-79-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab1e-8c7e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD134i-80-1

AC   CVCL_EN77

SY   NextGen_80_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD134i-80-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ab24-2732-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD135i-81-1

AC   CVCL_EN78

SY   NextGen_81_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD135i-81-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b49e-f140-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD136i-82-1

AC   CVCL_EN79

SY   NextGen_82_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD136i-82-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4ad-8d2b-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD137i-83-1

AC   CVCL_EN80

SY   NextGen_83_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD137i-83-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4b0-8efb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD138i-84-1

AC   CVCL_EN81

SY   NextGen_84_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD138i-84-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4b3-b5e6-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD139i-85-1

AC   CVCL_EN82

SY   NextGen_85_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD139i-85-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4c0-1645-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD140i-37-1

AC   CVCL_EN83

SY   NextGen_37_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD140i-37-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-966c-69e1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD141i-37-2

AC   CVCL_EN84

SY   NextGen_37_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD141i-37-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-966f-79be-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD142i-86-1

AC   CVCL_EN85

SY   NextGen_86_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD142i-86-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4f3-0cb4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD143i-87-1

AC   CVCL_EN86

SY   NextGen_87_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD143i-87-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4f9-6c80-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD144i-88-1

AC   CVCL_EN87

SY   NextGen_88_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD144i-88-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b4fb-b8fc-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD145i-89-1

AC   CVCL_EN88

SY   NextGen_89_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD145i-89-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b50b-3ce2-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD146i-10-1

AC   CVCL_EN89

SY   NextGen_10_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD146i-10-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-8132-0d2d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD147i-10-2

AC   CVCL_EN90

SY   NextGen_10_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD147i-10-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-812e-b921-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD148i-10-3

AC   CVCL_EN91

SY   NextGen_10_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD148i-10-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-8134-af33-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD149i-10-4

AC   CVCL_EN92

SY   NextGen_10_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD149i-10-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-8127-4c56-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD150i-11-1

AC   CVCL_EN93

SY   NextGen_11_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD150i-11-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-8173-772a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD151i-11-2

AC   CVCL_EN94

SY   NextGen_11_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD151i-11-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-8171-b8f4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD152i-11-3

AC   CVCL_EN95

SY   NextGen_11_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD152i-11-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-8176-a29c-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD153i-11-4

AC   CVCL_EN96

SY   NextGen_11_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD153i-11-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-813e-3296-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD154i-90-1

AC   CVCL_EN97

SY   NextGen_90_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD154i-90-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b50e-226a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD155i-12-1

AC   CVCL_EN98

SY   NextGen_12_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD155i-12-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-817f-9686-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD156i-12-2

AC   CVCL_EN99

SY   NextGen_12_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD156i-12-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-818d-537d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD157i-12-3

AC   CVCL_EP00

SY   NextGen_12_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD157i-12-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-8187-607e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD158i-12-4

AC   CVCL_EP01

SY   NextGen_12_4

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD158i-12-4.cmsx

WW   http://shared.eagle-i.net/i/00000150-818a-e7ff-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD159i-91-1

AC   CVCL_EP02

SY   NextGen_91_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD159i-91-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b511-6c5d-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD160i-92-1

AC   CVCL_EP03

SY   NextGen_92_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD160i-92-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b516-7614-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD161i-93-1

AC   CVCL_EP04

SY   NextGen_93_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD161i-93-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b51f-ac9c-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD162i-94-1

AC   CVCL_EP05

SY   NextGen_94_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD162i-94-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b523-b085-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD163i-95-1

AC   CVCL_EP06

SY   NextGen_95_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD163i-95-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b535-288e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD164i-96-1

AC   CVCL_EP07

SY   NextGen_96_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD164i-96-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b537-6dc3-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD165i-97-1

AC   CVCL_EP08

SY   NextGen_97_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD165i-97-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b53e-2546-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD166i-98-1

AC   CVCL_EP09

SY   NextGen_98_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD166i-98-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b540-b984-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD167i-99-1

AC   CVCL_EP10

SY   NextGen_99_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD167i-99-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b544-c241-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD168i-22-1

AC   CVCL_EP11

SY   NextGen_22_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD168i-22-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9093-1373-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD169i-22-2

AC   CVCL_EP12

SY   NextGen_22_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD169i-22-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-909b-4ba6-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD170i-22-3

AC   CVCL_EP13

SY   NextGen_22_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD170i-22-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-90a1-4bde-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD171i-100-1

AC   CVCL_EP14

SY   NextGen_100_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD171i-100-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b547-59d4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD172i-101-1

AC   CVCL_EP15

SY   NextGen_101_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD172i-101-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b54d-90c8-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD173i-18-1

AC   CVCL_EP16

SY   NextGen_18_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD173i-18-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-865c-964f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD174i-18-2

AC   CVCL_EP17

SY   NextGen_18_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD174i-18-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-8663-5637-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD175i-18-3

AC   CVCL_EP18

SY   NextGen_18_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD175i-18-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-866e-78fe-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD176i-17-1

AC   CVCL_EP19

SY   NextGen_17_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD176i-17-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-8204-0ddf-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD177i-17-2

AC   CVCL_EP20

SY   NextGen_17_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD177i-17-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-8201-41f5-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD178i-17-3

AC   CVCL_EP21

SY   NextGen_17_3

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD178i-17-3.cmsx

WW   http://shared.eagle-i.net/i/00000150-81fe-8dcb-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD179i-27-1

AC   CVCL_EP22

SY   NextGen_27_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD179i-27-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-912f-f1e1-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD180i-27-2

AC   CVCL_EP23

SY   NextGen_27_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD180i-27-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9145-cfec-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD181i-3-1

AC   CVCL_EP24

SY   NextGen_3_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD181i-3-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d60-5ba4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD182i-3-2 (CVCL_EP25).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD182i-3-2

AC   CVCL_EP25

SY   NextGen_3_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD182i-3-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-6d66-8c76-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD181i-3-1 (CVCL_EP24).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD183i-102-1

AC   CVCL_EP26

SY   NextGen_102_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD183i-102-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b552-5750-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD184i-8-1

AC   CVCL_EP27

SY   NextGen_8_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD184i-8-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-727e-fc99-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD185i-8-2 (CVCL_EP28).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD185i-8-2

AC   CVCL_EP28

SY   NextGen_8_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD185i-8-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-7283-87e0-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD184i-8-1 (CVCL_EP27).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD186i-103-1

AC   CVCL_EP29

SY   NextGen_103_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD186i-103-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b555-e99a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD187i-104-1

AC   CVCL_EP30

SY   NextGen_104_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD187i-104-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b559-6921-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD188i-105-1

AC   CVCL_EP31

SY   NextGen_105_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD188i-105-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b560-0f0a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD189i-28-1

AC   CVCL_EP32

SY   NextGen_28_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD189i-28-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-914d-7bf6-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD190i-28-2 (CVCL_EP33).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD190i-28-2

AC   CVCL_EP33

SY   NextGen_28_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD190i-28-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9155-a19a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD189i-28-1 (CVCL_EP32).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD191i-13-1

AC   CVCL_EP34

SY   NextGen_13_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD191i-13-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-81a1-ebc4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD192i-13-2 (CVCL_EP35).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD192i-13-2

AC   CVCL_EP35

SY   NextGen_13_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD192i-13-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-81a8-faa3-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD191i-13-1 (CVCL_EP34).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD193i-106-1

AC   CVCL_EP36

SY   NextGen_106_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD193i-106-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b564-b51f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD194i-29-1

AC   CVCL_EP37

SY   NextGen_29_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD194i-29-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9161-8158-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD195i-29-2 (CVCL_EP38).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD195i-29-2

AC   CVCL_EP38

SY   NextGen_29_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD195i-29-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9168-71e4-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD194i-29-1 (CVCL_EP37).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD196i-30-1

AC   CVCL_EP39

SY   NextGen_30_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD196i-30-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-95c3-c1c8-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD197i-30-2 (CVCL_EP40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD197i-30-2

AC   CVCL_EP40

SY   NextGen_30_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD197i-30-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9600-6720-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD196i-30-1 (CVCL_EP39).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD198i-23-1

AC   CVCL_EP41

SY   NextGen_23_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD198i-23-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-90aa-b832-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD199i-107-1

AC   CVCL_EP42

SY   NextGen_107_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD199i-107-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b959-6876-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD200i-4-1

AC   CVCL_EP43

SY   NextGen_4_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD200i-4-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-71c4-ff5e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD201i-4-2 (CVCL_EP44).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD201i-4-2

AC   CVCL_EP44

SY   NextGen_4_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD201i-4-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-71ca-4144-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD200i-4-1 (CVCL_EP43).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD202i-108-1

AC   CVCL_EP45

SY   NextGen_108_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD202i-108-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b967-9a5e-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD203i-109-1

AC   CVCL_EP46

SY   NextGen_109_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD203i-109-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b97f-6d70-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD204i-26-1

AC   CVCL_EP47

SY   NextGen_26_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD204i-26-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-911d-30e9-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD205i-110-1

AC   CVCL_EP48

SY   NextGen_110_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD205i-110-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba2a-3e28-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD206i-31-1

AC   CVCL_EP49

SY   NextGen_31_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD206i-31-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-9615-a697-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD207i-31-2 (CVCL_EP50).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD207i-31-2

AC   CVCL_EP50

SY   NextGen_31_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD207i-31-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9628-f435-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from monozygotic twin of UCSD206i-31-1 (CVCL_EP49).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD208i-111-1

AC   CVCL_EP51

SY   NextGen_111_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD208i-111-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-b981-c6ea-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD209i-24-1

AC   CVCL_EP52

SY   NextGen_24_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD209i-24-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-90bb-c3a2-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD210i-112-1

AC   CVCL_EP53

SY   NextGen_112_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD210i-112-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba01-da8a-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD211i-32-1

AC   CVCL_EP54

SY   NextGen_32_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD211i-32-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-962d-71ea-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from dizygotic twin of UCSD212i-32-2 (CVCL_EP55).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD212i-32-2

AC   CVCL_EP55

SY   NextGen_32_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD212i-32-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-9634-ce05-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from dizygotic twin of UCSD211i-32-1 (CVCL_EP54).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD213i-14-1

AC   CVCL_EP56

SY   NextGen_14_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD213i-14-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-81ba-f517-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from dizygotic twin of UCSD214i-14-2 (CVCL_EP57).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD214i-14-2

AC   CVCL_EP57

SY   NextGen_14_2

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD214i-14-2.cmsx

WW   http://shared.eagle-i.net/i/00000150-81c3-2e6f-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

CC   Miscellaneous: Established from dizygotic twin of UCSD213i-14-1 (CVCL_EP56).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD215i-113-1

AC   CVCL_EP58

SY   NextGen_113_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD215i-113-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba24-2e04-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD216i-114-1

AC   CVCL_EP59

SY   NextGen_114_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD216i-114-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba0c-4d50-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD217i-115-1

AC   CVCL_EP60

SY   NextGen_115_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD217i-115-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba10-8880-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD218i-116-1

AC   CVCL_EP61

SY   NextGen_116_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD218i-116-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba13-35da-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD219i-117-1

AC   CVCL_EP62

SY   NextGen_117_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD219i-117-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba16-b1d0-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD220i-118-1

AC   CVCL_EP63

SY   NextGen_118_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD220i-118-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba21-1465-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD221i-119-1

AC   CVCL_EP64

SY   NextGen_119_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD221i-119-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba18-f724-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD222i-120-1

AC   CVCL_EP65

SY   NextGen_120_1

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD222i-120-1.cmsx

WW   http://shared.eagle-i.net/i/00000150-ba1a-ea26-e23c-e57880000000

CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.

CC   From: Frazer K.A.; University of California, San Diego; San Diego; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD223i-NDC1-1

AC   CVCL_EJ84

SY   NDC1.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD223i-NDC1-1.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ85 ! UCSD224i-NDC1-2

OI   CVCL_EJ86 ! UCSD225i-NDC1-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD224i-NDC1-2

AC   CVCL_EJ85

SY   NDC1.2

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD224i-NDC1-2.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ84 ! UCSD223i-NDC1-1

OI   CVCL_EJ86 ! UCSD225i-NDC1-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD225i-NDC1-3

AC   CVCL_EJ86

SY   NDC1.3

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD225i-NDC1-3.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ84 ! UCSD223i-NDC1-1

OI   CVCL_EJ85 ! UCSD224i-NDC1-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD226i-NDC2-1

AC   CVCL_EJ87

SY   NDC2.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD226i-NDC2-1.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ88 ! UCSD227i-NDC2-2

OI   CVCL_EJ89 ! UCSD228i-NDC2-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD227i-NDC2-2

AC   CVCL_EJ88

SY   NDC2.2

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD227i-NDC2-2.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ87 ! UCSD226i-NDC2-1

OI   CVCL_EJ89 ! UCSD228i-NDC2-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD228i-NDC2-3

AC   CVCL_EJ89

SY   NDC2.3

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD228i-NDC2-3.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ87 ! UCSD226i-NDC2-1

OI   CVCL_EJ88 ! UCSD227i-NDC2-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD229i-SAD1-1

AC   CVCL_EJ90

SY   sAD1.1; SAD1.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD229i-SAD1-1.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ91 ! UCSD230i-SAD1-2

OI   CVCL_EJ92 ! UCSD231i-SAD1-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD230i-SAD1-2

AC   CVCL_EJ91

SY   sAD1.2; SAD1.2

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD230i-SAD1-2.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ90 ! UCSD229i-SAD1-1

OI   CVCL_EJ92 ! UCSD231i-SAD1-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD231i-SAD1-3

AC   CVCL_EJ92

SY   sAD1.3; SAD1.3

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD231i-SAD1-3.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ90 ! UCSD229i-SAD1-1

OI   CVCL_EJ91 ! UCSD230i-SAD1-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD232i-SAD2-1

AC   CVCL_EJ93

SY   sAD2.1; SAD2.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD232i-SAD2-1.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N91 ! UCSD233i-SAD2-2

OI   CVCL_EJ94 ! UCSD234i-SAD2-3

OI   CVCL_EJ95 ! UCSD235i-SAD2-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD233i-SAD2-2

AC   CVCL_1N91

SY   sAD2.2; SAD2.2; GM24666

DR   Coriell; GM24666

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD233i-SAD2-2.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ93 ! UCSD232i-SAD2-1

OI   CVCL_EJ94 ! UCSD234i-SAD2-3

OI   CVCL_EJ95 ! UCSD235i-SAD2-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD234i-SAD2-3

AC   CVCL_EJ94

SY   sAD2.3; SAD2.3

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD234i-SAD2-3.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ93 ! UCSD232i-SAD2-1

OI   CVCL_1N91 ! UCSD233i-SAD2-2

OI   CVCL_EJ95 ! UCSD235i-SAD2-4

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD235i-SAD2-4

AC   CVCL_EJ95

SY   sAD2.4; SAD2.4

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD235i-SAD2-4.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ93 ! UCSD232i-SAD2-1

OI   CVCL_1N91 ! UCSD233i-SAD2-2

OI   CVCL_EJ94 ! UCSD234i-SAD2-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD236i-APP1-1

AC   CVCL_EJ96

SY   APPDp1.1; APP1.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD236i-APP1-1.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ97 ! UCSD237i-APP1-2

OI   CVCL_EJ98 ! UCSD238i-APP1-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD237i-APP1-2

AC   CVCL_EJ97

SY   APPDp1.2; Appdp1.2

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD237i-APP1-2.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ96 ! UCSD236i-APP1-1

OI   CVCL_EJ98 ! UCSD238i-APP1-3

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD238i-APP1-3

AC   CVCL_EJ98

SY   APPDp1.3; Appdp1.3

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD238i-APP1-3.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ96 ! UCSD236i-APP1-1

OI   CVCL_EJ97 ! UCSD237i-APP1-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   UCSD239i-APP2-1

AC   CVCL_EJ99

SY   APPDp2.1; Appdp2.1

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD239i-APP2-1.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EK00 ! UCSD240i-APP2-2

OI   CVCL_1N92 ! UCSD241i-APP2-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD240i-APP2-2

AC   CVCL_EK00

SY   APPDp2.2; Appdp2.2

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD240i-APP2-2.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ99 ! UCSD239i-APP2-1

OI   CVCL_1N92 ! UCSD241i-APP2-3

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSD241i-APP2-3

AC   CVCL_1N92

SY   APPDp2.3; Appdp2.3; APP2.3; GM24675

DR   Coriell; GM24675

RX   PubMed=22278060;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/UCSD241i-APP2-3.cmsx

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EJ99 ! UCSD239i-APP2-1

OI   CVCL_EK00 ! UCSD240i-APP2-2

SX   Female

CA   Induced pluripotent stem cell

//

ID   UCSF1

AC   CVCL_A019

SY   UCSF-1; UCSFe004-A

DR   hPSCreg; UCSFe004-A

CC   From: University of California, San Francisco; San Francisco; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCSF2

AC   CVCL_A020

SY   UCSF-2; UCSFe005-A

DR   hPSCreg; UCSFe005-A

CC   From: University of California, San Francisco; San Francisco; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   UCSF3

AC   CVCL_A021

SY   UCSF-3

DR   ISCR; 1521

CC   From: University of California, San Francisco; San Francisco; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSF4

AC   CVCL_A022

SY   UCSF-4

DR   EFO; EFO_0007116

DR   ENCODE; ENCBS274MNP

DR   ENCODE; ENCBS281XEU

DR   ENCODE; ENCBS296VOU

DR   ENCODE; ENCBS311CPE

DR   ENCODE; ENCBS488VWE

DR   ENCODE; ENCBS496TQG

DR   ENCODE; ENCBS838AWQ

DR   ISCR; 875

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=200

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0044.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   UCSFB-1

AC   CVCL_A023

SY   UCSFB1

DR   ISCR; 1522

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-10

AC   CVCL_A024

SY   UCSFB10

DR   ISCR; 1546

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-2

AC   CVCL_A025

SY   UCSFB2

DR   ISCR; 1523

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-3

AC   CVCL_A026

SY   UCSFB3

DR   ISCR; 1524

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-4

AC   CVCL_A027

SY   UCSFB4

DR   ISCR; 1525

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-5

AC   CVCL_A028

SY   UCSFB5

DR   ISCR; 1541

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-6

AC   CVCL_A029

SY   UCSFB6

DR   ISCR; 1542

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-7

AC   CVCL_A030

SY   UCSFB7

DR   ISCR; 1543

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-8

AC   CVCL_A031

SY   UCSFB8

DR   ISCR; 1544

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCSFB-9

AC   CVCL_A032

SY   UCSFB9

DR   ISCR; 1545

WW   http://grants.nih.gov/stem_cells/registry/pending.htm

CC   From: University of California, San Francisco; San Francisco; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; pending review.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   UCT-Mel 1

AC   CVCL_T304

SY   UCT Mel-1; University of Cape Town - Melanoma cell line 1

RX   PubMed=3091056;

RX   PubMed=6814752;

CC   Characteristics: Pigmented.

CC   Doubling time: 41 hours (PubMed=3091056).

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCT-Mel 2

AC   CVCL_T305

SY   UCT Mel-2; University of Cape Town - Melanoma cell line 2

RX   PubMed=3091056;

RX   PubMed=6814752;

CC   Characteristics: Pigmented.

CC   Doubling time: 50 hours (PubMed=3091056).

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCT-Mel 3

AC   CVCL_T306

SY   UCT Mel-3; University of Cape Town - Melanoma cell line 3

RX   PubMed=3091056;

RX   PubMed=3335422;

CC   Doubling time: 50 hours (PubMed=3091056).

CC   Derived from metastatic site: Liver.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCT-Mel 4

AC   CVCL_T307

SY   UCT Mel-4; University of Cape Town - Melanoma cell line 4

RX   PubMed=3091056;

CC   Doubling time: 52 hours (PubMed=3091056).

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCT-Mel 5

AC   CVCL_T308

SY   UCT Mel-5; University of Cape Town - Melanoma cell line 5

RX   PubMed=3091056;

CC   Doubling time: 58 hours (PubMed=3091056).

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCT-Mel 6

AC   CVCL_T309

SY   UCT Mel-6; University of Cape Town - Melanoma cell line 6

RX   PubMed=3091056;

CC   Doubling time: 33 hours (PubMed=3091056).

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCT-Mel 7

AC   CVCL_T310

SY   UCT Mel-7; UCT-Mel-7; University of Cape Town - Melanoma cell line 7

RX   PubMed=1562456;

RX   PubMed=3091056;

CC   Doubling time: 95 hours (PubMed=3091056).

CC   Derived from metastatic site: Femoral lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UCVA-1

AC   CVCL_1G10

SY   UCVA

RX   PubMed=6092175;

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UCW 10

AC   CVCL_0F82

RX   PubMed=6965094;

RX   PubMed=7193212;

RX   PubMed=7444715;

CC   Selected for resistance to: ChEBI; CHEBI:4781; Emetine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0F81 ! CHO-tsH1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UCW 113

AC   CVCL_5T99

RX   PubMed=6965094;

RX   PubMed=7193212;

RX   PubMed=7444715;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   UCW 124

AC   CVCL_5U00

RX   PubMed=6965094;

RX   PubMed=7444715;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5T99 ! UCW 113

SX   Male

CA   Spontaneously immortalized cell line

//

ID   UCW 181

AC   CVCL_5U01

RX   PubMed=6965094;

RX   PubMed=7444715;

CC   Selected for resistance to: ChEBI; CHEBI:4781; Emetine.

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5U00 ! UCW 124

SX   Male

CA   Spontaneously immortalized cell line

//

ID   UCW 206

AC   CVCL_0F85

SY   UCW206; Asn-5; lys 65a; CHO lys 65a

RX   PubMed=618867;

RX   PubMed=6836455;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0213 ! CHO

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UCW 282

AC   CVCL_5U02

SY   UCW-282

RX   PubMed=6965094;

CC   Selected for resistance to: ChEBI; CHEBI:4781; Emetine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_L858 ! B14-150

SX   Female

CA   Transformed cell line

//

ID   UCW 296

AC   CVCL_5U03

RX   PubMed=6965094;

CC   Selected for resistance to: ChEBI; CHEBI:4781; Emetine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_L858 ! B14-150

SX   Female

CA   Transformed cell line

//

ID   UCW 56

AC   CVCL_0F83

SY   UCW56

RX   PubMed=7193212;

RX   PubMed=9732752;

CC   Selected for resistance to: ChEBI; CHEBI:4781; Emetine.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0F82 ! UCW 10

SX   Female

CA   Spontaneously immortalized cell line

//

ID   UD-PTC

AC   CVCL_W337

RX   PubMed=24567186;

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UD-SCC-1

AC   CVCL_E324

SY   UD-SCC 1; UD-SCC1; UDSCC1

DR   Cosmic; 932281

RX   PubMed=10628319;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-2

AC   CVCL_E325

SY   UD-SCC 2; UD-SCC2; UDSCC2

DR   Cosmic; 932282

DR   Cosmic; 2296311

DR   Cosmic-CLP; 1299073

DR   GDSC; 1299073

RX   PubMed=10628319;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,13

ST   D18S51: 12,17

ST   D21S11: 30,31.2

ST   D3S1358: 14,16

ST   D5S818: 10,11

ST   D7S820: 8,9

ST   D8S1179: 13,15

ST   FGA: 20,27

ST   Penta D: 9,13

ST   Penta E: 10

ST   TH01: 8,9

ST   TPOX: 8,10

ST   vWA: 15,18

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UD-SCC-3

AC   CVCL_E326

SY   UD-SCC 3; UD-SCC3

DR   Cosmic; 932283

RX   PubMed=10628319;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-4

AC   CVCL_E327

SY   UD-SCC 4; UD-SCC4

DR   Cosmic; 932284

RX   PubMed=10628319;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-5

AC   CVCL_L548

SY   UD-SCC 5; UD-SCC5

DR   Cosmic; 932285

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-6

AC   CVCL_M120

SY   UD-SCC 6; UD-SCC6

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-7A

AC   CVCL_M118

SY   UD-SCC 7A; UD-SCC7A; UD-SCC7a

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UD-SCC-7B

AC   CVCL_M119

SY   UD-SCC 7B; UD-SCC7B

DR   Cosmic; 932286

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UE6E7-16

AC   CVCL_3233

SY   UEE-16

DR   CLO; CLO_0051559

DR   JCRB; JCRB1160

DR   JCRB; NIHS0457

DR   RCB; RCB2163

RX   PubMed=15923633;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0457; true.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7T-1

AC   CVCL_8306

SY   UEET-1; Th-1; ThMSC1

DR   JCRB; JCRB1131

DR   JCRB; NIHS0446

RX   PubMed=15293342;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0446; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7T-11

AC   CVCL_3234

AS   CVCL_4070

SY   UEET-11

DR   CLO; CLO_0051555

DR   JCRB; JCRB1149

DR   JCRB; NIHS0453

DR   RCB; RCB2159

RX   PubMed=15293342;

RX   PubMed=15923633;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0453; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7T-12

AC   CVCL_3235

AS   CVCL_4071

SY   UEET-12

DR   CLO; CLO_0051557

DR   JCRB; JCRB1151

DR   JCRB; NIHS0454

DR   RCB; RCB2160

RX   PubMed=15923633;

RX   PubMed=21155951;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0454; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7T-2

AC   CVCL_3236

SY   UEET-2; Th-2

DR   CLO; CLO_0051550

DR   GEO; GSM827241

DR   JCRB; JCRB1133

DR   JCRB; NIHS0447

DR   RCB; RCB2153

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0447; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11 (JCRB)

ST   TPOX: 11 (RCB)

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7T-3

AC   CVCL_3237

SY   UEET-3; Th-3

DR   CLO; CLO_0051551

DR   JCRB; JCRB1136

DR   JCRB; NIHS0448

DR   RCB; RCB2154

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0448; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE6E7TC-4

AC   CVCL_8307

SY   UEETC-4; TdHC1

DR   BioSample; SAMN03472383

DR   JCRB; JCRB1137

DR   JCRB; NIHS0449

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Discontinued: JCRB; NIHS0449; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,14

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE7T-13

AC   CVCL_3238

SY   UET-13

DR   CLO; CLO_0051556

DR   JCRB; JCRB1154

DR   JCRB; NIHS0455

DR   RCB; RCB2161

RX   PubMed=15293342;

RX   PubMed=15923633;

RX   PubMed=21155951;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

CC   Discontinued: JCRB; NIHS0455; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE7T-9

AC   CVCL_3239

SY   UET-9

DR   CLO; CLO_0051554

DR   JCRB; JCRB1147

DR   JCRB; NIHS0452

DR   RCB; RCB2158

RX   PubMed=15923633;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

CC   Discontinued: JCRB; NIHS0452; true.

ST   Source(s): JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6F32 ! H4-1 [Human bone marrow]

SX   Female

CA   Transformed cell line

//

ID   UE8

AC   CVCL_5T89

RX   DOI=10.2108/zsj.15.277;

RX   PubMed=9358279;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   UEC-4

AC   CVCL_D808

SY   Utricular Epithelial Cell line-4

RX   PubMed=9557974;

RX   PubMed=12382283;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Conditionally immortalized cell line

//

ID   UF-1

AC   CVCL_0567

DR   MCCL; MCC:0000472

DR   Cosmic; 787485

DR   Cosmic; 975309

DR   Cosmic; 1281359

RX   PubMed=8781440;

RX   PubMed=15234573;

CC   Doubling time: 72 hours (PubMed=8781440); 96 hours (PubMed=15234573).

DI   NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UFL-AG-286

AC   CVCL_Z440

SY   UFL-Ag-286; UFL-AG286; UFL-Ag286

RX   DOI=10.1007/BF02623546;

RX   PubMed=1367489;

RX   PubMed=12623313;

RX   PubMed=15926859;

RX   PubMed=19002870;

CC   Group: Insect cell line.

OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UG3

AC   CVCL_5382

SY   UG-3

DR   Cosmic; 787486

DR   Cosmic; 975310

DR   Cosmic; 1281360

RX   PubMed=9616150;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=UG3

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UGA-CiE1

AC   CVCL_AV43

RX   PubMed=20381615;

CC   Group: Insect cell line.

OX   NCBI_TaxID=68927; ! Chrysodeixis includens

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UHG-NP

AC   CVCL_A436

SY   UHGNP

DR   Cosmic; 1109109

DR   Cosmic; 1518081

DR   Cosmic; 1526658

DR   Cosmic; 1543777

DR   GEO; GSM692876

RX   PubMed=7838528;

RX   PubMed=9516836;

RX   PubMed=11319804;

RX   PubMed=22213050;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UHG-RaC '93

AC   CVCL_5U49

RX   PubMed=7586205;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60511; Rat squamous cell carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   UHKT-42

AC   CVCL_K243

RX   PubMed=7517692;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UHKT-893

AC   CVCL_M522

RX   PubMed=23290585;

CC   Characteristics: IL6 dependent.

CC   Doubling time: 3.4-3.8 days (PubMed=23290585).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UHKT-893a

AC   CVCL_HX22

RX   PubMed=23290585;

CC   Characteristics: In contrast to the parent cell line it is no longer IL6 dependent.

CC   Doubling time: 4.2-5.4 days (PubMed=23290585).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M522 ! UHKT-893

SX   Female

CA   Cancer cell line

//

ID   UHKT-944

AC   CVCL_1K05

RX   PubMed=25600340;

CC   Characteristics: IL6 dependent.

CC   Doubling time: 65-77 hours (PubMed=23290585).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UIA-MM1

AC   CVCL_A694

SY   UIA-MM 1

DR   Cosmic; 1016277

RX   PubMed=9072005;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM2

AC   CVCL_A695

SY   UIA-MM 2

DR   Cosmic; 1016278

RX   PubMed=9072005;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM3

AC   CVCL_A696

SY   UIA-MM 3

DR   Cosmic; 1016279

RX   PubMed=9072005;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM4

AC   CVCL_M479

SY   UIA-MM 4

RX   PubMed=9072005;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM5

AC   CVCL_A697

SY   UIA-MM 5

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM6

AC   CVCL_M480

SY   UIA-MM 6

RX   PubMed=9072005;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM7

AC   CVCL_A698

SY   UIA-MM 7

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UIA-MM8

AC   CVCL_A699

SY   UIA-MM 8

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UISO-BCA-1

AC   CVCL_D249

SY   UISO BCA 1

RX   DOI=10.1016/0165-4608(96)85254-X;

RX   PubMed=1377894;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UISO-BCA-2

AC   CVCL_D250

SY   UISO BCA 2

RX   DOI=10.1016/0165-4608(96)85254-X;

RX   PubMed=1377894;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UISO-BCA-3

AC   CVCL_D251

SY   UISO BCA 3

RX   DOI=10.1016/0165-4608(96)85254-X;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UISO-BCA-4

AC   CVCL_D252

SY   UISO BCA 4

RX   DOI=10.1016/0165-4608(96)85254-X;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UISO-MCC-1

AC   CVCL_E996

SY   UISO-MCC 1; UISO-MCC1; UISO-mcc1; UISO

DR   Cosmic; 1693074

DR   Cosmic; 1699814

DR   GDSC; 1299074

RX   PubMed=8227544;

RX   PubMed=12209990;

RX   PubMed=20444890;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UISO-RS-3

AC   CVCL_Y581

RX   PubMed=2243060;

RX   PubMed=23882450;

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UIV-SL-373

AC   CVCL_AV44

RX   DOI=10.1007/BF02618358;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7109; ! Spodoptera littoralis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UIV-SL-573

AC   CVCL_AV45

RX   DOI=10.1007/BF02618358;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7109; ! Spodoptera littoralis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UIV-SL-673

AC   CVCL_AV46

RX   DOI=10.1007/BF02618358;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7109; ! Spodoptera littoralis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   UKBi005-A

AC   CVCL_1E85

SY   iLB-C-31f-r1; iLB-C-31f-R1; LB-31-1

DR   BioSamples; SAMEA4584351

DR   EBiSC; UKBi005-A

DR   ECACC; 66540008

DR   hPSCreg; UKBi005-A

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKBi006-A

AC   CVCL_1E86

SY   iLB-C-35m-R1; LB-35-1

DR   BioSamples; SAMEA2590936

DR   EBiSC; UKBi006-A

DR   ECACC; 66540004

DR   hPSCreg; UKBi006-A

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UKBi010-A

AC   CVCL_IU29

SY   iLB-DS-95f-r8

DR   BioSamples; SAMEA104008300

DR   hPSCreg; UKBi010-A

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C116573; Dravet syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKE-1

AC   CVCL_0104

SY   UKE1; GM23245

DR   BTO; BTO:0004765

DR   EFO; EFO_0006307

DR   Coriell; GM23245

DR   Cosmic; 1012055

DR   Cosmic; 1281361

DR   Cosmic; 1519161

DR   Cosmic; 1633514

DR   Cosmic; 2306996

DR   GEO; GSM1374976

RX   PubMed=10640966;

RX   PubMed=16408098;

RX   PubMed=22829968;

RX   PubMed=25485619;

CC   Characteristics: Patient had a essential thrombocythemia transformed into acute leukemia.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3407; Essential thrombocythemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKE-1/TGR

AC   CVCL_4Z62

RX   PubMed=21976548;

CC   Selected for resistance to: ChEBI; CHEBI:90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide).

DI   NCIt; C3407; Essential thrombocythemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0104 ! UKE-1

SX   Female

CA   Cancer cell line

//

ID   UKEAC-99

AC   CVCL_EJ02

RX   PubMed=12680226;

RX   PubMed=26951071;

CC   Miscellaneous: Cell line has been discarded (PubMed=26951071).

DI   NCIt; C6650; Ampulla of Vater adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKERi001-A

AC   CVCL_IT77

SY   UKERiG3G-R1-047

DR   hPSCreg; UKERi001-A

DR   BioSamples; SAMEA104010735

CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKERi004-A

AC   CVCL_IT78

SY   UKERi88H-R1-001

DR   hPSCreg; UKERi004-A

DR   BioSamples; SAMEA104010911

CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKERi005-A

AC   CVCL_IT79

SY   UKERiO3H-R1-001

DR   hPSCreg; UKERi005-A

DR   BioSamples; SAMEA104010913

CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UKERi006-A

AC   CVCL_IT80

SY   UKERi82A-R1-002

DR   hPSCreg; UKERi006-A

DR   BioSamples; SAMEA104011169

CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKF-NB-2

AC   CVCL_9902

SY   UKF-NB2

RX   CelloPub=CLPUB00123;

RX   PubMed=9201287;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-2 CDDP

AC   CVCL_9908

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9902 ! UKF-NB-2

CA   Cancer cell line

//

ID   UKF-NB-2 DOXO

AC   CVCL_9909

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9902 ! UKF-NB-2

CA   Cancer cell line

//

ID   UKF-NB-2 VCR

AC   CVCL_9910

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9902 ! UKF-NB-2

CA   Cancer cell line

//

ID   UKF-NB-2AD169

AC   CVCL_9903

RX   PubMed=9443419;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9902 ! UKF-NB-2

CA   Cancer cell line

//

ID   UKF-NB-3

AC   CVCL_9904

SY   UKF-NB3

RX   CelloPub=CLPUB00123;

RX   PubMed=9201287;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9902 ! UKF-NB-2

CA   Cancer cell line

//

ID   UKF-NB-3 CDDP

AC   CVCL_M478

RX   PubMed=17505515;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-3 DOXO

AC   CVCL_9911

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-3 VCR

AC   CVCL_9912

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-3rDOX20

AC   CVCL_9906

RX   PubMed=16142320;

RX   PubMed=19147553;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-3rVCR10

AC   CVCL_9905

RX   PubMed=16142320;

RX   PubMed=19147553;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9904 ! UKF-NB-3

CA   Cancer cell line

//

ID   UKF-NB-4

AC   CVCL_9907

SY   UKF-NB4

RX   CelloPub=CLPUB00123;

RX   PubMed=9201287;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKF-NB-4 CDDP

AC   CVCL_9913

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9907 ! UKF-NB-4

CA   Cancer cell line

//

ID   UKF-NB-4 DOXO

AC   CVCL_9914

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9907 ! UKF-NB-4

CA   Cancer cell line

//

ID   UKF-NB-4 VCR

AC   CVCL_9915

RX   PubMed=16151587;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9907 ! UKF-NB-4

CA   Cancer cell line

//

ID   UKF-NB-6

AC   CVCL_M474

CC   From: Cinatl J. Jr.; Goethe University; Frankfurt; Germany.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKF-NB-6 CDDP

AC   CVCL_M475

RX   PubMed=17505515;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M474 ! UKF-NB-6

CA   Cancer cell line

//

ID   UKF-NB-6 DOX

AC   CVCL_M476

RX   PubMed=17505515;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M474 ! UKF-NB-6

CA   Cancer cell line

//

ID   UKF-NB-6 VCR

AC   CVCL_M477

RX   PubMed=17505515;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M474 ! UKF-NB-6

CA   Cancer cell line

//

ID   UKF-Rhb-1

AC   CVCL_4Z17

RX   PubMed=19147553;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKF-Rhb-1rVCR10

AC   CVCL_4Z18

RX   PubMed=19147553;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Z17 ! UKF-Rhb-1

CA   Cancer cell line

//

ID   UKKi006-A

AC   CVCL_9S59

SY   NP0053-5; M4C4; iP-MSC D4 cB; D4-CB

DR   BioSamples; SAMEA2825851

DR   EBiSC; UKKi006-A

DR   ECACC; 66540018

DR   hPSCreg; UKKi006-A

RX   PubMed=23032973;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKKi007-A

AC   CVCL_2Z94

SY   NP0014-6; NP0014

DR   BioSamples; SAMEA2629464

DR   EBiSC; UKKi007-A

DR   ECACC; 66540001

DR   hPSCreg; UKKi007-A

RX   PubMed=22178870;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9S36 ! UKKi007-B

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKKi007-B

AC   CVCL_9S36

SY   NP0014-5

DR   BioSamples; SAMEA2698638

DR   EBiSC; UKKi007-B

DR   ECACC; 66540013

DR   hPSCreg; UKKi007-B

RX   PubMed=22178870;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2Z94 ! UKKi007-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKKi008-A

AC   CVCL_9S60

SY   NP0016-3; V240M-LQTS-3

DR   BioSamples; SAMEA4583697

DR   EBiSC; UKKi008-A

DR   ECACC; 66540015

DR   hPSCreg; UKKi008-A

RX   PubMed=24349418;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UKKi009-A

AC   CVCL_9S61

SY   NP0011-8

DR   BioSamples; SAMEA4583816

DR   EBiSC; UKKi009-A

DR   ECACC; 66540002

DR   ECACC; 66540031

DR   hPSCreg; UKKi009-A

RX   PubMed=27345990;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

CC   Discontinued: ECACC; 66540031; probable.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9S62 ! UKKi009-B

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKKi009-B

AC   CVCL_9S62

SY   NP0011-19

DR   BioSamples; SAMEA2825897

DR   EBiSC; UKKi009-B

DR   ECACC; 66540032

DR   hPSCreg; UKKi009-B

RX   PubMed=27345990;

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

DI   NCIt; C34786; Long QT syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9S61 ! UKKi009-A

SX   Female

CA   Induced pluripotent stem cell

//

ID   UKKi011-A

AC   CVCL_9S63

SY   NP0040-8

DR   BioSamples; SAMEA2774610

DR   EBiSC; UKKi011-A

DR   ECACC; 66540010

DR   hPSCreg; UKKi011-A

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UKKi012-A

AC   CVCL_9S64

SY   NP0041-17; NP0041

DR   BioSamples; SAMEA2825964

DR   EBiSC; UKKi012-A

DR   ECACC; 66540019

DR   hPSCreg; UKKi012-A

CC   From: Institute for Neurophysiology, Medical Faculty; University of Cologne; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   UKRV-Mel-01

AC   CVCL_N789

SY   UKRV-Mel-1

DR   Cosmic; 1846688

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-02

AC   CVCL_A700

SY   UKRV-Mel-2

DR   BTO; BTO:0005335

DR   Cosmic; 1846689

DR   Cosmic; 2163821

DR   ECACC; 13012436

DR   ESTDAB; ESTDAB-109

RX   PubMed=17311103;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   FGA: 20

ST   TH01: 6,9.3

ST   TPOX: 10

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-03

AC   CVCL_A701

SY   UKRV-Mel-3

DR   Cosmic; 1846690

DR   Cosmic; 2163858

DR   ECACC; 13012499

DR   ESTDAB; ESTDAB-176

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 10,11

ST   FGA: 22

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-04

AC   CVCL_A702

SY   UKRV-Mel-4

DR   BTO; BTO:0005334

DR   Cosmic; 906467

RX   PubMed=15760917;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-05

AC   CVCL_A703

SY   UKRV-Mel-5

DR   Cosmic; 906468

DR   Cosmic; 1846692

DR   ESTDAB; ESTDAB-145

RX   PubMed=15760917;

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D3S1358: 16,17

ST   D5S818: 9

ST   D7S820: 10

ST   FGA: 21

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-06a

AC   CVCL_A704

SY   UKRV-Mel-6a

DR   BTO; BTO:0005347

DR   ESTDAB; ESTDAB-111

RX   PubMed=10594685;

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 12,13

ST   FGA: 23

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A705 ! UKRV-Mel-06b

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-06b

AC   CVCL_A705

SY   UKRV-Mel-6b

DR   Cosmic; 1846693

DR   ECACC; 13012538

DR   ESTDAB; ESTDAB-222

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11 (ECACC)

ST   CSF1PO: 7,11 (ESTDAB)

ST   D13S317: 11

ST   D16S539: 9,11

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 12,13

ST   FGA: 23

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A704 ! UKRV-Mel-06a

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-07

AC   CVCL_A706

SY   UKRV-Mel-7; UKRV MEL7

DR   Cosmic; 972285

DR   Cosmic; 1846694

RX   PubMed=10594685;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-10

AC   CVCL_A707

SY   UKRV-MEL-10

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-11

AC   CVCL_A708

DR   Cosmic; 906469

RX   PubMed=15760917;

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-12

AC   CVCL_A709

DR   Cosmic; 1846696

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-12a

AC   CVCL_C659

DR   Cosmic; 1846697

DR   ESTDAB; ESTDAB-223

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 8,11

ST   FGA: 22,25

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C660 ! UKRV-Mel-12b

CA   Cancer cell line

//

ID   UKRV-Mel-12b

AC   CVCL_C660

DR   Cosmic; 1846698

DR   ESTDAB; ESTDAB-224

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 8,11

ST   FGA: 22,25

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C659 ! UKRV-Mel-12a

CA   Cancer cell line

//

ID   UKRV-Mel-13

AC   CVCL_C408

DR   Cosmic; 2163859

DR   ESTDAB; ESTDAB-179

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 11,12

ST   D3S1358: 17

ST   D5S818: 13,14

ST   D7S820: 8

ST   FGA: 23.2,24

ST   TH01: 7,9.3

ST   TPOX: 8,12

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   UKRV-Mel-14a

AC   CVCL_A710

DR   Cosmic; 2163822

DR   ESTDAB; ESTDAB-110

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   FGA: 25

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A711 ! UKRV-Mel-14b

OI   CVCL_C409 ! UKRV-Mel-14c

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-14b

AC   CVCL_A711

DR   Cosmic; 1846700

DR   ECACC; 13012529

DR   ESTDAB; ESTDAB-225

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 11

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   FGA: 25

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A710 ! UKRV-Mel-14a

OI   CVCL_C409 ! UKRV-Mel-14c

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-14c

AC   CVCL_C409

DR   Cosmic; 1846701

DR   ESTDAB; ESTDAB-226

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   FGA: 25

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A710 ! UKRV-Mel-14a

OI   CVCL_A711 ! UKRV-Mel-14b

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-15

AC   CVCL_A712

SY   UKRV-MEL-15

DR   Cosmic; 1846702

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-15a

AC   CVCL_A713

SY   UKRV-Mel-15A

DR   Cosmic; 2163819

DR   ESTDAB; ESTDAB-107

RX   PubMed=10594685;

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,12

ST   FGA: 21,22

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C397 ! UKRV-Mel-15b

OI   CVCL_C398 ! UKRV-Mel-15c

OI   CVCL_A714 ! UKRV-Mel-15d

CA   Cancer cell line

//

ID   UKRV-Mel-15b

AC   CVCL_C397

DR   Cosmic; 1846703

DR   ESTDAB; ESTDAB-227

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,12

ST   FGA: 21,22

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A713 ! UKRV-Mel-15a

OI   CVCL_C398 ! UKRV-Mel-15c

OI   CVCL_A714 ! UKRV-Mel-15d

CA   Cancer cell line

//

ID   UKRV-Mel-15c

AC   CVCL_C398

DR   ESTDAB; ESTDAB-228

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A713 ! UKRV-Mel-15a

OI   CVCL_C397 ! UKRV-Mel-15b

OI   CVCL_A714 ! UKRV-Mel-15d

CA   Cancer cell line

//

ID   UKRV-Mel-15d

AC   CVCL_A714

DR   Cosmic; 906463

DR   Cosmic; 1846704

DR   ESTDAB; ESTDAB-229

RX   PubMed=15760917;

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,12

ST   FGA: 21,22

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A713 ! UKRV-Mel-15a

OI   CVCL_C397 ! UKRV-Mel-15b

OI   CVCL_C398 ! UKRV-Mel-15c

CA   Cancer cell line

//

ID   UKRV-Mel-16

AC   CVCL_A715

DR   ESTDAB; ESTDAB-180

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D3S1358: 16

ST   D5S818: 9,12

ST   D7S820: 8

ST   FGA: 26

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-17

AC   CVCL_A716

DR   Cosmic; 2163837

DR   ECACC; 13012514

DR   ESTDAB; ESTDAB-147

RX   PubMed=10594685;

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 10,13

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 8

ST   FGA: 21,24

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-18a

AC   CVCL_A717

SY   UKRV-Mel-18A

DR   ESTDAB; ESTDAB-106

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A718 ! UKRV-Mel-18b

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-18b

AC   CVCL_A718

SY   UKRV-Mel-18B

DR   ESTDAB; ESTDAB-230

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 10,11

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 8,11

ST   FGA: 19,22

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A717 ! UKRV-Mel-18a

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-19

AC   CVCL_A719

RX   PubMed=17311103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-19a

AC   CVCL_A720

DR   Cosmic; 906464

DR   Cosmic; 1846707

RX   PubMed=10594685;

RX   PubMed=15760917;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C399 ! UKRV-Mel-19b

OI   CVCL_C400 ! UKRV-Mel-19c

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-19b

AC   CVCL_C399

DR   Cosmic; 1846708

DR   ECACC; 13012536

DR   ESTDAB; ESTDAB-231

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 11

ST   D3S1358: 14,20

ST   D5S818: 11

ST   D7S820: 11,12

ST   FGA: 22,23

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A720 ! UKRV-Mel-19a

OI   CVCL_C400 ! UKRV-Mel-19c

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-19c

AC   CVCL_C400

DR   ESTDAB; ESTDAB-232

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D3S1358: 14,20

ST   D5S818: 11

ST   D7S820: 11,12

ST   FGA: 22,23

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A720 ! UKRV-Mel-19a

OI   CVCL_C399 ! UKRV-Mel-19b

SX   Female

CA   Cancer cell line

//

ID   UKRV-Mel-20a

AC   CVCL_A721

DR   Cosmic; 1846710

RX   PubMed=17311103;

CC   Derived from metastatic site: Cutaneous/subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C401 ! UKRV-Mel-20b

OI   CVCL_C402 ! UKRV-Mel-20c

OI   CVCL_C403 ! UKRV-Mel-20e

OI   CVCL_C404 ! UKRV-Mel-20f

OI   CVCL_C405 ! UKRV-Mel-20h

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-20b

AC   CVCL_C401

DR   ESTDAB; ESTDAB-233

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A721 ! UKRV-Mel-20a

OI   CVCL_C402 ! UKRV-Mel-20c

OI   CVCL_C403 ! UKRV-Mel-20e

OI   CVCL_C404 ! UKRV-Mel-20f

OI   CVCL_C405 ! UKRV-Mel-20h

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-20c

AC   CVCL_C402

DR   Cosmic; 1846711

DR   ESTDAB; ESTDAB-234

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 12

ST   D3S1358: 16,17

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 21,25

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A721 ! UKRV-Mel-20a

OI   CVCL_C401 ! UKRV-Mel-20b

OI   CVCL_C403 ! UKRV-Mel-20e

OI   CVCL_C404 ! UKRV-Mel-20f

OI   CVCL_C405 ! UKRV-Mel-20h

SX   Male

CA   Cancer cell line

//

ID   UKRV-Mel-20e

AC   CVCL_C403

DR   Cosmic; 1846712

DR   ESTDAB; ESTDAB-235

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D3S1358: 16,17

ST   D5S818: 12,14

ST   D7S820: 10,12

ST   FGA: 21,25

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A721 ! UKRV-Mel-20a

OI   CVCL_C401 ! UKRV-Mel-20b

OI   CVCL_C402 ! UKRV-Mel-20c

OI   CVCL_C404 ! UKRV-Mel-20f

OI   CVCL_C405 ! UKRV-Mel-20h

SX   Male

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 98及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。